{
  "directed": true,
  "graph": {
    "annotation_list": {
      "Cell_Line": [
        "CG-4",
        "COS7",
        "HCN2A"
      ],
      "Method": [
        "Chromatin Immunoprecipitation",
        "Chromatography",
        "Chromatography, Affinity",
        "Chromatography, FPLC",
        "Chromatography, Gel filtration",
        "Chromatography, Ni-NTA-Sepharose",
        "Chymotrypsin Assay",
        "Co-Immunoprecipitation",
        "Comet Assay",
        "Confocal Microscopy",
        "Confocal Microscopy, Laser Scanning",
        "Deglycosylation Assay",
        "Degradation Assay, 20S Proteasomal",
        "Dephosphorylation Assay",
        "Dephosphorylation Assay, Colorimetric",
        "Dot Blot",
        "Dot blot",
        "ELISA",
        "Electron Microscopy",
        "Electron Microscopy, Immunological",
        "Enhanced Chemioluminescence visualization (ECL)",
        "F-actin depolymerization assay",
        "Immunoaffinity Chromatography",
        "Immunoblotting",
        "Immunocytochemistry",
        "Immunofluorescence",
        "Immunofluorescence Imaging",
        "Immunohistochemistry",
        "Immunoprecipitation",
        "Imunofluorescence",
        "In vitro actin-bundling assay",
        "LDH Assay",
        "Mass Spectrometry",
        "Microtubule Co-Sedimentation Assay",
        "Microtubule Sedimentation Assay",
        "Microtubule polzmerization Assay",
        "Microtubule-binding Assay",
        "Non-denaturing Fast Halo Assay",
        "Phosphorylation Assay",
        "Protease-coupled Assay",
        "Pull-down Assay",
        "Pull-down Assay, GFP",
        "Pull-down Assay, GST",
        "Pull-down Assay, His-tagged",
        "Pull-down assay, GST",
        "Pull-down assay, His-tagged",
        "RNA Interference, shRNA",
        "RNA Interference, siRNA",
        "RP HPLC",
        "RT-PCR",
        "SDS-PAGE",
        "Scanning electron microscopy (SEM)",
        "Surface Plasmon Resonance",
        "Tandem Affinity Purification, TAP",
        "Transmission electron microscopy (TEM)",
        "Ubiquitination Assay",
        "Western Blot",
        "Yeast Two-Hybrid Assay"
      ],
      "MouseStrain": [
        "K3 model with hyperphoshorylated tau resembling FTD"
      ],
      "TauIsoform": [
        "Isoform F (441 aa)"
      ]
    },
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Kristian Kolpeja",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved",
      "description": "TAU Interactions Section of TauBase",
      "licenses": "CC BY 4.0",
      "name": "Tau and Interaction Partners",
      "version": "1.2.5"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"
    },
    "path": "tau/taubase/tau_interaction_partners.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Microtubule-binding Assay": true
        }
      },
      "citation": {
        "authors": [
          "Butner KA",
          "Kirschner MW"
        ],
        "date": "1991-11-01",
        "db": "PubMed",
        "db_id": "1918161",
        "db_name": "Tau protein binds to microtubules through a flexible array of distributed weak sites.",
        "first": "Butner KA",
        "journal": "The Journal of cell biology",
        "last": "Kirschner MW",
        "pages": "717-30",
        "volume": "115"
      },
      "evidence": "Tau protein plays a role in the extension and maintenance of neuronal processes through a direct association with microtubules. It is found in the axonal microtubules of mature neurons (Binder et al ., 1985) and in the axonlike elongated neurite processes synthesized by differentiating neurons in culture. To address this issue, three different tau protein fragments were synthesized in vitro: (a) the tau protein repeat domain (residues 237 to 367); (b) the amino terminal half of tau protein (residues 1-237) ; and (c) the carboxy terminal nonrepeat domain of tau protein (residues 358 to 430). From these results, we conclude the repeat domain contributes most of the binding energy for microtubules.",
      "key": "36913c8918d3affc8ad6ee900b13cd55",
      "line": 91,
      "object": {
        "location": {
          "name": "axon cytoplasm",
          "namespace": "GO"
        }
      },
      "relation": "directlyIncreases",
      "source": 125,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ],
        "date": "1999-09-03",
        "db": "PubMed",
        "db_id": "10464280",
        "db_name": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "first": "Sontag E",
        "journal": "The Journal of biological chemistry",
        "last": "Bloom GS",
        "pages": "25490-8",
        "volume": "274"
      },
      "evidence": "ABaC binds directly to MTs through a site that encompasses its catalytic subunit and is distinct from its binding site for tau, and ABaC and tau bind to different domains on MTs.",
      "key": "8020bfb113eabb45c923c9e9133af804",
      "line": 299,
      "relation": "association",
      "source": 125,
      "target": 31
    },
    {
      "key": "b4d004f396bcdd2ccf61a2d5231cedd8",
      "relation": "hasVariant",
      "source": 125,
      "target": 127
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Microtubule-binding Assay": true
        }
      },
      "citation": {
        "authors": [
          "Butner KA",
          "Kirschner MW"
        ],
        "date": "1991-11-01",
        "db": "PubMed",
        "db_id": "1918161",
        "db_name": "Tau protein binds to microtubules through a flexible array of distributed weak sites.",
        "first": "Butner KA",
        "journal": "The Journal of cell biology",
        "last": "Kirschner MW",
        "pages": "717-30",
        "volume": "115"
      },
      "evidence": "Tau protein plays a role in the extension and maintenance of neuronal processes through a direct association with microtubules. It is found in the axonal microtubules of mature neurons (Binder et al ., 1985) and in the axonlike elongated neurite processes synthesized by differentiating neurons in culture. To address this issue, three different tau protein fragments were synthesized in vitro: (a) the tau protein repeat domain (residues 237 to 367); (b) the amino terminal half of tau protein (residues 1-237) ; and (c) the carboxy terminal nonrepeat domain of tau protein (residues 358 to 430). From these results, we conclude the repeat domain contributes most of the binding energy for microtubules.",
      "key": "2c1b68bbb69a64ef1bbd69636265f0d1",
      "line": 95,
      "relation": "positiveCorrelation",
      "source": 125,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Microtubule-binding Assay": true
        }
      },
      "citation": {
        "authors": [
          "Butner KA",
          "Kirschner MW"
        ],
        "date": "1991-11-01",
        "db": "PubMed",
        "db_id": "1918161",
        "db_name": "Tau protein binds to microtubules through a flexible array of distributed weak sites.",
        "first": "Butner KA",
        "journal": "The Journal of cell biology",
        "last": "Kirschner MW",
        "pages": "717-30",
        "volume": "115"
      },
      "evidence": "Tau protein plays a role in the extension and maintenance of neuronal processes through a direct association with microtubules. It is found in the axonal microtubules of mature neurons (Binder et al ., 1985) and in the axonlike elongated neurite processes synthesized by differentiating neurons in culture. To address this issue, three different tau protein fragments were synthesized in vitro: (a) the tau protein repeat domain (residues 237 to 367); (b) the amino terminal half of tau protein (residues 1-237) ; and (c) the carboxy terminal nonrepeat domain of tau protein (residues 358 to 430). From these results, we conclude the repeat domain contributes most of the binding energy for microtubules.",
      "key": "d257dac20c828f5179654bd64bf66450",
      "line": 96,
      "relation": "positiveCorrelation",
      "source": 125,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy": true,
          "F-actin depolymerization assay": true,
          "Immunocytochemistry": true,
          "In vitro actin-bundling assay": true,
          "Scanning electron microscopy (SEM)": true,
          "Transmission electron microscopy (TEM)": true
        },
        "Species": {
          "10090": true,
          "7215": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Elson-Schwab I",
          "Feany MB",
          "Fulga TA",
          "Hyman BT",
          "Khurana V",
          "Spires TL",
          "Steinhilb ML"
        ],
        "date": "2007-02-01",
        "db": "PubMed",
        "db_id": "17187063",
        "db_name": "Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.",
        "first": "Fulga TA",
        "journal": "Nature cell biology",
        "last": "Feany MB",
        "pages": "139-48",
        "volume": "9"
      },
      "evidence": "These results are consistent with previous in vitro studies and indicate that tau induces actin-filament bundling in vitro and F-actin accumulation in vivo, most likely through a direct interaction with F-actin.For genetic analysis, we selected a line of tauV337M-expressing flies that has a moderate rough eye and is a good substrate for genetic modification. Coexpressing an actin transgene (UAS–Act5C–EGFP;GMR– GAL4 driver) markedly enhanced tauV337M-induced toxicity.",
      "key": "9d9362d4240cb8fbadfc623265e2579e",
      "line": 112,
      "relation": "directlyIncreases",
      "source": 125,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy": true,
          "F-actin depolymerization assay": true,
          "Immunocytochemistry": true,
          "In vitro actin-bundling assay": true,
          "Scanning electron microscopy (SEM)": true,
          "Transmission electron microscopy (TEM)": true
        },
        "Species": {
          "10090": true,
          "7215": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Elson-Schwab I",
          "Feany MB",
          "Fulga TA",
          "Hyman BT",
          "Khurana V",
          "Spires TL",
          "Steinhilb ML"
        ],
        "date": "2007-02-01",
        "db": "PubMed",
        "db_id": "17187063",
        "db_name": "Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.",
        "first": "Fulga TA",
        "journal": "Nature cell biology",
        "last": "Feany MB",
        "pages": "139-48",
        "volume": "9"
      },
      "evidence": "These results are consistent with previous in vitro studies and indicate that tau induces actin-filament bundling in vitro and F-actin accumulation in vivo, most likely through a direct interaction with F-actin.For genetic analysis, we selected a line of tauV337M-expressing flies that has a moderate rough eye and is a good substrate for genetic modification. Coexpressing an actin transgene (UAS–Act5C–EGFP;GMR– GAL4 driver) markedly enhanced tauV337M-induced toxicity.",
      "key": "d89577ec35c7bf7493852b898f806bc3",
      "line": 113,
      "relation": "directlyIncreases",
      "source": 125,
      "target": 23
    },
    {
      "key": "530bc2fcb5d4b1c79dc51a5a0fe4b919",
      "relation": "partOf",
      "source": 125,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy": true,
          "F-actin depolymerization assay": true,
          "Immunocytochemistry": true,
          "In vitro actin-bundling assay": true,
          "Scanning electron microscopy (SEM)": true,
          "Transmission electron microscopy (TEM)": true
        },
        "Species": {
          "10090": true,
          "7215": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Elson-Schwab I",
          "Feany MB",
          "Fulga TA",
          "Hyman BT",
          "Khurana V",
          "Spires TL",
          "Steinhilb ML"
        ],
        "date": "2007-02-01",
        "db": "PubMed",
        "db_id": "17187063",
        "db_name": "Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.",
        "first": "Fulga TA",
        "journal": "Nature cell biology",
        "last": "Feany MB",
        "pages": "139-48",
        "volume": "9"
      },
      "evidence": "These results are consistent with previous in vitro studies and indicate that tau induces actin-filament bundling in vitro and F-actin accumulation in vivo, most likely through a direct interaction with F-actin.For genetic analysis, we selected a line of tauV337M-expressing flies that has a moderate rough eye and is a good substrate for genetic modification. Coexpressing an actin transgene (UAS–Act5C–EGFP;GMR– GAL4 driver) markedly enhanced tauV337M-induced toxicity.",
      "key": "978926316f35199038e911946facaa24",
      "line": 114,
      "relation": "increases",
      "source": 125,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Aamodt EJ",
          "Williams RC Jr"
        ],
        "date": "1984-12-04",
        "db": "PubMed",
        "db_id": "6543144",
        "db_name": "Microtubule-associated proteins connect microtubules and neurofilaments in vitro.",
        "first": "Aamodt EJ",
        "journal": "Biochemistry",
        "last": "Williams RC Jr",
        "pages": "6023-31",
        "volume": "23"
      },
      "evidence": "The resulting MAP-decorated neurofilaments formed a viscous complex with microtubules, showing that some component of the MAPs mediated the association between the two filamentous organelles.",
      "key": "44e4f0178fb21041195e8d85304f89fb",
      "line": 129,
      "relation": "association",
      "source": 125,
      "target": 32
    },
    {
      "key": "5388826487023ba0e37cd7fd9f727316",
      "relation": "partOf",
      "source": 125,
      "target": 43
    },
    {
      "key": "27e9bee72dd577c70598500f0d691556",
      "relation": "partOf",
      "source": 125,
      "target": 37
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Astrocytes": true,
          "Axons": true,
          "Dendrites": true,
          "Polyribosomes": true
        },
        "Method": {
          "Immunoblotting": true,
          "Immunohistochemistry": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Papasozomenos SC"
        ],
        "date": "1987-01-01",
        "db": "PubMed",
        "db_id": "2446784",
        "db_name": "Phosphorylation determines two distinct species of Tau in the central nervous system.",
        "first": "Papasozomenos SC",
        "journal": "Cell motility and the cytoskeleton",
        "last": "Binder LI",
        "pages": "210-26",
        "volume": "8"
      },
      "evidence": "This antibody binds only to tau and localizes along microtubules in axons, somata, dendrites, and astrocytes and on ribosomes (polysomes) without phosphatase pretreatment.",
      "key": "4510e63f1849eab75ee9a79a19e8c5eb",
      "line": 141,
      "relation": "association",
      "source": 125,
      "target": 37
    },
    {
      "key": "b55193aa0fda6319970bfbd4e6f7e0fb",
      "relation": "partOf",
      "source": 125,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunoaffinity Chromatography": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Microtubule Sedimentation Assay": true,
          "Pull-down Assay": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Neufield KD",
          "Paudel HK",
          "Qureshi HY",
          "Sobue K",
          "Sun W"
        ],
        "date": "2002-04-05",
        "db": "PubMed",
        "db_id": "11812770",
        "db_name": "Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.",
        "first": "Sun W",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "11933-40",
        "volume": "277"
      },
      "evidence": "GSK3Beta may directly bind to tau within a GSK3Beta-tau complex.To identify the GSK3Beta-binding region within tau, we constructed three tau deletion mutants: R-tau-(1–244) containing the N-terminal projection domain, R-tau-(245–369) containing the microtubule-binding region, and R-tau-(245–441) containing both the microtubule-binding region and the C-terminal tail. We evaluated the binding of these mutants and wild-type R-tau with GST-GSK3Beta by the GST pull-down assay. GSK3Beta bound to wild type (Fig. 5B) and R-tau-(1–244) (Fig. 5C) but not R-tau-(245–369) (Fig. 5D) and R-tau-(245–441) (Fig.5E). These data demonstrate that GSK3Beta binds to the Nterminal projection domain of tau.",
      "key": "b4d7db44cf35f41923406b5b7f9343c7",
      "line": 164,
      "relation": "positiveCorrelation",
      "source": 125,
      "target": 57
    },
    {
      "key": "1e0ee28ba66fc0ad352a46d8cc5b59ca",
      "relation": "hasVariant",
      "source": 125,
      "target": 126
    },
    {
      "key": "740acd60993c53a82ffe1e9bc2854919",
      "relation": "hasVariant",
      "source": 125,
      "target": 128
    },
    {
      "key": "dc4e548b5c6139ccbdb7961366bc5d05",
      "relation": "hasVariant",
      "source": 125,
      "target": 129
    },
    {
      "key": "d845e71b421460b0250f675dab5197ff",
      "relation": "partOf",
      "source": 125,
      "target": 55
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true,
          "oligodendrocyte": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        }
      },
      "citation": {
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ],
        "date": "2008-10-01",
        "db": "PubMed",
        "db_id": "18680553",
        "db_name": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "first": "Belkadi A",
        "journal": "Journal of neurochemistry",
        "last": "LoPresti P",
        "pages": "351-60",
        "volume": "107"
      },
      "evidence": "Furthermore, Tau binds Fyn both in neuronal and oligodendroglial cells (Brandt et al. 1995; Klein et al.2002), and Fyn phosphorylates Tau in neuronal cells (Lee et al. 2004). The main Fyn SH3 domain-binding PXXP motif (Pro, Lys, Ser, Pro) in adult rat Tau is at the residues 223-226 (Kosik et al. 1989; Lee et al. 1998).",
      "key": "a1f7f35b836e57a30ec4b967e31c5d89",
      "line": 177,
      "relation": "increases",
      "source": 125,
      "target": 55
    },
    {
      "annotations": {
        "Cell": {
          "oligodendrocyte": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ],
        "date": "2008-10-01",
        "db": "PubMed",
        "db_id": "18680553",
        "db_name": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "first": "Belkadi A",
        "journal": "Journal of neurochemistry",
        "last": "LoPresti P",
        "pages": "351-60",
        "volume": "107"
      },
      "evidence": "Here we demonstrate that the Tau-Fyn interaction has a role in developmental myelination. CG-4 cells were stably transfected with control and experimental truncated Tau and transplanted in the brain and spinal cord of the md rats. In the brain, experimental cells have a severe defect in their ability to extend cellular processes and form myelin; in the spinal cord the cells extend cellular processes but the extent of myelination rostral and caudal to the injection site was decreased compared to control. Cultured experimental cells display shorter cellular process length. In addition experimental cells have Fyn largely in the cell body, whereas control cells distribute Fyn both in the cell body and the processes. Taken together these results demonstrate a direct effect of Tau in OLGs in in vivo myelination.",
      "key": "5718a594e686c281a3027cfaf930249e",
      "line": 197,
      "relation": "increases",
      "source": 125,
      "target": 55
    },
    {
      "key": "064f60bbd4e86ec0d71e89e733af2e71",
      "relation": "hasVariant",
      "source": 125,
      "target": 131
    },
    {
      "annotations": {
        "Cell": {
          "oligodendrocyte": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ],
        "date": "2008-10-01",
        "db": "PubMed",
        "db_id": "18680553",
        "db_name": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "first": "Belkadi A",
        "journal": "Journal of neurochemistry",
        "last": "LoPresti P",
        "pages": "351-60",
        "volume": "107"
      },
      "evidence": "Here we demonstrate that the Tau-Fyn interaction has a role in developmental myelination. CG-4 cells were stably transfected with control and experimental truncated Tau and transplanted in the brain and spinal cord of the md rats. In the brain, experimental cells have a severe defect in their ability to extend cellular processes and form myelin; in the spinal cord the cells extend cellular processes but the extent of myelination rostral and caudal to the injection site was decreased compared to control. Cultured experimental cells display shorter cellular process length. In addition experimental cells have Fyn largely in the cell body, whereas control cells distribute Fyn both in the cell body and the processes. Taken together these results demonstrate a direct effect of Tau in OLGs in in vivo myelination.",
      "key": "ee8622ced2ea5bd3cb2e8e89307e6de6",
      "line": 200,
      "relation": "association",
      "source": 125,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "c6055b91b82bdc90fd6bc970367fe87d",
      "line": 214,
      "relation": "association",
      "source": 125,
      "target": 155
    },
    {
      "key": "0c9ea17dfc7627943feab312718fe3fe",
      "relation": "partOf",
      "source": 125,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "fd339fdbf99517112419c68f9f73a79d",
      "line": 218,
      "relation": "isA",
      "source": 125,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "27a7b0a755f08f93de86244d6399686e",
      "line": 219,
      "relation": "association",
      "source": 125,
      "target": 149
    },
    {
      "key": "49baf66d494d5d28be594ba005ee0725",
      "relation": "partOf",
      "source": 125,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "c9e8a486d0a67b18d1f8dff066d22a8a",
      "line": 222,
      "relation": "isA",
      "source": 125,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "5c15c3cbe60dba4774afede720d14512",
      "line": 224,
      "relation": "association",
      "source": 125,
      "target": 117
    },
    {
      "key": "23122ba321d5c7ebd3d6f205ed7c20a6",
      "relation": "partOf",
      "source": 125,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "931aeb8b947378814582c168e11b2dbb",
      "line": 225,
      "relation": "association",
      "source": 125,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "7e5a2b266d78ab2cb33c2b4523931c1e",
      "line": 229,
      "relation": "association",
      "source": 125,
      "target": 144
    },
    {
      "key": "088e82d3eca7b25d4fe4bf3218642dba",
      "relation": "partOf",
      "source": 125,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "ccf8345cfbb461f1f32860d8df2a8074",
      "line": 232,
      "relation": "isA",
      "source": 125,
      "target": 66
    },
    {
      "key": "ca589e31522afb5c95cb25d752c1c90c",
      "relation": "partOf",
      "source": 125,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ],
        "date": "1999-09-03",
        "db": "PubMed",
        "db_id": "10464280",
        "db_name": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "first": "Sontag E",
        "journal": "The Journal of biological chemistry",
        "last": "Bloom GS",
        "pages": "25490-8",
        "volume": "274"
      },
      "evidence": "ABaC binds directly to MTs through a site that encompasses its catalytic subunit and is distinct from its binding site for tau, and ABaC and tau bind to different domains on MTs.",
      "key": "b24382f62d6dd2230899ca1ed6e30610",
      "line": 300,
      "relation": "increases",
      "source": 125,
      "target": 41
    },
    {
      "key": "63a28ba2366c9bc781f077d75094e9d3",
      "relation": "partOf",
      "source": 125,
      "target": 71
    },
    {
      "key": "5ca30cccc695fc10072e3879e21516b8",
      "relation": "partOf",
      "source": 125,
      "target": 49
    },
    {
      "key": "b5ef526ab5a17da51fd96bb875e02aac",
      "relation": "hasVariant",
      "source": 125,
      "target": 130
    },
    {
      "key": "0309b11a2fd9a6efc80893e9f528772e",
      "relation": "partOf",
      "source": 125,
      "target": 63
    },
    {
      "key": "a67df7a62742a557664a7a71e385dc7f",
      "relation": "hasVariant",
      "source": 125,
      "target": 141
    },
    {
      "key": "0e0ec3a09e8df8d002dd41b58ef30e38",
      "relation": "hasVariant",
      "source": 125,
      "target": 133
    },
    {
      "key": "66af6af91bc9c8705b42c7338defb2de",
      "relation": "hasVariant",
      "source": 125,
      "target": 138
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy, Laser Scanning": true,
          "Immunocytochemistry": true,
          "Mass Spectrometry": true,
          "Pull-down Assay, GFP": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        }
      },
      "citation": {
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "Sebö-Lemke Z",
          "Weissmann C"
        ],
        "date": "2011-02-21",
        "db": "PubMed",
        "db_id": "21339331",
        "db_name": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "first": "Gauthier-Kemper A",
        "journal": "The Journal of cell biology",
        "last": "Brandt R",
        "pages": "647-61",
        "volume": "192"
      },
      "evidence": "The quantification of all immunoreactive bands revealed that the R406W mutation exhibits a decreased phosphorylation at T205, T212, and the PHF1 epitope (S396/S404; reductions of 40–65%) as compared with wt tau, whereas other sites were not affected or only slightly affected (T181, S199, S214, and S262).",
      "key": "ec33133b2af7dbcd490c589f6802fe05",
      "line": 886,
      "relation": "causesNoChange",
      "source": 125,
      "target": 138
    },
    {
      "key": "deebc6415a1d74c0501fe5fae6165d64",
      "relation": "hasVariant",
      "source": 125,
      "target": 136
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy, Laser Scanning": true,
          "Immunocytochemistry": true,
          "Mass Spectrometry": true,
          "Pull-down Assay, GFP": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        }
      },
      "citation": {
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "Sebö-Lemke Z",
          "Weissmann C"
        ],
        "date": "2011-02-21",
        "db": "PubMed",
        "db_id": "21339331",
        "db_name": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "first": "Gauthier-Kemper A",
        "journal": "The Journal of cell biology",
        "last": "Brandt R",
        "pages": "647-61",
        "volume": "192"
      },
      "evidence": "The quantification of all immunoreactive bands revealed that the R406W mutation exhibits a decreased phosphorylation at T205, T212, and the PHF1 epitope (S396/S404; reductions of 40–65%) as compared with wt tau, whereas other sites were not affected or only slightly affected (T181, S199, S214, and S262).",
      "key": "4a7ae7e6ebe0f5daa30da89e6f40e5b4",
      "line": 888,
      "relation": "causesNoChange",
      "source": 125,
      "target": 136
    },
    {
      "key": "e9808fec4b7de2906ee3a9ab9d1ef29e",
      "relation": "hasVariant",
      "source": 125,
      "target": 137
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy, Laser Scanning": true,
          "Immunocytochemistry": true,
          "Mass Spectrometry": true,
          "Pull-down Assay, GFP": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        }
      },
      "citation": {
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "Sebö-Lemke Z",
          "Weissmann C"
        ],
        "date": "2011-02-21",
        "db": "PubMed",
        "db_id": "21339331",
        "db_name": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "first": "Gauthier-Kemper A",
        "journal": "The Journal of cell biology",
        "last": "Brandt R",
        "pages": "647-61",
        "volume": "192"
      },
      "evidence": "The quantification of all immunoreactive bands revealed that the R406W mutation exhibits a decreased phosphorylation at T205, T212, and the PHF1 epitope (S396/S404; reductions of 40–65%) as compared with wt tau, whereas other sites were not affected or only slightly affected (T181, S199, S214, and S262).",
      "key": "6262cbfc8ad694d9c2eae410d93b383e",
      "line": 889,
      "relation": "causesNoChange",
      "source": 125,
      "target": 137
    },
    {
      "key": "5ebca45c8ab3a4129bebcc5ba2747544",
      "relation": "partOf",
      "source": 125,
      "target": 52
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Degradation Assay, 20S Proteasomal": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ],
        "date": "2007-12-21",
        "db": "PubMed",
        "db_id": "17954934",
        "db_name": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "first": "Elliott E",
        "journal": "The Journal of biological chemistry",
        "last": "Ginzburg I",
        "pages": "37276-84",
        "volume": "282"
      },
      "evidence": "BAG-1, an Hsp70/Hsc70 binding partner, has been implicated as a mediator of neuronal function. In this work we show that BAG-1 associates with Tau protein in an Hsc70-dependent manner. Overexpression of BAG-1 induced an increase in Tau levels, which is shown to be due to an inhibition of protein degradation.",
      "key": "542401670da47145b1d85b4e1f315b30",
      "line": 449,
      "relation": "isA",
      "source": 125,
      "target": 52
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Degradation Assay, 20S Proteasomal": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ],
        "date": "2007-12-21",
        "db": "PubMed",
        "db_id": "17954934",
        "db_name": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "first": "Elliott E",
        "journal": "The Journal of biological chemistry",
        "last": "Ginzburg I",
        "pages": "37276-84",
        "volume": "282"
      },
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "key": "f5d9045e7541b4345da8850baa946887",
      "line": 459,
      "relation": "positiveCorrelation",
      "source": 125,
      "target": 104
    },
    {
      "key": "b7b579ecf563c224aa323bc2dd184b60",
      "relation": "partOf",
      "source": 125,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Electron Microscopy": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ],
        "date": "1993-06-01",
        "db": "PubMed",
        "db_id": "8391280",
        "db_name": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "first": "Morishima-Kawashima M",
        "journal": "Neuron",
        "last": "Ihara Y",
        "pages": "1151-60",
        "volume": "10"
      },
      "evidence": "We show here for the first time that the N-terminal projection domain of tau binds to the C-terminus of the p150 subunit of the dynactin complex. The sequences of tau encoded by exons 1 and 4, which lie at the tip of the N-terminal projection domain, interact with the C-terminal region of p150.",
      "key": "a94ec4f4f80b16d46e6f5acf3d9cf5d3",
      "line": 493,
      "relation": "isA",
      "source": 125,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Electron Microscopy": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ],
        "date": "1993-06-01",
        "db": "PubMed",
        "db_id": "8391280",
        "db_name": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "first": "Morishima-Kawashima M",
        "journal": "Neuron",
        "last": "Ihara Y",
        "pages": "1151-60",
        "volume": "10"
      },
      "evidence": "Tau and dynactin show extensive colocalization, and the attachment of the dynactin complex to microtubules is enhanced by tau.",
      "key": "1c3863e16baf8d701684fbaa29c42304",
      "line": 502,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 125,
      "target": 159
    },
    {
      "key": "13995767904f2c704ae2c85b287ed5eb",
      "relation": "hasVariant",
      "source": 125,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "ELISA": true,
          "Immunocytochemistry": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true
        }
      },
      "citation": {
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ],
        "date": "1999-06-24",
        "db": "PubMed",
        "db_id": "10391244",
        "db_name": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "first": "Lu PJ",
        "journal": "Nature",
        "last": "Lu KP",
        "pages": "784-8",
        "volume": "399"
      },
      "evidence": "To examine whether Pin1 affects the ability of pTau to bind microtubules, we generated pTau in vitro using purified Cdc2 (refs 17, 18), and determined its ability to bind Taxol-stabilized microtubules with or without Pin1. Although Cdc2 phosphorylation disrupted the ability of tau to bind microtubules; the binding was fully restored by preincubation with Pin1 (Fig. 5a). Furthermore, Pin1 was detected in the fraction of tau-bound microtubules (Fig. 5a). However, no Pin1 was detected in the microtubule fraction if pTau was not added (Fig. 5a), indicating that Pin1 does not bind microtubules directly. Thus, Pin1 binds pTau and restores its ability to bind microtubules.",
      "key": "f3a7fb56ef1eb4529edcb9fb880e2c37",
      "line": 574,
      "relation": "negativeCorrelation",
      "source": 125,
      "subject": {
        "effect": {
          "name": "microtubule binding",
          "namespace": "GO"
        },
        "modifier": "Activity"
      },
      "target": 140
    },
    {
      "key": "e2db2898586010f0aa2d1d4ec1efba00",
      "relation": "partOf",
      "source": 125,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "7e89ee3e7c0a11f8f26975c440ae9183",
      "line": 636,
      "relation": "isA",
      "source": 125,
      "target": 54
    },
    {
      "key": "ad1be30c6afe7368ba26966e10eeeefe",
      "relation": "hasVariant",
      "source": 125,
      "target": 132
    },
    {
      "key": "9e938dd8a4d676ac7b555922b68d8a48",
      "relation": "partOf",
      "source": 125,
      "target": 50
    },
    {
      "key": "181696a30cf7f6b4b05d338cf6667dac",
      "relation": "partOf",
      "source": 125,
      "target": 68
    },
    {
      "key": "66a0ff7d5f221b0d68cbc5dbafef81f5",
      "relation": "hasVariant",
      "source": 125,
      "target": 134
    },
    {
      "key": "55a0cc9e48187fc8d6cfd504159557bb",
      "relation": "hasVariant",
      "source": 125,
      "target": 135
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Previous work showed that Hsp90 inhibition with 17-AAG reduced phospho-tau levels in vivo (16, 23). We speculated that Cdc37 might modulate Hsp90 inhibitor efficacy for phosphotau. M17 cells were transfected with Cdc37 siRNA and then treated with 1 μM 17-AAG for 24 h. Indeed, reducing Cdc37 synergized with Hsp90 inhibition to reduce tau levels more potently than either condition alone (Fig. 6A).",
      "key": "7dfc1eec0bb9b92981a59c276a38e2b7",
      "line": 699,
      "relation": "negativeCorrelation",
      "source": 125,
      "subject": {
        "modifier": "Degradation"
      },
      "target": 47
    },
    {
      "key": "172df8741d7e7079bda2fed985b07303",
      "relation": "partOf",
      "source": 125,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ],
        "date": "1990-09-03",
        "db": "PubMed",
        "db_id": "2123288",
        "db_name": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "first": "Padilla R",
        "journal": "Molecular and cellular biochemistry",
        "last": "Avila J",
        "pages": "35-41",
        "volume": "97"
      },
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "key": "581d0f5350cdaf15c9d515390cd81dd3",
      "line": 732,
      "relation": "isA",
      "source": 125,
      "target": 46
    },
    {
      "key": "b139468cda1e9f0cce11d070c9b5fbbf",
      "relation": "partOf",
      "source": 125,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ],
        "date": "1990-09-03",
        "db": "PubMed",
        "db_id": "2123288",
        "db_name": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "first": "Padilla R",
        "journal": "Molecular and cellular biochemistry",
        "last": "Avila J",
        "pages": "35-41",
        "volume": "97"
      },
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "key": "e66f23545c437292431bb68e2f1bb25d",
      "line": 735,
      "relation": "negativeCorrelation",
      "source": 125,
      "subject": {
        "modifier": "Activity"
      },
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ],
        "date": "1990-09-03",
        "db": "PubMed",
        "db_id": "2123288",
        "db_name": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "first": "Padilla R",
        "journal": "Molecular and cellular biochemistry",
        "last": "Avila J",
        "pages": "35-41",
        "volume": "97"
      },
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "key": "d1217c7db968deac87bac23295017185",
      "line": 736,
      "relation": "increases",
      "source": 125,
      "subject": {
        "modifier": "Activity"
      },
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Affinity": true,
          "Chromatography, FPLC": true,
          "Phosphorylation Assay": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Baudier J",
          "Cole RD"
        ],
        "date": "1988-04-25",
        "db": "PubMed",
        "db_id": "2833519",
        "db_name": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "first": "Baudier J",
        "journal": "The Journal of biological chemistry",
        "last": "Cole RD",
        "pages": "5876-83",
        "volume": "263"
      },
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+ concentration to the 100 μM range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "key": "7e806b213851bdee72d04cc48d25b441",
      "line": 753,
      "relation": "association",
      "source": 125,
      "target": 152
    },
    {
      "key": "4af0b8970414a5f0ad7a765cecf82e87",
      "relation": "partOf",
      "source": 125,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Affinity": true,
          "Chromatography, FPLC": true,
          "Phosphorylation Assay": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Baudier J",
          "Cole RD"
        ],
        "date": "1988-04-25",
        "db": "PubMed",
        "db_id": "2833519",
        "db_name": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "first": "Baudier J",
        "journal": "The Journal of biological chemistry",
        "last": "Cole RD",
        "pages": "5876-83",
        "volume": "263"
      },
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+ concentration to the 100 μM range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "key": "1fd0b688820352ddca8aecb0e2d79502",
      "line": 756,
      "relation": "isA",
      "source": 125,
      "target": 69
    },
    {
      "key": "21bb94cbc2c95d93a5057eece5fc30f4",
      "relation": "partOf",
      "source": 125,
      "target": 79
    },
    {
      "key": "fb2e6ce1db14e0328c5b6de039f45d2c",
      "relation": "partOf",
      "source": 125,
      "target": 58
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, FPLC": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ],
        "date": "2003-04-11",
        "db": "PubMed",
        "db_id": "12551948",
        "db_name": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "first": "Agarwal-Mawal A",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "12722-8",
        "volume": "278"
      },
      "evidence": "These observations suggested that 14-3-3zeta may be bound to GSK3Beta and/or tau within brain microtubules and may be a component of tau phosphorylation complex.Therefore, 14-3-3 must be the central molecule that holds tau and GSK3Beta within the complex. Indeed, FLAG-tau co-immunoprecipitated with HA-GSK3Beta from cells overexpressing FLAG-tau and HA-GSK3Beta only when these cells also overexpressed Xpress-14-3-3zeta (Fig. 6A, lanes 8 and 9), indicating that GSK3Beta associates with tau only in the presence of 14-3-3zeta. As discussed above, 14-3-3zeta binds to tau (36) and GSK3Beta (Fig. 5) directly. Taken together, these observations indicated that 14-3-3zeta connects GSK3Beta to tau in vivo.",
      "key": "acc1ec9945eaa1767a855723a02bf1f1",
      "line": 847,
      "relation": "isA",
      "source": 125,
      "target": 58
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, FPLC": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ],
        "date": "2003-04-11",
        "db": "PubMed",
        "db_id": "12551948",
        "db_name": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "first": "Agarwal-Mawal A",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "12722-8",
        "volume": "278"
      },
      "evidence": "These observations suggested that 14-3-3zeta may be bound to GSK3Beta and/or tau within brain microtubules and may be a component of tau phosphorylation complex.Therefore, 14-3-3 must be the central molecule that holds tau and GSK3Beta within the complex. Indeed, FLAG-tau co-immunoprecipitated with HA-GSK3Beta from cells overexpressing FLAG-tau and HA-GSK3Beta only when these cells also overexpressed Xpress-14-3-3zeta (Fig. 6A, lanes 8 and 9), indicating that GSK3Beta associates with tau only in the presence of 14-3-3zeta. As discussed above, 14-3-3zeta binds to tau (36) and GSK3Beta (Fig. 5) directly. Taken together, these observations indicated that 14-3-3zeta connects GSK3Beta to tau in vivo.",
      "key": "877f18dc268ad283f1bef4ba06008326",
      "line": 844,
      "relation": "association",
      "source": 125,
      "target": 158
    },
    {
      "key": "706ef101cb24bd226ca7ca8bfd47fca9",
      "relation": "hasVariant",
      "source": 125,
      "target": 139
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy, Laser Scanning": true,
          "Immunocytochemistry": true,
          "Mass Spectrometry": true,
          "Pull-down Assay, GFP": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        }
      },
      "citation": {
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "Sebö-Lemke Z",
          "Weissmann C"
        ],
        "date": "2011-02-21",
        "db": "PubMed",
        "db_id": "21339331",
        "db_name": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "first": "Gauthier-Kemper A",
        "journal": "The Journal of cell biology",
        "last": "Brandt R",
        "pages": "647-61",
        "volume": "192"
      },
      "evidence": "The quantification of all immunoreactive bands revealed that the R406W mutation exhibits a decreased phosphorylation at T205, T212, and the PHF1 epitope (S396/S404; reductions of 40–65%) as compared with wt tau, whereas other sites were not affected or only slightly affected (T181, S199, S214, and S262).",
      "key": "48fb85f121fec031f3a9422fdc4e6d31",
      "line": 887,
      "relation": "causesNoChange",
      "source": 125,
      "target": 139
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy, Laser Scanning": true,
          "Immunocytochemistry": true,
          "Mass Spectrometry": true,
          "Pull-down Assay, GFP": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        }
      },
      "citation": {
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "Sebö-Lemke Z",
          "Weissmann C"
        ],
        "date": "2011-02-21",
        "db": "PubMed",
        "db_id": "21339331",
        "db_name": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "first": "Gauthier-Kemper A",
        "journal": "The Journal of cell biology",
        "last": "Brandt R",
        "pages": "647-61",
        "volume": "192"
      },
      "evidence": "The data suggest that tau’s membrane association causes retention of tau in the tip of neurites, which is compromised by the R406W mutation. Also, after BAPTA treatment, the difference in the retention of wt tau and R406W tau was abolished (Fig. 9 D), which again suggests that tau trapping is caused by an interaction with AnxA2 at the membrane.",
      "key": "7af0f6bf06400d10cf7ff0f0a4d75ea0",
      "line": 896,
      "relation": "association",
      "source": 125,
      "target": 103
    },
    {
      "key": "29dfa062fcc2424e5aac30f09d79aa8b",
      "relation": "partOf",
      "source": 125,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy, Laser Scanning": true,
          "Immunocytochemistry": true,
          "Mass Spectrometry": true,
          "Pull-down Assay, GFP": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        }
      },
      "citation": {
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "Sebö-Lemke Z",
          "Weissmann C"
        ],
        "date": "2011-02-21",
        "db": "PubMed",
        "db_id": "21339331",
        "db_name": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "first": "Gauthier-Kemper A",
        "journal": "The Journal of cell biology",
        "last": "Brandt R",
        "pages": "647-61",
        "volume": "192"
      },
      "evidence": "The data suggest that tau’s membrane association causes retention of tau in the tip of neurites, which is compromised by the R406W mutation. Also, after BAPTA treatment, the difference in the retention of wt tau and R406W tau was abolished (Fig. 9 D), which again suggests that tau trapping is caused by an interaction with AnxA2 at the membrane.",
      "key": "d6bac0392e66a98a35bb991ebb9d95ec",
      "line": 898,
      "relation": "isA",
      "source": 125,
      "target": 51
    },
    {
      "key": "a99b18fa47e2eb3cf116b74ca3e4474e",
      "relation": "partOf",
      "source": 125,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Non-denaturing Fast Halo Assay": true
        }
      },
      "citation": {
        "authors": [
          "Bonnefoy E",
          "Buée L",
          "Bégard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ],
        "date": "2011-02-11",
        "db": "PubMed",
        "db_id": "21131359",
        "db_name": "Nuclear tau, a key player in neuronal DNA protection.",
        "first": "Sultan A",
        "journal": "The Journal of biological chemistry",
        "last": "Galas MC",
        "pages": "4566-75",
        "volume": "286"
      },
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "key": "9df0d71fec54271bcfb3ec4cfcabfba4",
      "line": 938,
      "relation": "isA",
      "source": 125,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Non-denaturing Fast Halo Assay": true
        }
      },
      "citation": {
        "authors": [
          "Bonnefoy E",
          "Buée L",
          "Bégard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ],
        "date": "2011-02-11",
        "db": "PubMed",
        "db_id": "21131359",
        "db_name": "Nuclear tau, a key player in neuronal DNA protection.",
        "first": "Sultan A",
        "journal": "The Journal of biological chemistry",
        "last": "Galas MC",
        "pages": "4566-75",
        "volume": "286"
      },
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "key": "104eabe3d4fb26e3bb87f2d74e819732",
      "line": 937,
      "relation": "association",
      "source": 125,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Non-denaturing Fast Halo Assay": true
        }
      },
      "citation": {
        "authors": [
          "Bonnefoy E",
          "Buée L",
          "Bégard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ],
        "date": "2011-02-11",
        "db": "PubMed",
        "db_id": "21131359",
        "db_name": "Nuclear tau, a key player in neuronal DNA protection.",
        "first": "Sultan A",
        "journal": "The Journal of biological chemistry",
        "last": "Galas MC",
        "pages": "4566-75",
        "volume": "286"
      },
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "key": "022253171a1e4855b26990b36b088b3a",
      "line": 942,
      "relation": "negativeCorrelation",
      "source": 125,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Aamodt EJ",
          "Williams RC Jr"
        ],
        "date": "1984-12-04",
        "db": "PubMed",
        "db_id": "6543144",
        "db_name": "Microtubule-associated proteins connect microtubules and neurofilaments in vitro.",
        "first": "Aamodt EJ",
        "journal": "Biochemistry",
        "last": "Williams RC Jr",
        "pages": "6023-31",
        "volume": "23"
      },
      "evidence": "The resulting MAP-decorated neurofilaments formed a viscous complex with microtubules, showing that some component of the MAPs mediated the association between the two filamentous organelles.",
      "key": "c45163c16c3abeec4191f2ec3b406e3b",
      "line": 130,
      "relation": "association",
      "source": 31,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ],
        "date": "1999-09-03",
        "db": "PubMed",
        "db_id": "10464280",
        "db_name": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "first": "Sontag E",
        "journal": "The Journal of biological chemistry",
        "last": "Bloom GS",
        "pages": "25490-8",
        "volume": "274"
      },
      "evidence": "Using tau deletion mutants, we found that ABaC binds a domain on tau that is indistinguishable from its MT-binding domain.",
      "key": "1e82e17e0264495694b9eecd234ecaef",
      "line": 290,
      "relation": "positiveCorrelation",
      "source": 31,
      "subject": {
        "modifier": "Activity"
      },
      "target": 88
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ],
        "date": "1999-09-03",
        "db": "PubMed",
        "db_id": "10464280",
        "db_name": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "first": "Sontag E",
        "journal": "The Journal of biological chemistry",
        "last": "Bloom GS",
        "pages": "25490-8",
        "volume": "274"
      },
      "evidence": "ABaC binds directly to MTs through a site that encompasses its catalytic subunit and is distinct from its binding site for tau, and ABaC and tau bind to different domains on MTs.",
      "key": "29290f35c5631dfaa7dc6ae4d5c2f054",
      "line": 296,
      "relation": "association",
      "source": 31,
      "target": 150
    },
    {
      "key": "459913a432c2a980d3fbf4cfd2034a0f",
      "relation": "partOf",
      "source": 31,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ],
        "date": "1999-09-03",
        "db": "PubMed",
        "db_id": "10464280",
        "db_name": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "first": "Sontag E",
        "journal": "The Journal of biological chemistry",
        "last": "Bloom GS",
        "pages": "25490-8",
        "volume": "274"
      },
      "evidence": "ABaC binds directly to MTs through a site that encompasses its catalytic subunit and is distinct from its binding site for tau, and ABaC and tau bind to different domains on MTs.",
      "key": "f8b87c49f4bfe756a906a486fd0dd6b2",
      "line": 299,
      "relation": "association",
      "source": 31,
      "target": 125
    },
    {
      "key": "90dcebc78fe66174857b42e6fcb14b30",
      "relation": "partOf",
      "source": 31,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ],
        "date": "1999-09-03",
        "db": "PubMed",
        "db_id": "10464280",
        "db_name": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "first": "Sontag E",
        "journal": "The Journal of biological chemistry",
        "last": "Bloom GS",
        "pages": "25490-8",
        "volume": "274"
      },
      "evidence": "Thus, MTs inhibited the rate of tau dephosphorylation by ABaC.",
      "key": "20984a93ef3bee954e92502d6323a84d",
      "line": 305,
      "object": {
        "modifier": "Activity"
      },
      "relation": "directlyDecreases",
      "source": 31,
      "subject": {
        "modifier": "Activity"
      },
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Pull-down assay, GST": true,
          "SDS-PAGE": true,
          "Surface Plasmon Resonance": true,
          "Western Blot": true,
          "Yeast Two-Hybrid Assay": true
        }
      },
      "citation": {
        "authors": [
          "Kuret J",
          "Lee G",
          "Sarkar M"
        ],
        "date": "2008-09-01",
        "db": "PubMed",
        "db_id": "18500754",
        "db_name": "Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.",
        "first": "Sarkar M",
        "journal": "Journal of neuroscience research",
        "last": "Lee G",
        "pages": "2763-73",
        "volume": "86"
      },
      "evidence": "The location of the hsc70-binding site in the tau MTBR suggests that hsc70 cannot bind microtubule-associated tau. The location of the hsc70-binding site also suggests that hsc70 might compete with tubulin or microtubules for binding to tau. Our data implicating I308/V309 in tau’s binding to hsp70 similarly suggest that tau cannot bind simultaneously to hsp70 and microtubules. However, unlike hsc70, which does not associate directly with tubulin or microtubules (Gache et al. 2005), hsp70 binds microtubules, presumably through its N-terminus (Sanchez et al. 1994). This would allow hsp70 to simultaneously bind to tau through its C-terminal substrate-binding domain and to microtubules through its N-terminus.",
      "key": "1ad2342bc265da324c544221473c3889",
      "line": 325,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 31,
      "subject": {
        "modifier": "Activity"
      },
      "target": 120
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Pull-down assay, GST": true,
          "SDS-PAGE": true,
          "Surface Plasmon Resonance": true,
          "Western Blot": true,
          "Yeast Two-Hybrid Assay": true
        }
      },
      "citation": {
        "authors": [
          "Kuret J",
          "Lee G",
          "Sarkar M"
        ],
        "date": "2008-09-01",
        "db": "PubMed",
        "db_id": "18500754",
        "db_name": "Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.",
        "first": "Sarkar M",
        "journal": "Journal of neuroscience research",
        "last": "Lee G",
        "pages": "2763-73",
        "volume": "86"
      },
      "evidence": "The location of the hsc70-binding site in the tau MTBR suggests that hsc70 cannot bind microtubule-associated tau. The location of the hsc70-binding site also suggests that hsc70 might compete with tubulin or microtubules for binding to tau. Our data implicating I308/V309 in tau’s binding to hsp70 similarly suggest that tau cannot bind simultaneously to hsp70 and microtubules. However, unlike hsc70, which does not associate directly with tubulin or microtubules (Gache et al. 2005), hsp70 binds microtubules, presumably through its N-terminus (Sanchez et al. 1994). This would allow hsp70 to simultaneously bind to tau through its C-terminal substrate-binding domain and to microtubules through its N-terminus.",
      "key": "107ce8abd8dff60a898cc4c94ada044d",
      "line": 327,
      "relation": "association",
      "source": 31,
      "target": 161
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ],
        "date": "2010-02-09",
        "db": "PubMed",
        "db_id": "20133804",
        "db_name": "A role for FKBP52 in Tau protein function.",
        "first": "Chambraud B",
        "journal": "Proceedings of the National Academy of Sciences of the United States of America",
        "last": "Baulieu EE",
        "pages": "2658-63",
        "volume": "107"
      },
      "evidence": "We concluded that FKBP52 inhibits the promotion of microtubule assembly by Tau.",
      "key": "8d5005532422a8a0341c2ed9cc03b8d3",
      "line": 597,
      "relation": "positiveCorrelation",
      "source": 31,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Microtubule-binding Assay": true
        }
      },
      "citation": {
        "authors": [
          "Butner KA",
          "Kirschner MW"
        ],
        "date": "1991-11-01",
        "db": "PubMed",
        "db_id": "1918161",
        "db_name": "Tau protein binds to microtubules through a flexible array of distributed weak sites.",
        "first": "Butner KA",
        "journal": "The Journal of cell biology",
        "last": "Kirschner MW",
        "pages": "717-30",
        "volume": "115"
      },
      "evidence": "Tau protein plays a role in the extension and maintenance of neuronal processes through a direct association with microtubules. It is found in the axonal microtubules of mature neurons (Binder et al ., 1985) and in the axonlike elongated neurite processes synthesized by differentiating neurons in culture. To address this issue, three different tau protein fragments were synthesized in vitro: (a) the tau protein repeat domain (residues 237 to 367); (b) the amino terminal half of tau protein (residues 1-237) ; and (c) the carboxy terminal nonrepeat domain of tau protein (residues 358 to 430). From these results, we conclude the repeat domain contributes most of the binding energy for microtubules.",
      "key": "95de274f3b9582f6e66226aa46eb0a99",
      "line": 92,
      "object": {
        "effect": {
          "name": "microtubule binding",
          "namespace": "GO"
        },
        "modifier": "Activity"
      },
      "relation": "directlyIncreases",
      "source": 127,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Microtubule-binding Assay": true
        }
      },
      "citation": {
        "authors": [
          "Butner KA",
          "Kirschner MW"
        ],
        "date": "1991-11-01",
        "db": "PubMed",
        "db_id": "1918161",
        "db_name": "Tau protein binds to microtubules through a flexible array of distributed weak sites.",
        "first": "Butner KA",
        "journal": "The Journal of cell biology",
        "last": "Kirschner MW",
        "pages": "717-30",
        "volume": "115"
      },
      "evidence": "Tau protein plays a role in the extension and maintenance of neuronal processes through a direct association with microtubules. It is found in the axonal microtubules of mature neurons (Binder et al ., 1985) and in the axonlike elongated neurite processes synthesized by differentiating neurons in culture. To address this issue, three different tau protein fragments were synthesized in vitro: (a) the tau protein repeat domain (residues 237 to 367); (b) the amino terminal half of tau protein (residues 1-237) ; and (c) the carboxy terminal nonrepeat domain of tau protein (residues 358 to 430). From these results, we conclude the repeat domain contributes most of the binding energy for microtubules.",
      "key": "023755726e2a3c102fa8f3370c52c1b0",
      "line": 94,
      "relation": "equivalentTo",
      "source": 127,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Microtubule-binding Assay": true
        }
      },
      "citation": {
        "authors": [
          "Butner KA",
          "Kirschner MW"
        ],
        "date": "1991-11-01",
        "db": "PubMed",
        "db_id": "1918161",
        "db_name": "Tau protein binds to microtubules through a flexible array of distributed weak sites.",
        "first": "Butner KA",
        "journal": "The Journal of cell biology",
        "last": "Kirschner MW",
        "pages": "717-30",
        "volume": "115"
      },
      "evidence": "Tau protein plays a role in the extension and maintenance of neuronal processes through a direct association with microtubules. It is found in the axonal microtubules of mature neurons (Binder et al ., 1985) and in the axonlike elongated neurite processes synthesized by differentiating neurons in culture. To address this issue, three different tau protein fragments were synthesized in vitro: (a) the tau protein repeat domain (residues 237 to 367); (b) the amino terminal half of tau protein (residues 1-237) ; and (c) the carboxy terminal nonrepeat domain of tau protein (residues 358 to 430). From these results, we conclude the repeat domain contributes most of the binding energy for microtubules.",
      "key": "5130378917f6e8e529e68e014c76a6f1",
      "line": 94,
      "relation": "equivalentTo",
      "source": 88,
      "target": 127
    },
    {
      "key": "1d4bbea02dd45553074cdc4af9c35913",
      "relation": "partOf",
      "source": 88,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ],
        "date": "1999-09-03",
        "db": "PubMed",
        "db_id": "10464280",
        "db_name": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "first": "Sontag E",
        "journal": "The Journal of biological chemistry",
        "last": "Bloom GS",
        "pages": "25490-8",
        "volume": "274"
      },
      "evidence": "Using tau deletion mutants, we found that ABaC binds a domain on tau that is indistinguishable from its MT-binding domain.",
      "key": "563d05daafc9b536a06d33ac74c9e473",
      "line": 289,
      "relation": "isA",
      "source": 88,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ],
        "date": "1999-09-03",
        "db": "PubMed",
        "db_id": "10464280",
        "db_name": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "first": "Sontag E",
        "journal": "The Journal of biological chemistry",
        "last": "Bloom GS",
        "pages": "25490-8",
        "volume": "274"
      },
      "evidence": "Using tau deletion mutants, we found that ABaC binds a domain on tau that is indistinguishable from its MT-binding domain.",
      "key": "0edb41d2c2bae83144ef48e2a46a9faf",
      "line": 290,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 88,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Pull-down assay, GST": true,
          "SDS-PAGE": true,
          "Surface Plasmon Resonance": true,
          "Western Blot": true,
          "Yeast Two-Hybrid Assay": true
        }
      },
      "citation": {
        "authors": [
          "Kuret J",
          "Lee G",
          "Sarkar M"
        ],
        "date": "2008-09-01",
        "db": "PubMed",
        "db_id": "18500754",
        "db_name": "Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.",
        "first": "Sarkar M",
        "journal": "Journal of neuroscience research",
        "last": "Lee G",
        "pages": "2763-73",
        "volume": "86"
      },
      "evidence": "The location of the hsc70-binding site in the tau MTBR suggests that hsc70 cannot bind microtubule-associated tau. The location of the hsc70-binding site also suggests that hsc70 might compete with tubulin or microtubules for binding to tau. Our data implicating I308/V309 in tau’s binding to hsp70 similarly suggest that tau cannot bind simultaneously to hsp70 and microtubules. However, unlike hsc70, which does not associate directly with tubulin or microtubules (Gache et al. 2005), hsp70 binds microtubules, presumably through its N-terminus (Sanchez et al. 1994). This would allow hsp70 to simultaneously bind to tau through its C-terminal substrate-binding domain and to microtubules through its N-terminus.",
      "key": "2e072ee4ab289f74e0b7a2fc485d20ac",
      "line": 324,
      "relation": "association",
      "source": 88,
      "target": 120
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Pull-down assay, GST": true,
          "SDS-PAGE": true,
          "Surface Plasmon Resonance": true,
          "Western Blot": true,
          "Yeast Two-Hybrid Assay": true
        }
      },
      "citation": {
        "authors": [
          "Kuret J",
          "Lee G",
          "Sarkar M"
        ],
        "date": "2008-09-01",
        "db": "PubMed",
        "db_id": "18500754",
        "db_name": "Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.",
        "first": "Sarkar M",
        "journal": "Journal of neuroscience research",
        "last": "Lee G",
        "pages": "2763-73",
        "volume": "86"
      },
      "evidence": "The location of the hsc70-binding site in the tau MTBR suggests that hsc70 cannot bind microtubule-associated tau. The location of the hsc70-binding site also suggests that hsc70 might compete with tubulin or microtubules for binding to tau. Our data implicating I308/V309 in tau’s binding to hsp70 similarly suggest that tau cannot bind simultaneously to hsp70 and microtubules. However, unlike hsc70, which does not associate directly with tubulin or microtubules (Gache et al. 2005), hsp70 binds microtubules, presumably through its N-terminus (Sanchez et al. 1994). This would allow hsp70 to simultaneously bind to tau through its C-terminal substrate-binding domain and to microtubules through its N-terminus.",
      "key": "afca56ed5b546bb7271b545e1049e3bc",
      "line": 328,
      "relation": "association",
      "source": 88,
      "target": 162
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunoblotting": true,
          "Mass Spectrometry": true,
          "RP HPLC": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ],
        "date": "1993-06-01",
        "db": "PubMed",
        "db_id": "8391280",
        "db_name": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "first": "Morishima-Kawashima M",
        "journal": "Neuron",
        "last": "Ihara Y",
        "pages": "1151-60",
        "volume": "10"
      },
      "evidence": "The ubiquitin-targeted protein was identified as tau in paired helical filaments, and the conjugation sites were localized to the microtubule-binding region.",
      "key": "5aff44be27d45c12c5cc946f7bae00ba",
      "line": 479,
      "relation": "association",
      "source": 88,
      "target": 98
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Microtubule-binding Assay": true
        }
      },
      "citation": {
        "authors": [
          "Butner KA",
          "Kirschner MW"
        ],
        "date": "1991-11-01",
        "db": "PubMed",
        "db_id": "1918161",
        "db_name": "Tau protein binds to microtubules through a flexible array of distributed weak sites.",
        "first": "Butner KA",
        "journal": "The Journal of cell biology",
        "last": "Kirschner MW",
        "pages": "717-30",
        "volume": "115"
      },
      "evidence": "Tau protein plays a role in the extension and maintenance of neuronal processes through a direct association with microtubules. It is found in the axonal microtubules of mature neurons (Binder et al ., 1985) and in the axonlike elongated neurite processes synthesized by differentiating neurons in culture. To address this issue, three different tau protein fragments were synthesized in vitro: (a) the tau protein repeat domain (residues 237 to 367); (b) the amino terminal half of tau protein (residues 1-237) ; and (c) the carboxy terminal nonrepeat domain of tau protein (residues 358 to 430). From these results, we conclude the repeat domain contributes most of the binding energy for microtubules.",
      "key": "aa5c86a6cc424d22ff3848504e9c9510",
      "line": 95,
      "relation": "positiveCorrelation",
      "source": 30,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Microtubule-binding Assay": true
        }
      },
      "citation": {
        "authors": [
          "Butner KA",
          "Kirschner MW"
        ],
        "date": "1991-11-01",
        "db": "PubMed",
        "db_id": "1918161",
        "db_name": "Tau protein binds to microtubules through a flexible array of distributed weak sites.",
        "first": "Butner KA",
        "journal": "The Journal of cell biology",
        "last": "Kirschner MW",
        "pages": "717-30",
        "volume": "115"
      },
      "evidence": "Tau protein plays a role in the extension and maintenance of neuronal processes through a direct association with microtubules. It is found in the axonal microtubules of mature neurons (Binder et al ., 1985) and in the axonlike elongated neurite processes synthesized by differentiating neurons in culture. To address this issue, three different tau protein fragments were synthesized in vitro: (a) the tau protein repeat domain (residues 237 to 367); (b) the amino terminal half of tau protein (residues 1-237) ; and (c) the carboxy terminal nonrepeat domain of tau protein (residues 358 to 430). From these results, we conclude the repeat domain contributes most of the binding energy for microtubules.",
      "key": "67bef235df50168f3d5f069dda82671d",
      "line": 96,
      "relation": "positiveCorrelation",
      "source": 27,
      "target": 125
    },
    {
      "key": "fe62f4cbe8bb6ba60ea7df49f8416645",
      "relation": "partOf",
      "source": 24,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy": true,
          "F-actin depolymerization assay": true,
          "Immunocytochemistry": true,
          "In vitro actin-bundling assay": true,
          "Scanning electron microscopy (SEM)": true,
          "Transmission electron microscopy (TEM)": true
        },
        "Species": {
          "10090": true,
          "7215": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Elson-Schwab I",
          "Feany MB",
          "Fulga TA",
          "Hyman BT",
          "Khurana V",
          "Spires TL",
          "Steinhilb ML"
        ],
        "date": "2007-02-01",
        "db": "PubMed",
        "db_id": "17187063",
        "db_name": "Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.",
        "first": "Fulga TA",
        "journal": "Nature cell biology",
        "last": "Feany MB",
        "pages": "139-48",
        "volume": "9"
      },
      "evidence": "These results are consistent with previous in vitro studies and indicate that tau induces actin-filament bundling in vitro and F-actin accumulation in vivo, most likely through a direct interaction with F-actin.For genetic analysis, we selected a line of tauV337M-expressing flies that has a moderate rough eye and is a good substrate for genetic modification. Coexpressing an actin transgene (UAS–Act5C–EGFP;GMR– GAL4 driver) markedly enhanced tauV337M-induced toxicity.",
      "key": "b87e8ddd8b25d96f99528eb45eac4f29",
      "line": 115,
      "relation": "increases",
      "source": 39,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy": true,
          "F-actin depolymerization assay": true,
          "Immunocytochemistry": true,
          "In vitro actin-bundling assay": true,
          "Scanning electron microscopy (SEM)": true,
          "Transmission electron microscopy (TEM)": true
        },
        "Species": {
          "10090": true,
          "7215": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Elson-Schwab I",
          "Feany MB",
          "Fulga TA",
          "Hyman BT",
          "Khurana V",
          "Spires TL",
          "Steinhilb ML"
        ],
        "date": "2007-02-01",
        "db": "PubMed",
        "db_id": "17187063",
        "db_name": "Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.",
        "first": "Fulga TA",
        "journal": "Nature cell biology",
        "last": "Feany MB",
        "pages": "139-48",
        "volume": "9"
      },
      "evidence": "These results are consistent with previous in vitro studies and indicate that tau induces actin-filament bundling in vitro and F-actin accumulation in vivo, most likely through a direct interaction with F-actin.For genetic analysis, we selected a line of tauV337M-expressing flies that has a moderate rough eye and is a good substrate for genetic modification. Coexpressing an actin transgene (UAS–Act5C–EGFP;GMR– GAL4 driver) markedly enhanced tauV337M-induced toxicity.",
      "key": "e7d7f15a31dbbf185a38f8cfb1bad6d0",
      "line": 117,
      "relation": "positiveCorrelation",
      "source": 39,
      "target": 181
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy": true,
          "F-actin depolymerization assay": true,
          "Immunocytochemistry": true,
          "In vitro actin-bundling assay": true,
          "Scanning electron microscopy (SEM)": true,
          "Transmission electron microscopy (TEM)": true
        },
        "Species": {
          "10090": true,
          "7215": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Elson-Schwab I",
          "Feany MB",
          "Fulga TA",
          "Hyman BT",
          "Khurana V",
          "Spires TL",
          "Steinhilb ML"
        ],
        "date": "2007-02-01",
        "db": "PubMed",
        "db_id": "17187063",
        "db_name": "Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.",
        "first": "Fulga TA",
        "journal": "Nature cell biology",
        "last": "Feany MB",
        "pages": "139-48",
        "volume": "9"
      },
      "evidence": "These results are consistent with previous in vitro studies and indicate that tau induces actin-filament bundling in vitro and F-actin accumulation in vivo, most likely through a direct interaction with F-actin.For genetic analysis, we selected a line of tauV337M-expressing flies that has a moderate rough eye and is a good substrate for genetic modification. Coexpressing an actin transgene (UAS–Act5C–EGFP;GMR– GAL4 driver) markedly enhanced tauV337M-induced toxicity.",
      "key": "ff24c1c18397dd7557b107af62f6d081",
      "line": 116,
      "relation": "increases",
      "source": 85,
      "target": 181
    },
    {
      "key": "5d4eeb8a9fa2049029b8f7a6636d9d7a",
      "relation": "hasVariant",
      "source": 83,
      "target": 85
    },
    {
      "key": "371d026b5b178a146f72c1fa10065084",
      "relation": "hasVariant",
      "source": 83,
      "target": 84
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy": true,
          "F-actin depolymerization assay": true,
          "Immunocytochemistry": true,
          "In vitro actin-bundling assay": true,
          "Scanning electron microscopy (SEM)": true,
          "Transmission electron microscopy (TEM)": true
        },
        "Species": {
          "10090": true,
          "7215": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Elson-Schwab I",
          "Feany MB",
          "Fulga TA",
          "Hyman BT",
          "Khurana V",
          "Spires TL",
          "Steinhilb ML"
        ],
        "date": "2007-02-01",
        "db": "PubMed",
        "db_id": "17187063",
        "db_name": "Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.",
        "first": "Fulga TA",
        "journal": "Nature cell biology",
        "last": "Feany MB",
        "pages": "139-48",
        "volume": "9"
      },
      "evidence": "These results are consistent with previous in vitro studies and indicate that tau induces actin-filament bundling in vitro and F-actin accumulation in vivo, most likely through a direct interaction with F-actin.For genetic analysis, we selected a line of tauV337M-expressing flies that has a moderate rough eye and is a good substrate for genetic modification. Coexpressing an actin transgene (UAS–Act5C–EGFP;GMR– GAL4 driver) markedly enhanced tauV337M-induced toxicity.",
      "key": "f841e55590a6f11befe8434b3e04650a",
      "line": 117,
      "relation": "positiveCorrelation",
      "source": 181,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Aamodt EJ",
          "Williams RC Jr"
        ],
        "date": "1984-12-04",
        "db": "PubMed",
        "db_id": "6543144",
        "db_name": "Microtubule-associated proteins connect microtubules and neurofilaments in vitro.",
        "first": "Aamodt EJ",
        "journal": "Biochemistry",
        "last": "Williams RC Jr",
        "pages": "6023-31",
        "volume": "23"
      },
      "evidence": "The resulting MAP-decorated neurofilaments formed a viscous complex with microtubules, showing that some component of the MAPs mediated the association between the two filamentous organelles.",
      "key": "9f586da195898acbab4d77ab581e52df",
      "line": 129,
      "relation": "association",
      "source": 32,
      "target": 125
    },
    {
      "key": "942424f5b2a30230bcf1532fced2093a",
      "relation": "partOf",
      "source": 32,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Aamodt EJ",
          "Williams RC Jr"
        ],
        "date": "1984-12-04",
        "db": "PubMed",
        "db_id": "6543144",
        "db_name": "Microtubule-associated proteins connect microtubules and neurofilaments in vitro.",
        "first": "Aamodt EJ",
        "journal": "Biochemistry",
        "last": "Williams RC Jr",
        "pages": "6023-31",
        "volume": "23"
      },
      "evidence": "The resulting MAP-decorated neurofilaments formed a viscous complex with microtubules, showing that some component of the MAPs mediated the association between the two filamentous organelles.",
      "key": "1f723efb20a67b3d2dd08e90004323b5",
      "line": 130,
      "relation": "association",
      "source": 43,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Astrocytes": true,
          "Axons": true,
          "Dendrites": true,
          "Polyribosomes": true
        },
        "Method": {
          "Immunoblotting": true,
          "Immunohistochemistry": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Papasozomenos SC"
        ],
        "date": "1987-01-01",
        "db": "PubMed",
        "db_id": "2446784",
        "db_name": "Phosphorylation determines two distinct species of Tau in the central nervous system.",
        "first": "Papasozomenos SC",
        "journal": "Cell motility and the cytoskeleton",
        "last": "Binder LI",
        "pages": "210-26",
        "volume": "8"
      },
      "evidence": "This antibody binds only to tau and localizes along microtubules in axons, somata, dendrites, and astrocytes and on ribosomes (polysomes) without phosphatase pretreatment.",
      "key": "832306c78dd6fb3fb8922822ba666085",
      "line": 141,
      "relation": "association",
      "source": 37,
      "target": 125
    },
    {
      "key": "e558b795ef63fded554616c630017346",
      "relation": "partOf",
      "source": 9,
      "target": 37
    },
    {
      "key": "e88a51659cc55dc1a857542b9b15dbe2",
      "relation": "partOf",
      "source": 9,
      "target": 36
    },
    {
      "key": "d892788f073dca403a6ef5f643d24140",
      "relation": "partOf",
      "source": 9,
      "target": 38
    },
    {
      "key": "fa7ea0d1f3746a05e1e2c08843d01860",
      "relation": "partOf",
      "source": 118,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunoaffinity Chromatography": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Microtubule Sedimentation Assay": true,
          "Pull-down Assay": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Neufield KD",
          "Paudel HK",
          "Qureshi HY",
          "Sobue K",
          "Sun W"
        ],
        "date": "2002-04-05",
        "db": "PubMed",
        "db_id": "11812770",
        "db_name": "Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.",
        "first": "Sun W",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "11933-40",
        "volume": "277"
      },
      "evidence": "GSK3Beta may directly bind to tau within a GSK3Beta-tau complex.To identify the GSK3Beta-binding region within tau, we constructed three tau deletion mutants: R-tau-(1–244) containing the N-terminal projection domain, R-tau-(245–369) containing the microtubule-binding region, and R-tau-(245–441) containing both the microtubule-binding region and the C-terminal tail. We evaluated the binding of these mutants and wild-type R-tau with GST-GSK3Beta by the GST pull-down assay. GSK3Beta bound to wild type (Fig. 5B) and R-tau-(1–244) (Fig. 5C) but not R-tau-(245–369) (Fig. 5D) and R-tau-(245–441) (Fig.5E). These data demonstrate that GSK3Beta binds to the Nterminal projection domain of tau.",
      "key": "227ba7fdc0dc0940a4c22d12d3627181",
      "line": 156,
      "relation": "directlyIncreases",
      "source": 118,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunoaffinity Chromatography": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Microtubule Sedimentation Assay": true,
          "Pull-down Assay": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Neufield KD",
          "Paudel HK",
          "Qureshi HY",
          "Sobue K",
          "Sun W"
        ],
        "date": "2002-04-05",
        "db": "PubMed",
        "db_id": "11812770",
        "db_name": "Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.",
        "first": "Sun W",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "11933-40",
        "volume": "277"
      },
      "evidence": "GSK3Beta may directly bind to tau within a GSK3Beta-tau complex.To identify the GSK3Beta-binding region within tau, we constructed three tau deletion mutants: R-tau-(1–244) containing the N-terminal projection domain, R-tau-(245–369) containing the microtubule-binding region, and R-tau-(245–441) containing both the microtubule-binding region and the C-terminal tail. We evaluated the binding of these mutants and wild-type R-tau with GST-GSK3Beta by the GST pull-down assay. GSK3Beta bound to wild type (Fig. 5B) and R-tau-(1–244) (Fig. 5C) but not R-tau-(245–369) (Fig. 5D) and R-tau-(245–441) (Fig.5E). These data demonstrate that GSK3Beta binds to the Nterminal projection domain of tau.",
      "key": "3866b7927a4d57436811c07ff91bc9fd",
      "line": 163,
      "relation": "positiveCorrelation",
      "source": 118,
      "target": 57
    },
    {
      "key": "9ee42fc192813b19a8b6444034a1ebe3",
      "relation": "partOf",
      "source": 118,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunoaffinity Chromatography": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Microtubule Sedimentation Assay": true,
          "Pull-down Assay": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Neufield KD",
          "Paudel HK",
          "Qureshi HY",
          "Sobue K",
          "Sun W"
        ],
        "date": "2002-04-05",
        "db": "PubMed",
        "db_id": "11812770",
        "db_name": "Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.",
        "first": "Sun W",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "11933-40",
        "volume": "277"
      },
      "evidence": "GSK3Beta may directly bind to tau within a GSK3Beta-tau complex.To identify the GSK3Beta-binding region within tau, we constructed three tau deletion mutants: R-tau-(1–244) containing the N-terminal projection domain, R-tau-(245–369) containing the microtubule-binding region, and R-tau-(245–441) containing both the microtubule-binding region and the C-terminal tail. We evaluated the binding of these mutants and wild-type R-tau with GST-GSK3Beta by the GST pull-down assay. GSK3Beta bound to wild type (Fig. 5B) and R-tau-(1–244) (Fig. 5C) but not R-tau-(245–369) (Fig. 5D) and R-tau-(245–441) (Fig.5E). These data demonstrate that GSK3Beta binds to the Nterminal projection domain of tau.",
      "key": "3304f5a813722a087d463d615b0cf86d",
      "line": 157,
      "relation": "directlyIncreases",
      "source": 118,
      "target": 59
    },
    {
      "key": "aabd247a8d57ca0031305267af628f21",
      "relation": "partOf",
      "source": 118,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunoaffinity Chromatography": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Microtubule Sedimentation Assay": true,
          "Pull-down Assay": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Neufield KD",
          "Paudel HK",
          "Qureshi HY",
          "Sobue K",
          "Sun W"
        ],
        "date": "2002-04-05",
        "db": "PubMed",
        "db_id": "11812770",
        "db_name": "Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.",
        "first": "Sun W",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "11933-40",
        "volume": "277"
      },
      "evidence": "GSK3Beta may directly bind to tau within a GSK3Beta-tau complex.To identify the GSK3Beta-binding region within tau, we constructed three tau deletion mutants: R-tau-(1–244) containing the N-terminal projection domain, R-tau-(245–369) containing the microtubule-binding region, and R-tau-(245–441) containing both the microtubule-binding region and the C-terminal tail. We evaluated the binding of these mutants and wild-type R-tau with GST-GSK3Beta by the GST pull-down assay. GSK3Beta bound to wild type (Fig. 5B) and R-tau-(1–244) (Fig. 5C) but not R-tau-(245–369) (Fig. 5D) and R-tau-(245–441) (Fig.5E). These data demonstrate that GSK3Beta binds to the Nterminal projection domain of tau.",
      "key": "36282057dbf6e70921eec8c16df29519",
      "line": 158,
      "relation": "directlyDecreases",
      "source": 118,
      "target": 60
    },
    {
      "key": "6f3285e32c3eef9f198b83ead1a48bb1",
      "relation": "partOf",
      "source": 118,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunoaffinity Chromatography": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Microtubule Sedimentation Assay": true,
          "Pull-down Assay": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Neufield KD",
          "Paudel HK",
          "Qureshi HY",
          "Sobue K",
          "Sun W"
        ],
        "date": "2002-04-05",
        "db": "PubMed",
        "db_id": "11812770",
        "db_name": "Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.",
        "first": "Sun W",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "11933-40",
        "volume": "277"
      },
      "evidence": "GSK3Beta may directly bind to tau within a GSK3Beta-tau complex.To identify the GSK3Beta-binding region within tau, we constructed three tau deletion mutants: R-tau-(1–244) containing the N-terminal projection domain, R-tau-(245–369) containing the microtubule-binding region, and R-tau-(245–441) containing both the microtubule-binding region and the C-terminal tail. We evaluated the binding of these mutants and wild-type R-tau with GST-GSK3Beta by the GST pull-down assay. GSK3Beta bound to wild type (Fig. 5B) and R-tau-(1–244) (Fig. 5C) but not R-tau-(245–369) (Fig. 5D) and R-tau-(245–441) (Fig.5E). These data demonstrate that GSK3Beta binds to the Nterminal projection domain of tau.",
      "key": "e939fac1edb8047ab10678efdc9409fc",
      "line": 159,
      "relation": "directlyDecreases",
      "source": 118,
      "target": 61
    },
    {
      "annotations": {
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Deglycosylation Assay": true,
          "Dephosphorylation Assay": true,
          "Immunoblotting": true,
          "Immunocytochemistry": true,
          "Phosphorylation Assay": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Ubiquitination Assay": true
        }
      },
      "citation": {
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ],
        "date": "2004-02-06",
        "db": "PubMed",
        "db_id": "14612456",
        "db_name": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "4869-76",
        "volume": "279"
      },
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 μg of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "key": "58d4452fe5db28186631fa35bf4b0738",
      "line": 414,
      "relation": "directlyIncreases",
      "source": 118,
      "target": 133
    },
    {
      "annotations": {
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Deglycosylation Assay": true,
          "Dephosphorylation Assay": true,
          "Immunoblotting": true,
          "Immunocytochemistry": true,
          "Phosphorylation Assay": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Ubiquitination Assay": true
        }
      },
      "citation": {
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ],
        "date": "2004-02-06",
        "db": "PubMed",
        "db_id": "14612456",
        "db_name": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "4869-76",
        "volume": "279"
      },
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 μg of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "key": "8638e555f22616dc5ce5ce2b7a1abda6",
      "line": 415,
      "relation": "directlyIncreases",
      "source": 118,
      "target": 138
    },
    {
      "annotations": {
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Deglycosylation Assay": true,
          "Dephosphorylation Assay": true,
          "Immunoblotting": true,
          "Immunocytochemistry": true,
          "Phosphorylation Assay": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Ubiquitination Assay": true
        }
      },
      "citation": {
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ],
        "date": "2004-02-06",
        "db": "PubMed",
        "db_id": "14612456",
        "db_name": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "4869-76",
        "volume": "279"
      },
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 μg of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "key": "a2b00c0a48b9d3fb3f4032e7227bf092",
      "line": 416,
      "relation": "directlyIncreases",
      "source": 118,
      "target": 136
    },
    {
      "annotations": {
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Deglycosylation Assay": true,
          "Dephosphorylation Assay": true,
          "Immunoblotting": true,
          "Immunocytochemistry": true,
          "Phosphorylation Assay": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Ubiquitination Assay": true
        }
      },
      "citation": {
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ],
        "date": "2004-02-06",
        "db": "PubMed",
        "db_id": "14612456",
        "db_name": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "4869-76",
        "volume": "279"
      },
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 μg of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "key": "02f3c642d415b7cb36b44948ffa07ceb",
      "line": 417,
      "relation": "directlyIncreases",
      "source": 118,
      "target": 137
    },
    {
      "key": "cf26414172b4f2dbd1cd7e2820e6bbb3",
      "relation": "hasVariant",
      "source": 118,
      "target": 119
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "In general, GSK-3β phosphorylation is inhibited through the canonical Wnt signalling pathway [5]. Wnt, binding to frizzled receptor, recruits dishevelled protein, which in turn antagonizes GSK-3β activity.",
      "key": "f8f67dc9470db2f25255eb31a9df2be3",
      "line": 770,
      "relation": "negativeCorrelation",
      "source": 118,
      "subject": {
        "modifier": "Activity"
      },
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "For example, ongoing inflammation can trigger various cell stress-response pathways, including overexpression of the secreted glycoprotein Dickopff-1 (DKK-1). DKK-1 up-regulates GSK-3β activity, promotes tau hyper-phosphorylation, NFT formation and neuronal degeneration. Thus, DKK-1 inhibits Wnt signalling in a manner similar to Aβ, and thereby fosters a self-sustaining feedback loop resulting in cellular injury",
      "key": "840e7a7c4e764d8c06ebc15dbafa1433",
      "line": 780,
      "relation": "increases",
      "source": 118,
      "subject": {
        "modifier": "Activity"
      },
      "target": 130
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "For example, ongoing inflammation can trigger various cell stress-response pathways, including overexpression of the secreted glycoprotein Dickopff-1 (DKK-1). DKK-1 up-regulates GSK-3β activity, promotes tau hyper-phosphorylation, NFT formation and neuronal degeneration. Thus, DKK-1 inhibits Wnt signalling in a manner similar to Aβ, and thereby fosters a self-sustaining feedback loop resulting in cellular injury",
      "key": "930162a16178fe3f0a40130d0858efac",
      "line": 781,
      "relation": "increases",
      "source": 118,
      "subject": {
        "modifier": "Activity"
      },
      "target": 99
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "For example, ongoing inflammation can trigger various cell stress-response pathways, including overexpression of the secreted glycoprotein Dickopff-1 (DKK-1). DKK-1 up-regulates GSK-3β activity, promotes tau hyper-phosphorylation, NFT formation and neuronal degeneration. Thus, DKK-1 inhibits Wnt signalling in a manner similar to Aβ, and thereby fosters a self-sustaining feedback loop resulting in cellular injury",
      "key": "fd18ccb07b942232d238158bd1c061f2",
      "line": 782,
      "relation": "negativeCorrelation",
      "source": 118,
      "subject": {
        "modifier": "Activity"
      },
      "target": 16
    },
    {
      "key": "4b2c7c3338b56b19e5ea6374b385c639",
      "relation": "partOf",
      "source": 118,
      "target": 58
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, FPLC": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ],
        "date": "2003-04-11",
        "db": "PubMed",
        "db_id": "12551948",
        "db_name": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "first": "Agarwal-Mawal A",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "12722-8",
        "volume": "278"
      },
      "evidence": "These observations suggested that 14-3-3zeta may be bound to GSK3Beta and/or tau within brain microtubules and may be a component of tau phosphorylation complex.Therefore, 14-3-3 must be the central molecule that holds tau and GSK3Beta within the complex. Indeed, FLAG-tau co-immunoprecipitated with HA-GSK3Beta from cells overexpressing FLAG-tau and HA-GSK3Beta only when these cells also overexpressed Xpress-14-3-3zeta (Fig. 6A, lanes 8 and 9), indicating that GSK3Beta associates with tau only in the presence of 14-3-3zeta. As discussed above, 14-3-3zeta binds to tau (36) and GSK3Beta (Fig. 5) directly. Taken together, these observations indicated that 14-3-3zeta connects GSK3Beta to tau in vivo.",
      "key": "2d932c4da05e78c08f1090ce1d86e12a",
      "line": 846,
      "relation": "isA",
      "source": 118,
      "target": 58
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, FPLC": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ],
        "date": "2003-04-11",
        "db": "PubMed",
        "db_id": "12551948",
        "db_name": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "first": "Agarwal-Mawal A",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "12722-8",
        "volume": "278"
      },
      "evidence": "These observations suggested that 14-3-3zeta may be bound to GSK3Beta and/or tau within brain microtubules and may be a component of tau phosphorylation complex.Therefore, 14-3-3 must be the central molecule that holds tau and GSK3Beta within the complex. Indeed, FLAG-tau co-immunoprecipitated with HA-GSK3Beta from cells overexpressing FLAG-tau and HA-GSK3Beta only when these cells also overexpressed Xpress-14-3-3zeta (Fig. 6A, lanes 8 and 9), indicating that GSK3Beta associates with tau only in the presence of 14-3-3zeta. As discussed above, 14-3-3zeta binds to tau (36) and GSK3Beta (Fig. 5) directly. Taken together, these observations indicated that 14-3-3zeta connects GSK3Beta to tau in vivo.",
      "key": "06355893dd1e1b131d1ec75db7398c51",
      "line": 845,
      "relation": "association",
      "source": 118,
      "target": 158
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, FPLC": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ],
        "date": "2003-04-11",
        "db": "PubMed",
        "db_id": "12551948",
        "db_name": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "first": "Agarwal-Mawal A",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "12722-8",
        "volume": "278"
      },
      "evidence": "In cells that were co-transfected with fixed amounts of FLAG-tau and HA-GSK3Beta but different amounts of Xpress-14-3-3zeta, FLAG-tau phosphorylation increased progressively with the increase in the amount of Xpress-14-3-3zeta (lanes 7–9). This increase was evident not only by an increased immunoreactivity against all tau phosphorylation-sensitive antibodies tested but also by a retarded mobility of FLAG-tau on the SDS gel, a characteristic feature of hyperphosphorylated tau (2, 3). Thus, 14-3-3zeta profoundly stimulated GSK3Beta-catalyzed tau phosphorylation in vivo.",
      "key": "94095f74a775cd6b3ff616f48eae287a",
      "line": 857,
      "relation": "increases",
      "source": 118,
      "subject": {
        "modifier": "Activity"
      },
      "target": 131
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunoaffinity Chromatography": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Microtubule Sedimentation Assay": true,
          "Pull-down Assay": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Neufield KD",
          "Paudel HK",
          "Qureshi HY",
          "Sobue K",
          "Sun W"
        ],
        "date": "2002-04-05",
        "db": "PubMed",
        "db_id": "11812770",
        "db_name": "Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.",
        "first": "Sun W",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "11933-40",
        "volume": "277"
      },
      "evidence": "GSK3Beta may directly bind to tau within a GSK3Beta-tau complex.To identify the GSK3Beta-binding region within tau, we constructed three tau deletion mutants: R-tau-(1–244) containing the N-terminal projection domain, R-tau-(245–369) containing the microtubule-binding region, and R-tau-(245–441) containing both the microtubule-binding region and the C-terminal tail. We evaluated the binding of these mutants and wild-type R-tau with GST-GSK3Beta by the GST pull-down assay. GSK3Beta bound to wild type (Fig. 5B) and R-tau-(1–244) (Fig. 5C) but not R-tau-(245–369) (Fig. 5D) and R-tau-(245–441) (Fig.5E). These data demonstrate that GSK3Beta binds to the Nterminal projection domain of tau.",
      "key": "49312689ab17a049405a91e9c7972866",
      "line": 163,
      "relation": "positiveCorrelation",
      "source": 57,
      "target": 118
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunoaffinity Chromatography": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Microtubule Sedimentation Assay": true,
          "Pull-down Assay": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Neufield KD",
          "Paudel HK",
          "Qureshi HY",
          "Sobue K",
          "Sun W"
        ],
        "date": "2002-04-05",
        "db": "PubMed",
        "db_id": "11812770",
        "db_name": "Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.",
        "first": "Sun W",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "11933-40",
        "volume": "277"
      },
      "evidence": "GSK3Beta may directly bind to tau within a GSK3Beta-tau complex.To identify the GSK3Beta-binding region within tau, we constructed three tau deletion mutants: R-tau-(1–244) containing the N-terminal projection domain, R-tau-(245–369) containing the microtubule-binding region, and R-tau-(245–441) containing both the microtubule-binding region and the C-terminal tail. We evaluated the binding of these mutants and wild-type R-tau with GST-GSK3Beta by the GST pull-down assay. GSK3Beta bound to wild type (Fig. 5B) and R-tau-(1–244) (Fig. 5C) but not R-tau-(245–369) (Fig. 5D) and R-tau-(245–441) (Fig.5E). These data demonstrate that GSK3Beta binds to the Nterminal projection domain of tau.",
      "key": "c367b80986b3fda816945f630fb6fdde",
      "line": 164,
      "relation": "positiveCorrelation",
      "source": 57,
      "target": 125
    },
    {
      "key": "eb8187c2a64193905face753f00d1fca",
      "relation": "partOf",
      "source": 126,
      "target": 59
    },
    {
      "key": "aa32e05708a1fa2896b259103fd2eb29",
      "relation": "partOf",
      "source": 128,
      "target": 60
    },
    {
      "key": "1578c71cfca751bdf99eeb9584f86df4",
      "relation": "partOf",
      "source": 129,
      "target": 61
    },
    {
      "annotations": {
        "Cell": {
          "oligodendrocyte": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ],
        "date": "2008-10-01",
        "db": "PubMed",
        "db_id": "18680553",
        "db_name": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "first": "Belkadi A",
        "journal": "Journal of neurochemistry",
        "last": "LoPresti P",
        "pages": "351-60",
        "volume": "107"
      },
      "evidence": "Here we demonstrate that the Tau-Fyn interaction has a role in developmental myelination. CG-4 cells were stably transfected with control and experimental truncated Tau and transplanted in the brain and spinal cord of the md rats. In the brain, experimental cells have a severe defect in their ability to extend cellular processes and form myelin; in the spinal cord the cells extend cellular processes but the extent of myelination rostral and caudal to the injection site was decreased compared to control. Cultured experimental cells display shorter cellular process length. In addition experimental cells have Fyn largely in the cell body, whereas control cells distribute Fyn both in the cell body and the processes. Taken together these results demonstrate a direct effect of Tau in OLGs in in vivo myelination.",
      "key": "673ad35f3a1e7d865dba7c81aefc9145",
      "line": 199,
      "relation": "positiveCorrelation",
      "source": 55,
      "target": 19
    },
    {
      "key": "665fbdfeecf7710bee364c9f5fbc2d34",
      "relation": "partOf",
      "source": 115,
      "target": 55
    },
    {
      "annotations": {
        "Cell": {
          "oligodendrocyte": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ],
        "date": "2008-10-01",
        "db": "PubMed",
        "db_id": "18680553",
        "db_name": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "first": "Belkadi A",
        "journal": "Journal of neurochemistry",
        "last": "LoPresti P",
        "pages": "351-60",
        "volume": "107"
      },
      "evidence": "Here we demonstrate that the Tau-Fyn interaction has a role in developmental myelination. CG-4 cells were stably transfected with control and experimental truncated Tau and transplanted in the brain and spinal cord of the md rats. In the brain, experimental cells have a severe defect in their ability to extend cellular processes and form myelin; in the spinal cord the cells extend cellular processes but the extent of myelination rostral and caudal to the injection site was decreased compared to control. Cultured experimental cells display shorter cellular process length. In addition experimental cells have Fyn largely in the cell body, whereas control cells distribute Fyn both in the cell body and the processes. Taken together these results demonstrate a direct effect of Tau in OLGs in in vivo myelination.",
      "key": "7899ea1be13e5296ac570d521e473a89",
      "line": 198,
      "relation": "increases",
      "source": 115,
      "target": 55
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        }
      },
      "citation": {
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ],
        "date": "2008-10-01",
        "db": "PubMed",
        "db_id": "18680553",
        "db_name": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "first": "Belkadi A",
        "journal": "Journal of neurochemistry",
        "last": "LoPresti P",
        "pages": "351-60",
        "volume": "107"
      },
      "evidence": "Furthermore, Tau binds Fyn both in neuronal and oligodendroglial cells (Brandt et al. 1995; Klein et al.2002), and Fyn phosphorylates Tau in neuronal cells (Lee et al. 2004). The main Fyn SH3 domain-binding PXXP motif (Pro, Lys, Ser, Pro) in adult rat Tau is at the residues 223-226 (Kosik et al. 1989; Lee et al. 1998).",
      "key": "cda74c09f69dc584f5b7e6931b088906",
      "line": 179,
      "relation": "increases",
      "source": 115,
      "target": 131
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ],
        "date": "2008-10-01",
        "db": "PubMed",
        "db_id": "18680553",
        "db_name": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "first": "Belkadi A",
        "journal": "Journal of neurochemistry",
        "last": "LoPresti P",
        "pages": "351-60",
        "volume": "107"
      },
      "evidence": "Furthermore, Tau binds Fyn both in neuronal and oligodendroglial cells (Brandt et al. 1995; Klein et al.2002), and Fyn phosphorylates Tau in neuronal cells (Lee et al. 2004). The main Fyn SH3 domain-binding PXXP motif (Pro, Lys, Ser, Pro) in adult rat Tau is at the residues 223-226 (Kosik et al. 1989; Lee et al. 1998).",
      "key": "4d16bf6420476a048510541aac890faa",
      "line": 181,
      "relation": "association",
      "source": 115,
      "target": 178
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "The binding of all four SH3 domains tested (from Fyn, p85alpha, PLCgamma1, and the N-terminal SH3 of Grb2) was considerably decreased by phosphorylation.",
      "key": "a9450da2e38427fb645dc93261546e34",
      "line": 240,
      "relation": "decreases",
      "source": 131,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "The binding of all four SH3 domains tested (from Fyn, p85alpha, PLCgamma1, and the N-terminal SH3 of Grb2) was considerably decreased by phosphorylation.",
      "key": "4435b00e1276bd6619a475c7e3fdf592",
      "line": 241,
      "relation": "decreases",
      "source": 131,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "The binding of all four SH3 domains tested (from Fyn, p85alpha, PLCgamma1, and the N-terminal SH3 of Grb2) was considerably decreased by phosphorylation.",
      "key": "f4217a3e1c78d857cb1ff68a403036dd",
      "line": 242,
      "relation": "decreases",
      "source": 131,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "The binding of all four SH3 domains tested (from Fyn, p85alpha, PLCgamma1, and the N-terminal SH3 of Grb2) was considerably decreased by phosphorylation.",
      "key": "a7d5b1ca39299d95036a66a8b188fd1c",
      "line": 243,
      "relation": "decreases",
      "source": 131,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ],
        "date": "1999-09-03",
        "db": "PubMed",
        "db_id": "10464280",
        "db_name": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "first": "Sontag E",
        "journal": "The Journal of biological chemistry",
        "last": "Bloom GS",
        "pages": "25490-8",
        "volume": "274"
      },
      "evidence": "Thus, MTs inhibited the rate of tau dephosphorylation by ABaC.",
      "key": "fb0beabbaa042f704538a713ae2ba594",
      "line": 307,
      "relation": "negativeCorrelation",
      "source": 131,
      "target": 184
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dot Blot": true,
          "Immunoprecipitation": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ],
        "date": "2009-01-01",
        "db": "PubMed",
        "db_id": "19363271",
        "db_name": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "first": "Tortosa E",
        "journal": "Journal of Alzheimer's disease : JAD",
        "last": "Avila J",
        "pages": "319-25",
        "volume": "17"
      },
      "evidence": "To test the effect of Hsp90 on tau phosphorylation, this protein was mixed with tau protein in the presence of GSK-3 and ATP. Figure 4 shows that tau phosphorylation increases in the presence of increased added amounts of Hsp90.",
      "key": "7fa74b781aade93e184cf570975657c4",
      "line": 350,
      "relation": "positiveCorrelation",
      "source": 131,
      "target": 95
    },
    {
      "key": "363653ff1cab53cb1b62df177949d94f",
      "relation": "partOf",
      "source": 131,
      "target": 65
    },
    {
      "annotations": {
        "Anatomy": {
          "temporal cortex": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ],
        "date": "2004-04-23",
        "db": "PubMed",
        "db_id": "14963027",
        "db_name": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "17957-62",
        "volume": "279"
      },
      "evidence": "Here we show that heat shock protein 27 (Hsp27) preferentially binds pathological hyperphosphorylated tau and paired helical filaments tau directly but not non-phosphorylated tau. The formation of this complex altered the conformation of pathological hyperphosphorylated tau and reduced its concentration by facilitating its degradation and dephosphorylation.",
      "key": "7d7730e513c338950b9b7f5954e7b54f",
      "line": 379,
      "relation": "increases",
      "source": 131,
      "target": 65
    },
    {
      "annotations": {
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Deglycosylation Assay": true,
          "Dephosphorylation Assay": true,
          "Immunoblotting": true,
          "Immunocytochemistry": true,
          "Phosphorylation Assay": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Ubiquitination Assay": true
        }
      },
      "citation": {
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ],
        "date": "2004-02-06",
        "db": "PubMed",
        "db_id": "14612456",
        "db_name": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "4869-76",
        "volume": "279"
      },
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 μg of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "key": "9a8ef1225e67bc7a008d5531d1637471",
      "line": 422,
      "relation": "positiveCorrelation",
      "source": 131,
      "target": 141
    },
    {
      "key": "80b85ee7e66e32d0516fc2f89b799f53",
      "relation": "partOf",
      "source": 131,
      "target": 72
    },
    {
      "annotations": {
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Deglycosylation Assay": true,
          "Dephosphorylation Assay": true,
          "Immunoblotting": true,
          "Immunocytochemistry": true,
          "Phosphorylation Assay": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Ubiquitination Assay": true
        }
      },
      "citation": {
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ],
        "date": "2004-02-06",
        "db": "PubMed",
        "db_id": "14612456",
        "db_name": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "4869-76",
        "volume": "279"
      },
      "evidence": "These data suggest a model by which phosphorylated tau is bound to a chaperone and the complex is recognized by the E3 Ub ligase CHIP. We further examined whether recombinant GST-CHIP ubiquitinates phosphorylated tau in vitro in the presence of UbcH5B and Hsc70. Ubiquitination of phosphorylated tau was detected as high molecular weight bands by immunoblotting with 5E2 in the presence of UbcH5B and Hsc70 (Fig. 2e).",
      "key": "8dc0d60fdc0816895ded65b2af569600",
      "line": 432,
      "relation": "isA",
      "source": 131,
      "target": 72
    },
    {
      "key": "108942b1b4818ee95a392ca24c15dbfb",
      "relation": "partOf",
      "source": 131,
      "target": 62
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ],
        "date": "2008-10-01",
        "db": "PubMed",
        "db_id": "18680553",
        "db_name": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "first": "Belkadi A",
        "journal": "Journal of neurochemistry",
        "last": "LoPresti P",
        "pages": "351-60",
        "volume": "107"
      },
      "evidence": "Furthermore, Tau binds Fyn both in neuronal and oligodendroglial cells (Brandt et al. 1995; Klein et al.2002), and Fyn phosphorylates Tau in neuronal cells (Lee et al. 2004). The main Fyn SH3 domain-binding PXXP motif (Pro, Lys, Ser, Pro) in adult rat Tau is at the residues 223-226 (Kosik et al. 1989; Lee et al. 1998).",
      "key": "b890755adc2f35167321b48db71cc24c",
      "line": 181,
      "relation": "association",
      "source": 178,
      "target": 115
    },
    {
      "key": "81502e39a285ea0ef865f3f1c21a0ff7",
      "relation": "hasVariant",
      "source": 177,
      "target": 178
    },
    {
      "key": "8d612fa01cfbe8d6060f3de503bb1b39",
      "relation": "partOf",
      "source": 177,
      "target": 76
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ],
        "date": "2005-10-15",
        "db": "PubMed",
        "db_id": "16176937",
        "db_name": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "first": "Utton MA",
        "journal": "Journal of cell science",
        "last": "Hanger DP",
        "pages": "4645-54",
        "volume": "118"
      },
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "key": "2504b55cf3319f78d44ebf996600ff54",
      "line": 528,
      "relation": "isA",
      "source": 177,
      "target": 76
    },
    {
      "key": "b5173036e8eefa79d60ed626fe09d52c",
      "relation": "partOf",
      "source": 177,
      "target": 77
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ],
        "date": "2005-10-15",
        "db": "PubMed",
        "db_id": "16176937",
        "db_name": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "first": "Utton MA",
        "journal": "Journal of cell science",
        "last": "Hanger DP",
        "pages": "4645-54",
        "volume": "118"
      },
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "key": "da711fab383046671ce1c2e89f3b4fe9",
      "line": 530,
      "relation": "isA",
      "source": 177,
      "target": 77
    },
    {
      "key": "81ac5169f532ac8d467f1682c518af63",
      "relation": "hasVariant",
      "source": 177,
      "target": 179
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ],
        "date": "2010-02-09",
        "db": "PubMed",
        "db_id": "20133804",
        "db_name": "A role for FKBP52 in Tau protein function.",
        "first": "Chambraud B",
        "journal": "Proceedings of the National Academy of Sciences of the United States of America",
        "last": "Baulieu EE",
        "pages": "2658-63",
        "volume": "107"
      },
      "evidence": "We concluded that FKBP52 inhibits the promotion of microtubule assembly by Tau.",
      "key": "dbdc71c4885e54cc1a3ab7f9630d4e32",
      "line": 596,
      "relation": "increases",
      "source": 177,
      "subject": {
        "modifier": "Activity"
      },
      "target": 13
    },
    {
      "annotations": {
        "CellLine": {
          "PC12": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ],
        "date": "2010-02-09",
        "db": "PubMed",
        "db_id": "20133804",
        "db_name": "A role for FKBP52 in Tau protein function.",
        "first": "Chambraud B",
        "journal": "Proceedings of the National Academy of Sciences of the United States of America",
        "last": "Baulieu EE",
        "pages": "2658-63",
        "volume": "107"
      },
      "evidence": "Because one role of Tau is to stimulate neurite outgrowth (12), we investigated the consequence of FKBP52 overexpression on neurite length in both PC12 and H7C2 cells. The inhibition of neurite outgrowth resulting from FKBP52 overexpression is in agreement with our previous report showing that the loss of FKBP52 in PC12 cells results in the formation of neurite extensions (9). The FKBP52 effect on neurite length could be explained by the binding of Tau to FKBP52, removing Tau from microtubules.",
      "key": "d554d27ff13c850aa63cc4a759a91bea",
      "line": 607,
      "relation": "increases",
      "source": 177,
      "subject": {
        "modifier": "Activity"
      },
      "target": 17
    },
    {
      "annotations": {
        "Cell": {
          "oligodendrocyte": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ],
        "date": "2008-10-01",
        "db": "PubMed",
        "db_id": "18680553",
        "db_name": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "first": "Belkadi A",
        "journal": "Journal of neurochemistry",
        "last": "LoPresti P",
        "pages": "351-60",
        "volume": "107"
      },
      "evidence": "Here we demonstrate that the Tau-Fyn interaction has a role in developmental myelination. CG-4 cells were stably transfected with control and experimental truncated Tau and transplanted in the brain and spinal cord of the md rats. In the brain, experimental cells have a severe defect in their ability to extend cellular processes and form myelin; in the spinal cord the cells extend cellular processes but the extent of myelination rostral and caudal to the injection site was decreased compared to control. Cultured experimental cells display shorter cellular process length. In addition experimental cells have Fyn largely in the cell body, whereas control cells distribute Fyn both in the cell body and the processes. Taken together these results demonstrate a direct effect of Tau in OLGs in in vivo myelination.",
      "key": "49ac86dd8765444b218ce8e52a2922f2",
      "line": 199,
      "relation": "positiveCorrelation",
      "source": 19,
      "target": 55
    },
    {
      "annotations": {
        "Cell": {
          "oligodendrocyte": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ],
        "date": "2008-10-01",
        "db": "PubMed",
        "db_id": "18680553",
        "db_name": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "first": "Belkadi A",
        "journal": "Journal of neurochemistry",
        "last": "LoPresti P",
        "pages": "351-60",
        "volume": "107"
      },
      "evidence": "Here we demonstrate that the Tau-Fyn interaction has a role in developmental myelination. CG-4 cells were stably transfected with control and experimental truncated Tau and transplanted in the brain and spinal cord of the md rats. In the brain, experimental cells have a severe defect in their ability to extend cellular processes and form myelin; in the spinal cord the cells extend cellular processes but the extent of myelination rostral and caudal to the injection site was decreased compared to control. Cultured experimental cells display shorter cellular process length. In addition experimental cells have Fyn largely in the cell body, whereas control cells distribute Fyn both in the cell body and the processes. Taken together these results demonstrate a direct effect of Tau in OLGs in in vivo myelination.",
      "key": "ccd5c97cd5da836a6884a78a8a0d68ea",
      "line": 200,
      "relation": "association",
      "source": 19,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "533453efdc43beaa880dafa08a68f493",
      "line": 214,
      "relation": "association",
      "source": 155,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "70f79fd17c3020eb6291e8c405d698b6",
      "line": 216,
      "relation": "equivalentTo",
      "source": 155,
      "target": 166
    },
    {
      "key": "c90a6bfc8180eed253a75c9c754aa94d",
      "relation": "hasVariant",
      "source": 154,
      "target": 155
    },
    {
      "key": "ff8c00056e3f4f83ab84ed664980fd50",
      "relation": "partOf",
      "source": 154,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "112c8bfcca9761998612d30c5ec3586f",
      "line": 217,
      "relation": "isA",
      "source": 154,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "aff7d9bdcbe5b3e4d3978957b7cc62e7",
      "line": 216,
      "relation": "equivalentTo",
      "source": 166,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "bbdade0e9472bf67451b1b87f9cf7d34",
      "line": 221,
      "relation": "equivalentTo",
      "source": 166,
      "target": 149
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "274c61fd41ed7934df2c4f3230347118",
      "line": 219,
      "relation": "association",
      "source": 149,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "a35f97d39a15b4e99fc13109c48f0785",
      "line": 221,
      "relation": "equivalentTo",
      "source": 149,
      "target": 166
    },
    {
      "key": "87cd4d3d152e5792c5f6c8d9af64fc9a",
      "relation": "hasVariant",
      "source": 148,
      "target": 149
    },
    {
      "key": "bb8baccf390e0b485e3e0ac77fb87797",
      "relation": "partOf",
      "source": 148,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "385fc48ea3d2413790162da299484063",
      "line": 223,
      "relation": "isA",
      "source": 148,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "2f08b5e35ed9c15e132a7ed3e8196282",
      "line": 224,
      "relation": "association",
      "source": 117,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "082ce298d7925f8025292140f485bfc6",
      "line": 226,
      "relation": "isA",
      "source": 117,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "d206d4f401c230d9cbe3e5b8cdbdbdf9",
      "line": 228,
      "relation": "equivalentTo",
      "source": 117,
      "target": 160
    },
    {
      "key": "87130fc4239b1223784ece62fcad11df",
      "relation": "hasVariant",
      "source": 116,
      "target": 117
    },
    {
      "key": "ffa0bd7afa8234073a543c2ad6ff5648",
      "relation": "partOf",
      "source": 116,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "cc7d351df70df744f59f96fbc43fcecb",
      "line": 225,
      "relation": "association",
      "source": 56,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "15eeb559a1ed56365e20f97e4a8927f1",
      "line": 228,
      "relation": "equivalentTo",
      "source": 160,
      "target": 117
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "e34963bd1a3c717fac4699e4a866af29",
      "line": 229,
      "relation": "association",
      "source": 144,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "673a90951aabb699f04aaa5c78ca8cbf",
      "line": 231,
      "relation": "equivalentTo",
      "source": 144,
      "target": 165
    },
    {
      "key": "8053e345cbfb4b23eb0ac0a4e82c501e",
      "relation": "hasVariant",
      "source": 143,
      "target": 144
    },
    {
      "key": "93c1e4973a2d9b7329c22a466869806b",
      "relation": "partOf",
      "source": 143,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "f6c6a1bc41aa0ce5738f257803b462f1",
      "line": 233,
      "relation": "isA",
      "source": 143,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Immunofluorescence Imaging": true,
          "Mass Spectrometry": true,
          "Pull-down assay, GST": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ],
        "date": "2008-06-27",
        "db": "PubMed",
        "db_id": "18467332",
        "db_name": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "first": "Reynolds CH",
        "journal": "The Journal of biological chemistry",
        "last": "Anderton BH",
        "pages": "18177-86",
        "volume": "283"
      },
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "key": "a9367da5624737fdd92926c0a61b2819",
      "line": 231,
      "relation": "equivalentTo",
      "source": 165,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28–33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "key": "6ccd7a6852f367a4e138f8a6af9dda91",
      "line": 255,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 124,
      "subject": {
        "modifier": "Activity"
      },
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28–33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "key": "856e1ab3315784d60075debb6b4b8dd6",
      "line": 260,
      "relation": "isA",
      "source": 124,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28–33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "key": "e95af66010ff46310e950d7cee048a9d",
      "line": 258,
      "relation": "association",
      "source": 124,
      "target": 123
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28–33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "key": "1906d1924c789f2349ecc0d5b2c9a217",
      "line": 255,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 25,
      "subject": {
        "modifier": "Activity"
      },
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28–33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "key": "4a38385e1dc6e483c3032b48cfe6a85f",
      "line": 256,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 25,
      "subject": {
        "modifier": "Activity"
      },
      "target": 123
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28–33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "key": "cd2ec07de1a191cd90d32ab6190693cd",
      "line": 262,
      "relation": "positiveCorrelation",
      "source": 25,
      "subject": {
        "modifier": "Activity"
      },
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28–33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "key": "f530547f0a9c762d7132327681510736",
      "line": 256,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 123,
      "subject": {
        "modifier": "Activity"
      },
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28–33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "key": "2c8545152af2aea332d46a8d625673a4",
      "line": 257,
      "relation": "isA",
      "source": 123,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28–33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "key": "389ac399daef7d50b8dbd8684a25fee9",
      "line": 258,
      "relation": "association",
      "source": 123,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28–33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "key": "9480e29056fcef46480c83558eb5c3dd",
      "line": 259,
      "relation": "isA",
      "source": 122,
      "target": 25
    },
    {
      "key": "566e45c971ad4f4e3ab11d1558a8eb96",
      "relation": "partOf",
      "source": 122,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28–33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "key": "ae14ac56ecf89c8b086f232d58c1b901",
      "line": 261,
      "relation": "increases",
      "source": 122,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28–33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "key": "56ad1c49235c74e35b83cfc2123169e3",
      "line": 262,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 18,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down assay, His-tagged": true,
          "Western Blot": true
        },
        "MouseStrain": {
          "K3 model with hyperphoshorylated tau resembling FTD": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "Thus, the lack of kinesin/JIP1 interaction occurs together with an aberrant Tau/JIP1 interaction in K3 brains.Taken together, our data reveal that hyperphosphorylated Tau competes with KLC for the interaction with JIP1.",
      "key": "4db8a9060b9fff2ef13cff07b154f793",
      "line": 272,
      "relation": "association",
      "source": 173,
      "target": 171
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down assay, His-tagged": true,
          "Western Blot": true
        },
        "MouseStrain": {
          "K3 model with hyperphoshorylated tau resembling FTD": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "Thus, the lack of kinesin/JIP1 interaction occurs together with an aberrant Tau/JIP1 interaction in K3 brains.Taken together, our data reveal that hyperphosphorylated Tau competes with KLC for the interaction with JIP1.",
      "key": "4d4877b616caa9b782d0c90cab642ea5",
      "line": 273,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 173,
      "target": 171
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down assay, His-tagged": true,
          "Western Blot": true
        },
        "MouseStrain": {
          "K3 model with hyperphoshorylated tau resembling FTD": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "Thus, the lack of kinesin/JIP1 interaction occurs together with an aberrant Tau/JIP1 interaction in K3 brains.Taken together, our data reveal that hyperphosphorylated Tau competes with KLC for the interaction with JIP1.",
      "key": "c08aacca921320c1d5f60560bedc9b85",
      "line": 274,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 173,
      "target": 170
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down assay, His-tagged": true,
          "Western Blot": true
        },
        "MouseStrain": {
          "K3 model with hyperphoshorylated tau resembling FTD": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "Thus, the lack of kinesin/JIP1 interaction occurs together with an aberrant Tau/JIP1 interaction in K3 brains.Taken together, our data reveal that hyperphosphorylated Tau competes with KLC for the interaction with JIP1.",
      "key": "84bae2f160212708aba1b94907233ff7",
      "line": 275,
      "relation": "negativeCorrelation",
      "source": 173,
      "target": 74
    },
    {
      "key": "d0260d683ca742c4ea3700a18197816c",
      "relation": "hasVariant",
      "source": 172,
      "target": 173
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Western Blot": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ],
        "date": "2008-05-01",
        "db": "PubMed",
        "db_id": "18096814",
        "db_name": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "first": "Williamson R",
        "journal": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "last": "Anderton BH",
        "pages": "1552-9",
        "volume": "22"
      },
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fyn’s localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "key": "b23992fc1158ddd688af0f28071d9a57",
      "line": 917,
      "relation": "negativeCorrelation",
      "source": 172,
      "subject": {
        "location": {
          "name": "membrane raft",
          "namespace": "GO"
        }
      },
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down assay, His-tagged": true,
          "Western Blot": true
        },
        "MouseStrain": {
          "K3 model with hyperphoshorylated tau resembling FTD": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "Thus, the lack of kinesin/JIP1 interaction occurs together with an aberrant Tau/JIP1 interaction in K3 brains.Taken together, our data reveal that hyperphosphorylated Tau competes with KLC for the interaction with JIP1.",
      "key": "8a84e4acb78e3fe936e30760da91d092",
      "line": 272,
      "relation": "association",
      "source": 171,
      "target": 173
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down assay, His-tagged": true,
          "Western Blot": true
        },
        "MouseStrain": {
          "K3 model with hyperphoshorylated tau resembling FTD": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "Thus, the lack of kinesin/JIP1 interaction occurs together with an aberrant Tau/JIP1 interaction in K3 brains.Taken together, our data reveal that hyperphosphorylated Tau competes with KLC for the interaction with JIP1.",
      "key": "dbf7c29c739bba150a7a5e2599f91230",
      "line": 273,
      "relation": "negativeCorrelation",
      "source": 171,
      "subject": {
        "modifier": "Activity"
      },
      "target": 173
    },
    {
      "key": "30981906268c5cb21ca35cab2d31f7fb",
      "relation": "partOf",
      "source": 171,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down assay, His-tagged": true,
          "Western Blot": true
        },
        "MouseStrain": {
          "K3 model with hyperphoshorylated tau resembling FTD": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "Thus, the lack of kinesin/JIP1 interaction occurs together with an aberrant Tau/JIP1 interaction in K3 brains.Taken together, our data reveal that hyperphosphorylated Tau competes with KLC for the interaction with JIP1.",
      "key": "d0197b7a22c60fe3f9575b9ad6910436",
      "line": 274,
      "relation": "negativeCorrelation",
      "source": 170,
      "subject": {
        "modifier": "Activity"
      },
      "target": 173
    },
    {
      "key": "565373dbd3ad10fd343fc601c36d88f5",
      "relation": "partOf",
      "source": 170,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down assay, His-tagged": true,
          "Western Blot": true
        },
        "MouseStrain": {
          "K3 model with hyperphoshorylated tau resembling FTD": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Götz J",
          "Ittner LM",
          "Ke YD"
        ],
        "date": "2009-07-31",
        "db": "PubMed",
        "db_id": "19491104",
        "db_name": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "first": "Ittner LM",
        "journal": "The Journal of biological chemistry",
        "last": "Götz J",
        "pages": "20909-16",
        "volume": "284"
      },
      "evidence": "Thus, the lack of kinesin/JIP1 interaction occurs together with an aberrant Tau/JIP1 interaction in K3 brains.Taken together, our data reveal that hyperphosphorylated Tau competes with KLC for the interaction with JIP1.",
      "key": "7732f94ce91efffe6b0eb34d0f74264a",
      "line": 275,
      "relation": "negativeCorrelation",
      "source": 74,
      "target": 173
    },
    {
      "key": "d196856da106d7405448965313d1f812",
      "relation": "partOf",
      "source": 29,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ],
        "date": "1999-09-03",
        "db": "PubMed",
        "db_id": "10464280",
        "db_name": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "first": "Sontag E",
        "journal": "The Journal of biological chemistry",
        "last": "Bloom GS",
        "pages": "25490-8",
        "volume": "274"
      },
      "evidence": "Using tau deletion mutants, we found that ABaC binds a domain on tau that is indistinguishable from its MT-binding domain.",
      "key": "96863710abb67d781dae6dc0a2a80284",
      "line": 288,
      "relation": "increases",
      "source": 29,
      "subject": {
        "modifier": "Activity"
      },
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ],
        "date": "1999-09-03",
        "db": "PubMed",
        "db_id": "10464280",
        "db_name": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "first": "Sontag E",
        "journal": "The Journal of biological chemistry",
        "last": "Bloom GS",
        "pages": "25490-8",
        "volume": "274"
      },
      "evidence": "Thus, MTs inhibited the rate of tau dephosphorylation by ABaC.",
      "key": "26769932c42134878620aad7a8e7e8a8",
      "line": 306,
      "relation": "increases",
      "source": 29,
      "subject": {
        "modifier": "Activity"
      },
      "target": 184
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ],
        "date": "1999-09-03",
        "db": "PubMed",
        "db_id": "10464280",
        "db_name": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "first": "Sontag E",
        "journal": "The Journal of biological chemistry",
        "last": "Bloom GS",
        "pages": "25490-8",
        "volume": "274"
      },
      "evidence": "ABaC binds directly to MTs through a site that encompasses its catalytic subunit and is distinct from its binding site for tau, and ABaC and tau bind to different domains on MTs.",
      "key": "e96aa2423b33edba629ba00dd32bd4e4",
      "line": 296,
      "relation": "association",
      "source": 150,
      "target": 31
    },
    {
      "key": "29a466fb3c41f63736001174498442d8",
      "relation": "partOf",
      "source": 150,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ],
        "date": "1999-09-03",
        "db": "PubMed",
        "db_id": "10464280",
        "db_name": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "first": "Sontag E",
        "journal": "The Journal of biological chemistry",
        "last": "Bloom GS",
        "pages": "25490-8",
        "volume": "274"
      },
      "evidence": "ABaC binds directly to MTs through a site that encompasses its catalytic subunit and is distinct from its binding site for tau, and ABaC and tau bind to different domains on MTs.",
      "key": "90d294921f2cb04749075aacc323d75c",
      "line": 297,
      "relation": "increases",
      "source": 150,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ],
        "date": "1999-09-03",
        "db": "PubMed",
        "db_id": "10464280",
        "db_name": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "first": "Sontag E",
        "journal": "The Journal of biological chemistry",
        "last": "Bloom GS",
        "pages": "25490-8",
        "volume": "274"
      },
      "evidence": "ABaC binds directly to MTs through a site that encompasses its catalytic subunit and is distinct from its binding site for tau, and ABaC and tau bind to different domains on MTs.",
      "key": "b9200cb253d83b88c8950bf87d391cf7",
      "line": 298,
      "relation": "isA",
      "source": 150,
      "target": 29
    },
    {
      "key": "6c1bee562113945b7f67f787f39a2753",
      "relation": "hasReactant",
      "source": 184,
      "target": 131
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ],
        "date": "1999-09-03",
        "db": "PubMed",
        "db_id": "10464280",
        "db_name": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "first": "Sontag E",
        "journal": "The Journal of biological chemistry",
        "last": "Bloom GS",
        "pages": "25490-8",
        "volume": "274"
      },
      "evidence": "Thus, MTs inhibited the rate of tau dephosphorylation by ABaC.",
      "key": "c7e70772123178f38beee135d2dd68a2",
      "line": 307,
      "relation": "negativeCorrelation",
      "source": 184,
      "target": 131
    },
    {
      "key": "03ded99650622017e19157d16db12045",
      "relation": "hasProduct",
      "source": 184,
      "target": 3
    },
    {
      "key": "599760a22a4f8efd3197f818e46563ab",
      "relation": "hasProduct",
      "source": 184,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Pull-down assay, GST": true,
          "SDS-PAGE": true,
          "Surface Plasmon Resonance": true,
          "Western Blot": true,
          "Yeast Two-Hybrid Assay": true
        }
      },
      "citation": {
        "authors": [
          "Kuret J",
          "Lee G",
          "Sarkar M"
        ],
        "date": "2008-09-01",
        "db": "PubMed",
        "db_id": "18500754",
        "db_name": "Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.",
        "first": "Sarkar M",
        "journal": "Journal of neuroscience research",
        "last": "Lee G",
        "pages": "2763-73",
        "volume": "86"
      },
      "evidence": "The location of the hsc70-binding site in the tau MTBR suggests that hsc70 cannot bind microtubule-associated tau. The location of the hsc70-binding site also suggests that hsc70 might compete with tubulin or microtubules for binding to tau. Our data implicating I308/V309 in tau’s binding to hsp70 similarly suggest that tau cannot bind simultaneously to hsp70 and microtubules. However, unlike hsc70, which does not associate directly with tubulin or microtubules (Gache et al. 2005), hsp70 binds microtubules, presumably through its N-terminus (Sanchez et al. 1994). This would allow hsp70 to simultaneously bind to tau through its C-terminal substrate-binding domain and to microtubules through its N-terminus.",
      "key": "fc9cdd2067fc78ad02f566a8bdd180e6",
      "line": 324,
      "relation": "association",
      "source": 120,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Pull-down assay, GST": true,
          "SDS-PAGE": true,
          "Surface Plasmon Resonance": true,
          "Western Blot": true,
          "Yeast Two-Hybrid Assay": true
        }
      },
      "citation": {
        "authors": [
          "Kuret J",
          "Lee G",
          "Sarkar M"
        ],
        "date": "2008-09-01",
        "db": "PubMed",
        "db_id": "18500754",
        "db_name": "Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.",
        "first": "Sarkar M",
        "journal": "Journal of neuroscience research",
        "last": "Lee G",
        "pages": "2763-73",
        "volume": "86"
      },
      "evidence": "The location of the hsc70-binding site in the tau MTBR suggests that hsc70 cannot bind microtubule-associated tau. The location of the hsc70-binding site also suggests that hsc70 might compete with tubulin or microtubules for binding to tau. Our data implicating I308/V309 in tau’s binding to hsp70 similarly suggest that tau cannot bind simultaneously to hsp70 and microtubules. However, unlike hsc70, which does not associate directly with tubulin or microtubules (Gache et al. 2005), hsp70 binds microtubules, presumably through its N-terminus (Sanchez et al. 1994). This would allow hsp70 to simultaneously bind to tau through its C-terminal substrate-binding domain and to microtubules through its N-terminus.",
      "key": "082d0ae4af54f08e13d7aeb20b7ee22f",
      "line": 325,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 120,
      "subject": {
        "modifier": "Activity"
      },
      "target": 31
    },
    {
      "key": "029bc7fa6214fc8b16e315982bfcfde4",
      "relation": "partOf",
      "source": 120,
      "target": 62
    },
    {
      "key": "c86eda7d4418b8c54f1c9c987deb9034",
      "relation": "partOf",
      "source": 120,
      "target": 52
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Degradation Assay, 20S Proteasomal": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ],
        "date": "2007-12-21",
        "db": "PubMed",
        "db_id": "17954934",
        "db_name": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "first": "Elliott E",
        "journal": "The Journal of biological chemistry",
        "last": "Ginzburg I",
        "pages": "37276-84",
        "volume": "282"
      },
      "evidence": "BAG-1, an Hsp70/Hsc70 binding partner, has been implicated as a mediator of neuronal function. In this work we show that BAG-1 associates with Tau protein in an Hsc70-dependent manner. Overexpression of BAG-1 induced an increase in Tau levels, which is shown to be due to an inhibition of protein degradation.",
      "key": "09d7e24041e09357002864b1abf5ef0c",
      "line": 450,
      "relation": "isA",
      "source": 120,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Pull-down assay, GST": true,
          "SDS-PAGE": true,
          "Surface Plasmon Resonance": true,
          "Western Blot": true,
          "Yeast Two-Hybrid Assay": true
        }
      },
      "citation": {
        "authors": [
          "Kuret J",
          "Lee G",
          "Sarkar M"
        ],
        "date": "2008-09-01",
        "db": "PubMed",
        "db_id": "18500754",
        "db_name": "Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.",
        "first": "Sarkar M",
        "journal": "Journal of neuroscience research",
        "last": "Lee G",
        "pages": "2763-73",
        "volume": "86"
      },
      "evidence": "The location of the hsc70-binding site in the tau MTBR suggests that hsc70 cannot bind microtubule-associated tau. The location of the hsc70-binding site also suggests that hsc70 might compete with tubulin or microtubules for binding to tau. Our data implicating I308/V309 in tau’s binding to hsp70 similarly suggest that tau cannot bind simultaneously to hsp70 and microtubules. However, unlike hsc70, which does not associate directly with tubulin or microtubules (Gache et al. 2005), hsp70 binds microtubules, presumably through its N-terminus (Sanchez et al. 1994). This would allow hsp70 to simultaneously bind to tau through its C-terminal substrate-binding domain and to microtubules through its N-terminus.",
      "key": "329c98d7554aec301bfc53ef7899142e",
      "line": 326,
      "relation": "decreases",
      "source": 71,
      "target": 37
    },
    {
      "key": "25ec63e0bec45702ec577717d8001030",
      "relation": "partOf",
      "source": 161,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Pull-down assay, GST": true,
          "SDS-PAGE": true,
          "Surface Plasmon Resonance": true,
          "Western Blot": true,
          "Yeast Two-Hybrid Assay": true
        }
      },
      "citation": {
        "authors": [
          "Kuret J",
          "Lee G",
          "Sarkar M"
        ],
        "date": "2008-09-01",
        "db": "PubMed",
        "db_id": "18500754",
        "db_name": "Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.",
        "first": "Sarkar M",
        "journal": "Journal of neuroscience research",
        "last": "Lee G",
        "pages": "2763-73",
        "volume": "86"
      },
      "evidence": "The location of the hsc70-binding site in the tau MTBR suggests that hsc70 cannot bind microtubule-associated tau. The location of the hsc70-binding site also suggests that hsc70 might compete with tubulin or microtubules for binding to tau. Our data implicating I308/V309 in tau’s binding to hsp70 similarly suggest that tau cannot bind simultaneously to hsp70 and microtubules. However, unlike hsc70, which does not associate directly with tubulin or microtubules (Gache et al. 2005), hsp70 binds microtubules, presumably through its N-terminus (Sanchez et al. 1994). This would allow hsp70 to simultaneously bind to tau through its C-terminal substrate-binding domain and to microtubules through its N-terminus.",
      "key": "28f22937138fd0cb4c58c9dd8276846c",
      "line": 327,
      "relation": "association",
      "source": 161,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Pull-down assay, GST": true,
          "SDS-PAGE": true,
          "Surface Plasmon Resonance": true,
          "Western Blot": true,
          "Yeast Two-Hybrid Assay": true
        }
      },
      "citation": {
        "authors": [
          "Kuret J",
          "Lee G",
          "Sarkar M"
        ],
        "date": "2008-09-01",
        "db": "PubMed",
        "db_id": "18500754",
        "db_name": "Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.",
        "first": "Sarkar M",
        "journal": "Journal of neuroscience research",
        "last": "Lee G",
        "pages": "2763-73",
        "volume": "86"
      },
      "evidence": "The location of the hsc70-binding site in the tau MTBR suggests that hsc70 cannot bind microtubule-associated tau. The location of the hsc70-binding site also suggests that hsc70 might compete with tubulin or microtubules for binding to tau. Our data implicating I308/V309 in tau’s binding to hsp70 similarly suggest that tau cannot bind simultaneously to hsp70 and microtubules. However, unlike hsc70, which does not associate directly with tubulin or microtubules (Gache et al. 2005), hsp70 binds microtubules, presumably through its N-terminus (Sanchez et al. 1994). This would allow hsp70 to simultaneously bind to tau through its C-terminal substrate-binding domain and to microtubules through its N-terminus.",
      "key": "5d8eaec1e979645107940427044048f1",
      "line": 328,
      "relation": "association",
      "source": 162,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dot Blot": true,
          "Immunoprecipitation": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ],
        "date": "2009-01-01",
        "db": "PubMed",
        "db_id": "19363271",
        "db_name": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "first": "Tortosa E",
        "journal": "Journal of Alzheimer's disease : JAD",
        "last": "Avila J",
        "pages": "319-25",
        "volume": "17"
      },
      "evidence": "This result suggests that the VQIVYK peptide plays a role in the interaction between Hsp90 and tau protein, a hypothesis which is also supported by the fact that a tau variant deleted for the peptide VQIVYK was unable to interact with Hsp90 under immunoprecipitation conditions (Fig. 2B).",
      "key": "0fe3dfa94b4f8c1c08726703c9758e6c",
      "line": 340,
      "relation": "association",
      "source": 95,
      "target": 86
    },
    {
      "key": "724c3cceba581216864cb582f1808483",
      "relation": "partOf",
      "source": 95,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dot Blot": true,
          "Immunoprecipitation": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ],
        "date": "2009-01-01",
        "db": "PubMed",
        "db_id": "19363271",
        "db_name": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "first": "Tortosa E",
        "journal": "Journal of Alzheimer's disease : JAD",
        "last": "Avila J",
        "pages": "319-25",
        "volume": "17"
      },
      "evidence": "This result suggests that the VQIVYK peptide plays a role in the interaction between Hsp90 and tau protein, a hypothesis which is also supported by the fact that a tau variant deleted for the peptide VQIVYK was unable to interact with Hsp90 under immunoprecipitation conditions (Fig. 2B).",
      "key": "45420311ae0bfaeb40d1fb79aa4a3a38",
      "line": 342,
      "relation": "increases",
      "source": 95,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dot Blot": true,
          "Immunoprecipitation": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ],
        "date": "2009-01-01",
        "db": "PubMed",
        "db_id": "19363271",
        "db_name": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "first": "Tortosa E",
        "journal": "Journal of Alzheimer's disease : JAD",
        "last": "Avila J",
        "pages": "319-25",
        "volume": "17"
      },
      "evidence": "To test the effect of Hsp90 on tau phosphorylation, this protein was mixed with tau protein in the presence of GSK-3 and ATP. Figure 4 shows that tau phosphorylation increases in the presence of increased added amounts of Hsp90.",
      "key": "f6b4cfe2ce97e3e5d9337567ac0049c4",
      "line": 350,
      "relation": "positiveCorrelation",
      "source": 95,
      "target": 131
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dot Blot": true,
          "Immunoprecipitation": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ],
        "date": "2009-01-01",
        "db": "PubMed",
        "db_id": "19363271",
        "db_name": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "first": "Tortosa E",
        "journal": "Journal of Alzheimer's disease : JAD",
        "last": "Avila J",
        "pages": "319-25",
        "volume": "17"
      },
      "evidence": "Figure 5 shows the presence of fibrillar polymers when the Hsp90 was mixed with tau protein. These filaments are similar to tau aggregates assembled in the presence of quinones [19] such as juglone, used here as a positive control (Fig. 5C). No filaments were observed in control samples of tau2R alone (Fig. 5A) or Hsp90 alone (data not shown).",
      "key": "0c47bbda0b50ce7cb428c4d2c8b46640",
      "line": 358,
      "relation": "positiveCorrelation",
      "source": 95,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true
        }
      },
      "citation": {
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ],
        "date": "2010-02-09",
        "db": "PubMed",
        "db_id": "20133804",
        "db_name": "A role for FKBP52 in Tau protein function.",
        "first": "Chambraud B",
        "journal": "Proceedings of the National Academy of Sciences of the United States of America",
        "last": "Baulieu EE",
        "pages": "2658-63",
        "volume": "107"
      },
      "evidence": "In addition to its peptidyl–prolyl isomerase activity, FKBP52 serves as a molecular chaperone. This activity depends on its tetratricopeptide repeat domain (27) to which the molecular chaperone HSP90 and other proteins bind.",
      "key": "a4b14be52c5dd9572faf964ecb7f5823",
      "line": 616,
      "relation": "association",
      "source": 95,
      "target": 111
    },
    {
      "key": "82b91286bb42898b8615db989ae14aef",
      "relation": "partOf",
      "source": 95,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "This coordination of kinase triage decisions by Hsp90 requires the co-chaperone Cdc37 (cell division cycle protein 37). The Hsp90/Cdc37 machine is essential for the maturation of a number of kinases, including Akt",
      "key": "9c6f4855d4197158b96fd7418d859437",
      "line": 676,
      "relation": "positiveCorrelation",
      "source": 95,
      "subject": {
        "modifier": "Activity"
      },
      "target": 105
    },
    {
      "key": "a9f5869c1b9ae2c0b4cbdc8ab0c8dcd2",
      "relation": "partOf",
      "source": 95,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dot Blot": true,
          "Immunoprecipitation": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ],
        "date": "2009-01-01",
        "db": "PubMed",
        "db_id": "19363271",
        "db_name": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "first": "Tortosa E",
        "journal": "Journal of Alzheimer's disease : JAD",
        "last": "Avila J",
        "pages": "319-25",
        "volume": "17"
      },
      "evidence": "This result suggests that the VQIVYK peptide plays a role in the interaction between Hsp90 and tau protein, a hypothesis which is also supported by the fact that a tau variant deleted for the peptide VQIVYK was unable to interact with Hsp90 under immunoprecipitation conditions (Fig. 2B).",
      "key": "7bbba407648229ebe53fa30a6424c896",
      "line": 340,
      "relation": "association",
      "source": 86,
      "target": 95
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dot Blot": true,
          "Immunoprecipitation": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ],
        "date": "2009-01-01",
        "db": "PubMed",
        "db_id": "19363271",
        "db_name": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "first": "Tortosa E",
        "journal": "Journal of Alzheimer's disease : JAD",
        "last": "Avila J",
        "pages": "319-25",
        "volume": "17"
      },
      "evidence": "This result suggests that the VQIVYK peptide plays a role in the interaction between Hsp90 and tau protein, a hypothesis which is also supported by the fact that a tau variant deleted for the peptide VQIVYK was unable to interact with Hsp90 under immunoprecipitation conditions (Fig. 2B).",
      "key": "756bb669298fff9ebef45c407a22020d",
      "line": 341,
      "relation": "isA",
      "source": 86,
      "target": 91
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dot Blot": true,
          "Immunoprecipitation": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ],
        "date": "2009-01-01",
        "db": "PubMed",
        "db_id": "19363271",
        "db_name": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "first": "Tortosa E",
        "journal": "Journal of Alzheimer's disease : JAD",
        "last": "Avila J",
        "pages": "319-25",
        "volume": "17"
      },
      "evidence": "This result suggests that the VQIVYK peptide plays a role in the interaction between Hsp90 and tau protein, a hypothesis which is also supported by the fact that a tau variant deleted for the peptide VQIVYK was unable to interact with Hsp90 under immunoprecipitation conditions (Fig. 2B).",
      "key": "255dfa80f12148ceb26adb7bde784bf9",
      "line": 343,
      "relation": "increases",
      "source": 86,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We then investigated what effect over-expression or knockdown of FKBP51 might have on the interaction of tau with other Hsp90 cochaperones that comprise a mature Hsp90 complex. Surprisingly, we found that FKBP51 over-expression decreased the endogenous association of another Hsp90 pro-folding cochaperone, Aha1, with tau despite increasing Hsp90 binding (Fig. 4C). Endogenous p23 binding to tau however was not detected. Conversely, knockdown of FKBP51 with siRNA increased the association of endogenous Aha1 with tau despite decreasing the number of Hsp90 tau complexes. Moreover, endogenous p23 binding to tau was only detectable when FKBP51 was knocked down (Fig. 4C).",
      "key": "9c19798b770f44830c467f0cf9b33a1f",
      "line": 655,
      "relation": "positiveCorrelation",
      "source": 49,
      "target": 113
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dot Blot": true,
          "Immunoprecipitation": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ],
        "date": "2009-01-01",
        "db": "PubMed",
        "db_id": "19363271",
        "db_name": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "first": "Tortosa E",
        "journal": "Journal of Alzheimer's disease : JAD",
        "last": "Avila J",
        "pages": "319-25",
        "volume": "17"
      },
      "evidence": "Figure 5 shows the presence of fibrillar polymers when the Hsp90 was mixed with tau protein. These filaments are similar to tau aggregates assembled in the presence of quinones [19] such as juglone, used here as a positive control (Fig. 5C). No filaments were observed in control samples of tau2R alone (Fig. 5A) or Hsp90 alone (data not shown).",
      "key": "157f595924f55061120d8df66c8af174",
      "line": 358,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 95
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Dot Blot": true,
          "Immunoprecipitation": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ],
        "date": "2009-01-01",
        "db": "PubMed",
        "db_id": "19363271",
        "db_name": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "first": "Tortosa E",
        "journal": "Journal of Alzheimer's disease : JAD",
        "last": "Avila J",
        "pages": "319-25",
        "volume": "17"
      },
      "evidence": "Figure 5 shows the presence of fibrillar polymers when the Hsp90 was mixed with tau protein. These filaments are similar to tau aggregates assembled in the presence of quinones [19] such as juglone, used here as a positive control (Fig. 5C). No filaments were observed in control samples of tau2R alone (Fig. 5A) or Hsp90 alone (data not shown).",
      "key": "c998339addfc544f56bfcf431094a7c8",
      "line": 359,
      "relation": "increases",
      "source": 6,
      "target": 14
    },
    {
      "annotations": {
        "Anatomy": {
          "temporal cortex": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ],
        "date": "2004-04-23",
        "db": "PubMed",
        "db_id": "14963027",
        "db_name": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "17957-62",
        "volume": "279"
      },
      "evidence": "Here we show that heat shock protein 27 (Hsp27) preferentially binds pathological hyperphosphorylated tau and paired helical filaments tau directly but not non-phosphorylated tau. The formation of this complex altered the conformation of pathological hyperphosphorylated tau and reduced its concentration by facilitating its degradation and dephosphorylation.",
      "key": "36b2251c7772d49b0250f12ffd28a272",
      "line": 375,
      "relation": "association",
      "source": 121,
      "target": 130
    },
    {
      "annotations": {
        "Anatomy": {
          "temporal cortex": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ],
        "date": "2004-04-23",
        "db": "PubMed",
        "db_id": "14963027",
        "db_name": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "17957-62",
        "volume": "279"
      },
      "evidence": "Taken together, pathological hyperphosphorylated tau caused cell death, and Hsp27 attenuated the cell toxicity of pathological hyperphosphorylated tau.",
      "key": "3eab9d9549183dc54f63826736f47135",
      "line": 388,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 121,
      "target": 130
    },
    {
      "key": "795c534d71fc6f075730def29e5e4261",
      "relation": "partOf",
      "source": 121,
      "target": 63
    },
    {
      "annotations": {
        "Anatomy": {
          "temporal cortex": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ],
        "date": "2004-04-23",
        "db": "PubMed",
        "db_id": "14963027",
        "db_name": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "17957-62",
        "volume": "279"
      },
      "evidence": "Here we show that heat shock protein 27 (Hsp27) preferentially binds pathological hyperphosphorylated tau and paired helical filaments tau directly but not non-phosphorylated tau. The formation of this complex altered the conformation of pathological hyperphosphorylated tau and reduced its concentration by facilitating its degradation and dephosphorylation.",
      "key": "bca373757a4ec0e3a3faac2fe0aa3536",
      "line": 376,
      "relation": "decreases",
      "source": 121,
      "target": 63
    },
    {
      "key": "bb14d809b3b6bb98ef68b26e3b9693a2",
      "relation": "partOf",
      "source": 121,
      "target": 64
    },
    {
      "annotations": {
        "Anatomy": {
          "temporal cortex": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ],
        "date": "2004-04-23",
        "db": "PubMed",
        "db_id": "14963027",
        "db_name": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "17957-62",
        "volume": "279"
      },
      "evidence": "Here we show that heat shock protein 27 (Hsp27) preferentially binds pathological hyperphosphorylated tau and paired helical filaments tau directly but not non-phosphorylated tau. The formation of this complex altered the conformation of pathological hyperphosphorylated tau and reduced its concentration by facilitating its degradation and dephosphorylation.",
      "key": "4c6020cffbc1da27592774ee305f0f3c",
      "line": 377,
      "relation": "increases",
      "source": 121,
      "target": 64
    },
    {
      "key": "d6cc36f0a251339f112b31f84cc358ed",
      "relation": "partOf",
      "source": 121,
      "target": 44
    },
    {
      "annotations": {
        "Anatomy": {
          "temporal cortex": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ],
        "date": "2004-04-23",
        "db": "PubMed",
        "db_id": "14963027",
        "db_name": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "17957-62",
        "volume": "279"
      },
      "evidence": "Here we show that heat shock protein 27 (Hsp27) preferentially binds pathological hyperphosphorylated tau and paired helical filaments tau directly but not non-phosphorylated tau. The formation of this complex altered the conformation of pathological hyperphosphorylated tau and reduced its concentration by facilitating its degradation and dephosphorylation.",
      "key": "bb1e2cb36c0c51d921e2da10c7c61f5d",
      "line": 378,
      "relation": "increases",
      "source": 121,
      "target": 44
    },
    {
      "key": "342c30fc01a9908723a955323000f05a",
      "relation": "partOf",
      "source": 121,
      "target": 65
    },
    {
      "annotations": {
        "Anatomy": {
          "temporal cortex": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ],
        "date": "2004-04-23",
        "db": "PubMed",
        "db_id": "14963027",
        "db_name": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "17957-62",
        "volume": "279"
      },
      "evidence": "Taken together, pathological hyperphosphorylated tau caused cell death, and Hsp27 attenuated the cell toxicity of pathological hyperphosphorylated tau.",
      "key": "bc213c9c800ce2622c704d2ad6d5495b",
      "line": 389,
      "relation": "negativeCorrelation",
      "source": 121,
      "target": 15
    },
    {
      "annotations": {
        "Anatomy": {
          "temporal cortex": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ],
        "date": "2004-04-23",
        "db": "PubMed",
        "db_id": "14963027",
        "db_name": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "17957-62",
        "volume": "279"
      },
      "evidence": "Here we show that heat shock protein 27 (Hsp27) preferentially binds pathological hyperphosphorylated tau and paired helical filaments tau directly but not non-phosphorylated tau. The formation of this complex altered the conformation of pathological hyperphosphorylated tau and reduced its concentration by facilitating its degradation and dephosphorylation.",
      "key": "5f4eb070873d27015cf3b410a9617800",
      "line": 375,
      "relation": "association",
      "source": 130,
      "target": 121
    },
    {
      "key": "886c28059f958a9c49962953412bef20",
      "relation": "partOf",
      "source": 130,
      "target": 64
    },
    {
      "annotations": {
        "Anatomy": {
          "temporal cortex": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ],
        "date": "2004-04-23",
        "db": "PubMed",
        "db_id": "14963027",
        "db_name": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "17957-62",
        "volume": "279"
      },
      "evidence": "Taken together, pathological hyperphosphorylated tau caused cell death, and Hsp27 attenuated the cell toxicity of pathological hyperphosphorylated tau.",
      "key": "a47fa7400503cdaa838e401f34f7f03e",
      "line": 387,
      "relation": "increases",
      "source": 130,
      "subject": {
        "modifier": "Activity"
      },
      "target": 15
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Degradation Assay, 20S Proteasomal": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ],
        "date": "2007-12-21",
        "db": "PubMed",
        "db_id": "17954934",
        "db_name": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "first": "Elliott E",
        "journal": "The Journal of biological chemistry",
        "last": "Ginzburg I",
        "pages": "37276-84",
        "volume": "282"
      },
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "key": "234eeb2916923ddbbc77c5c604cb06b3",
      "line": 464,
      "relation": "negativeCorrelation",
      "source": 130,
      "target": 104
    },
    {
      "key": "98240d10f1bfe8f3463f2621e2529c2f",
      "relation": "partOf",
      "source": 89,
      "target": 44
    },
    {
      "annotations": {
        "Anatomy": {
          "temporal cortex": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ],
        "date": "2004-04-23",
        "db": "PubMed",
        "db_id": "14963027",
        "db_name": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "17957-62",
        "volume": "279"
      },
      "evidence": "Here we show that heat shock protein 27 (Hsp27) preferentially binds pathological hyperphosphorylated tau and paired helical filaments tau directly but not non-phosphorylated tau. The formation of this complex altered the conformation of pathological hyperphosphorylated tau and reduced its concentration by facilitating its degradation and dephosphorylation.",
      "key": "1896c4d81e293932d39fd700b2bf44f4",
      "line": 380,
      "relation": "increases",
      "source": 65,
      "target": 183
    },
    {
      "annotations": {
        "Anatomy": {
          "temporal cortex": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ],
        "date": "2004-04-23",
        "db": "PubMed",
        "db_id": "14963027",
        "db_name": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "17957-62",
        "volume": "279"
      },
      "evidence": "Here we show that heat shock protein 27 (Hsp27) preferentially binds pathological hyperphosphorylated tau and paired helical filaments tau directly but not non-phosphorylated tau. The formation of this complex altered the conformation of pathological hyperphosphorylated tau and reduced its concentration by facilitating its degradation and dephosphorylation.",
      "key": "1cb4ba38e31b8c971e92b25984e52f11",
      "line": 381,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 65,
      "target": 130
    },
    {
      "key": "bda9a2491a8f287d1933c04368884a3b",
      "relation": "hasReactant",
      "source": 183,
      "target": 130
    },
    {
      "key": "671facb062315303d01df55cd78f95bd",
      "relation": "hasProduct",
      "source": 183,
      "target": 3
    },
    {
      "key": "cdb05a312ef37191aa73875716677a07",
      "relation": "hasProduct",
      "source": 183,
      "target": 125
    },
    {
      "annotations": {
        "Anatomy": {
          "temporal cortex": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ],
        "date": "2004-04-23",
        "db": "PubMed",
        "db_id": "14963027",
        "db_name": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "17957-62",
        "volume": "279"
      },
      "evidence": "Taken together, pathological hyperphosphorylated tau caused cell death, and Hsp27 attenuated the cell toxicity of pathological hyperphosphorylated tau.",
      "key": "e650cc69efe96140751eb4bd9e051f5b",
      "line": 389,
      "relation": "negativeCorrelation",
      "source": 15,
      "target": 121
    },
    {
      "annotations": {
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Deglycosylation Assay": true,
          "Dephosphorylation Assay": true,
          "Immunoblotting": true,
          "Immunocytochemistry": true,
          "Phosphorylation Assay": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Ubiquitination Assay": true
        }
      },
      "citation": {
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ],
        "date": "2004-02-06",
        "db": "PubMed",
        "db_id": "14612456",
        "db_name": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "4869-76",
        "volume": "279"
      },
      "evidence": "This result strongly suggested that the E2 conjugating enzyme for tau ubiquitination is UbcH5B.",
      "key": "082aa8572a8e5539c62d63a18fba119c",
      "line": 402,
      "relation": "positiveCorrelation",
      "source": 157,
      "target": 141
    },
    {
      "key": "d2fe9068f82e5f77127ccce76265bef7",
      "relation": "partOf",
      "source": 157,
      "target": 72
    },
    {
      "annotations": {
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Deglycosylation Assay": true,
          "Dephosphorylation Assay": true,
          "Immunoblotting": true,
          "Immunocytochemistry": true,
          "Phosphorylation Assay": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Ubiquitination Assay": true
        }
      },
      "citation": {
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ],
        "date": "2004-02-06",
        "db": "PubMed",
        "db_id": "14612456",
        "db_name": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "4869-76",
        "volume": "279"
      },
      "evidence": "These data suggest a model by which phosphorylated tau is bound to a chaperone and the complex is recognized by the E3 Ub ligase CHIP. We further examined whether recombinant GST-CHIP ubiquitinates phosphorylated tau in vitro in the presence of UbcH5B and Hsc70. Ubiquitination of phosphorylated tau was detected as high molecular weight bands by immunoblotting with 5E2 in the presence of UbcH5B and Hsc70 (Fig. 2e).",
      "key": "0a49258c4289285fee162222d0ba1240",
      "line": 430,
      "relation": "isA",
      "source": 157,
      "target": 72
    },
    {
      "key": "a5f656c92e0c141376e6fe9cd294c130",
      "relation": "partOf",
      "source": 157,
      "target": 62
    },
    {
      "annotations": {
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Deglycosylation Assay": true,
          "Dephosphorylation Assay": true,
          "Immunoblotting": true,
          "Immunocytochemistry": true,
          "Phosphorylation Assay": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Ubiquitination Assay": true
        }
      },
      "citation": {
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ],
        "date": "2004-02-06",
        "db": "PubMed",
        "db_id": "14612456",
        "db_name": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "4869-76",
        "volume": "279"
      },
      "evidence": "This result strongly suggested that the E2 conjugating enzyme for tau ubiquitination is UbcH5B.",
      "key": "0fd54c87c37816731dbdc72710ea837b",
      "line": 402,
      "relation": "positiveCorrelation",
      "source": 141,
      "target": 157
    },
    {
      "annotations": {
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Deglycosylation Assay": true,
          "Dephosphorylation Assay": true,
          "Immunoblotting": true,
          "Immunocytochemistry": true,
          "Phosphorylation Assay": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Ubiquitination Assay": true
        }
      },
      "citation": {
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ],
        "date": "2004-02-06",
        "db": "PubMed",
        "db_id": "14612456",
        "db_name": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "4869-76",
        "volume": "279"
      },
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 μg of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "key": "ae9ad4b9b0c9703bcfd8b55de66e2d08",
      "line": 422,
      "relation": "positiveCorrelation",
      "source": 141,
      "target": 131
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunoblotting": true,
          "Mass Spectrometry": true,
          "RP HPLC": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ],
        "date": "1993-06-01",
        "db": "PubMed",
        "db_id": "8391280",
        "db_name": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "first": "Morishima-Kawashima M",
        "journal": "Neuron",
        "last": "Ihara Y",
        "pages": "1151-60",
        "volume": "10"
      },
      "evidence": "The ubiquitin-targeted protein was identified as tau in paired helical filaments, and the conjugation sites were localized to the microtubule-binding region.",
      "key": "7dd3ff3d81209dc7a3e29dc98d5cac45",
      "line": 478,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 141,
      "subject": {
        "location": {
          "name": "paired helical filaments",
          "namespace": "CONSO"
        }
      },
      "target": 125
    },
    {
      "annotations": {
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Deglycosylation Assay": true,
          "Dephosphorylation Assay": true,
          "Immunoblotting": true,
          "Immunocytochemistry": true,
          "Phosphorylation Assay": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Ubiquitination Assay": true
        }
      },
      "citation": {
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ],
        "date": "2004-02-06",
        "db": "PubMed",
        "db_id": "14612456",
        "db_name": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "4869-76",
        "volume": "279"
      },
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 μg of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "key": "883f9c944140d6dcb78ff51315e4f79a",
      "line": 418,
      "relation": "isA",
      "source": 133,
      "target": 131
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "2a4ee9841f843b7ec581e35b05031952",
      "line": 639,
      "relation": "isA",
      "source": 133,
      "target": 179
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "c644cab1f53abe6a96eba88c28e2341f",
      "line": 642,
      "relation": "association",
      "source": 133,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "ea34af4a83ded758fbe625b01ad2f678",
      "line": 645,
      "relation": "positiveCorrelation",
      "source": 133,
      "target": 113
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "key": "88a8441ee25870f1e5cf389c2c79461c",
      "line": 686,
      "relation": "positiveCorrelation",
      "source": 133,
      "target": 105
    },
    {
      "annotations": {
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Deglycosylation Assay": true,
          "Dephosphorylation Assay": true,
          "Immunoblotting": true,
          "Immunocytochemistry": true,
          "Phosphorylation Assay": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Ubiquitination Assay": true
        }
      },
      "citation": {
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ],
        "date": "2004-02-06",
        "db": "PubMed",
        "db_id": "14612456",
        "db_name": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "4869-76",
        "volume": "279"
      },
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 μg of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "key": "c91c30220945da10dd299002ab6b2547",
      "line": 419,
      "relation": "isA",
      "source": 138,
      "target": 131
    },
    {
      "annotations": {
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Deglycosylation Assay": true,
          "Dephosphorylation Assay": true,
          "Immunoblotting": true,
          "Immunocytochemistry": true,
          "Phosphorylation Assay": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Ubiquitination Assay": true
        }
      },
      "citation": {
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ],
        "date": "2004-02-06",
        "db": "PubMed",
        "db_id": "14612456",
        "db_name": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "4869-76",
        "volume": "279"
      },
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 μg of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "key": "ab8d062f9b827b0cd7e746bdf029468d",
      "line": 420,
      "relation": "isA",
      "source": 136,
      "target": 131
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "4cf6dd84e46f791f64adc5a107e24438",
      "line": 637,
      "relation": "isA",
      "source": 136,
      "target": 179
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "71506aa0ecfb16012e6f404123eccf6e",
      "line": 640,
      "relation": "association",
      "source": 136,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "89d24aa23124dd68d9a5320fbad609db",
      "line": 643,
      "relation": "positiveCorrelation",
      "source": 136,
      "target": 113
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "key": "78f71acfd2d8408c44f58bee96fbedd9",
      "line": 687,
      "relation": "positiveCorrelation",
      "source": 136,
      "target": 105
    },
    {
      "annotations": {
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Deglycosylation Assay": true,
          "Dephosphorylation Assay": true,
          "Immunoblotting": true,
          "Immunocytochemistry": true,
          "Phosphorylation Assay": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Ubiquitination Assay": true
        }
      },
      "citation": {
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ],
        "date": "2004-02-06",
        "db": "PubMed",
        "db_id": "14612456",
        "db_name": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "4869-76",
        "volume": "279"
      },
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 μg of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "key": "9edb5670a7a81fe3def94c0ffde5af26",
      "line": 421,
      "relation": "isA",
      "source": 137,
      "target": 131
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "key": "174d4f372e1dc08828e4ca8a354ee942",
      "line": 688,
      "relation": "positiveCorrelation",
      "source": 137,
      "target": 105
    },
    {
      "key": "9a50ebf4909656553311ecb5669c9cca",
      "relation": "partOf",
      "source": 156,
      "target": 72
    },
    {
      "annotations": {
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Deglycosylation Assay": true,
          "Dephosphorylation Assay": true,
          "Immunoblotting": true,
          "Immunocytochemistry": true,
          "Phosphorylation Assay": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Ubiquitination Assay": true
        }
      },
      "citation": {
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ],
        "date": "2004-02-06",
        "db": "PubMed",
        "db_id": "14612456",
        "db_name": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "4869-76",
        "volume": "279"
      },
      "evidence": "These data suggest a model by which phosphorylated tau is bound to a chaperone and the complex is recognized by the E3 Ub ligase CHIP. We further examined whether recombinant GST-CHIP ubiquitinates phosphorylated tau in vitro in the presence of UbcH5B and Hsc70. Ubiquitination of phosphorylated tau was detected as high molecular weight bands by immunoblotting with 5E2 in the presence of UbcH5B and Hsc70 (Fig. 2e).",
      "key": "92ef908e37de3e858788725357bd0353",
      "line": 431,
      "relation": "isA",
      "source": 156,
      "target": 72
    },
    {
      "key": "f50aee445edd2ef1729ebd9381de9147",
      "relation": "partOf",
      "source": 156,
      "target": 62
    },
    {
      "annotations": {
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Deglycosylation Assay": true,
          "Dephosphorylation Assay": true,
          "Immunoblotting": true,
          "Immunocytochemistry": true,
          "Phosphorylation Assay": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true,
          "Ubiquitination Assay": true
        }
      },
      "citation": {
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ],
        "date": "2004-02-06",
        "db": "PubMed",
        "db_id": "14612456",
        "db_name": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "first": "Shimura H",
        "journal": "The Journal of biological chemistry",
        "last": "Kosik KS",
        "pages": "4869-76",
        "volume": "279"
      },
      "evidence": "These data suggest a model by which phosphorylated tau is bound to a chaperone and the complex is recognized by the E3 Ub ligase CHIP. We further examined whether recombinant GST-CHIP ubiquitinates phosphorylated tau in vitro in the presence of UbcH5B and Hsc70. Ubiquitination of phosphorylated tau was detected as high molecular weight bands by immunoblotting with 5E2 in the presence of UbcH5B and Hsc70 (Fig. 2e).",
      "key": "ff3af4b23f5fca30dff46aa395772b48",
      "line": 433,
      "relation": "directlyIncreases",
      "source": 62,
      "target": 141
    },
    {
      "key": "34b358e44a3b267df27202bbd1efc241",
      "relation": "partOf",
      "source": 104,
      "target": 52
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Degradation Assay, 20S Proteasomal": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ],
        "date": "2007-12-21",
        "db": "PubMed",
        "db_id": "17954934",
        "db_name": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "first": "Elliott E",
        "journal": "The Journal of biological chemistry",
        "last": "Ginzburg I",
        "pages": "37276-84",
        "volume": "282"
      },
      "evidence": "BAG-1, an Hsp70/Hsc70 binding partner, has been implicated as a mediator of neuronal function. In this work we show that BAG-1 associates with Tau protein in an Hsc70-dependent manner. Overexpression of BAG-1 induced an increase in Tau levels, which is shown to be due to an inhibition of protein degradation.",
      "key": "3a2989582c5ac8e1109640eec02c0c13",
      "line": 448,
      "relation": "isA",
      "source": 104,
      "target": 52
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Degradation Assay, 20S Proteasomal": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ],
        "date": "2007-12-21",
        "db": "PubMed",
        "db_id": "17954934",
        "db_name": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "first": "Elliott E",
        "journal": "The Journal of biological chemistry",
        "last": "Ginzburg I",
        "pages": "37276-84",
        "volume": "282"
      },
      "evidence": "BAG-1, an Hsp70/Hsc70 binding partner, has been implicated as a mediator of neuronal function. In this work we show that BAG-1 associates with Tau protein in an Hsc70-dependent manner. Overexpression of BAG-1 induced an increase in Tau levels, which is shown to be due to an inhibition of protein degradation.",
      "key": "9ba8f8176f6b2cc3138007ed6a1474ab",
      "line": 451,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 104,
      "target": 10
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Degradation Assay, 20S Proteasomal": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ],
        "date": "2007-12-21",
        "db": "PubMed",
        "db_id": "17954934",
        "db_name": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "first": "Elliott E",
        "journal": "The Journal of biological chemistry",
        "last": "Ginzburg I",
        "pages": "37276-84",
        "volume": "282"
      },
      "evidence": "BAG-1, an Hsp70/Hsc70 binding partner, has been implicated as a mediator of neuronal function. In this work we show that BAG-1 associates with Tau protein in an Hsc70-dependent manner. Overexpression of BAG-1 induced an increase in Tau levels, which is shown to be due to an inhibition of protein degradation.",
      "key": "7c687af3115dd495340cc87bca75123d",
      "line": 452,
      "relation": "increases",
      "source": 104,
      "target": 125
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Degradation Assay, 20S Proteasomal": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ],
        "date": "2007-12-21",
        "db": "PubMed",
        "db_id": "17954934",
        "db_name": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "first": "Elliott E",
        "journal": "The Journal of biological chemistry",
        "last": "Ginzburg I",
        "pages": "37276-84",
        "volume": "282"
      },
      "evidence": "BAG-1, an Hsp70/Hsc70 binding partner, has been implicated as a mediator of neuronal function. In this work we show that BAG-1 associates with Tau protein in an Hsc70-dependent manner. Overexpression of BAG-1 induced an increase in Tau levels, which is shown to be due to an inhibition of protein degradation.",
      "key": "aba6b99c181d47e293362c72f0898077",
      "line": 453,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 104,
      "target": 125
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Degradation Assay, 20S Proteasomal": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ],
        "date": "2007-12-21",
        "db": "PubMed",
        "db_id": "17954934",
        "db_name": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "first": "Elliott E",
        "journal": "The Journal of biological chemistry",
        "last": "Ginzburg I",
        "pages": "37276-84",
        "volume": "282"
      },
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "key": "541f69dfca04a45741d51a46f9403267",
      "line": 459,
      "relation": "positiveCorrelation",
      "source": 104,
      "target": 125
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Degradation Assay, 20S Proteasomal": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ],
        "date": "2007-12-21",
        "db": "PubMed",
        "db_id": "17954934",
        "db_name": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "first": "Elliott E",
        "journal": "The Journal of biological chemistry",
        "last": "Ginzburg I",
        "pages": "37276-84",
        "volume": "282"
      },
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "key": "46d2695571ece52b313ea2abb22c5078",
      "line": 462,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 104,
      "target": 125
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Degradation Assay, 20S Proteasomal": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ],
        "date": "2007-12-21",
        "db": "PubMed",
        "db_id": "17954934",
        "db_name": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "first": "Elliott E",
        "journal": "The Journal of biological chemistry",
        "last": "Ginzburg I",
        "pages": "37276-84",
        "volume": "282"
      },
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "key": "0a5bf6a8cd906aa73f1c5b4a2dd6a8bf",
      "line": 463,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 104,
      "target": 28
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Degradation Assay, 20S Proteasomal": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ],
        "date": "2007-12-21",
        "db": "PubMed",
        "db_id": "17954934",
        "db_name": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "first": "Elliott E",
        "journal": "The Journal of biological chemistry",
        "last": "Ginzburg I",
        "pages": "37276-84",
        "volume": "282"
      },
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "key": "5c95da5447a6e641ca9d2fb33a647a58",
      "line": 464,
      "relation": "negativeCorrelation",
      "source": 104,
      "target": 130
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Degradation Assay, 20S Proteasomal": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ],
        "date": "2007-12-21",
        "db": "PubMed",
        "db_id": "17954934",
        "db_name": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "first": "Elliott E",
        "journal": "The Journal of biological chemistry",
        "last": "Ginzburg I",
        "pages": "37276-84",
        "volume": "282"
      },
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "key": "9e88f8a130968efd2c0123bef69429ec",
      "line": 465,
      "relation": "causesNoChange",
      "source": 104,
      "target": 141
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Degradation Assay, 20S Proteasomal": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ],
        "date": "2007-12-21",
        "db": "PubMed",
        "db_id": "17954934",
        "db_name": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "first": "Elliott E",
        "journal": "The Journal of biological chemistry",
        "last": "Ginzburg I",
        "pages": "37276-84",
        "volume": "282"
      },
      "evidence": "BAG-1, an Hsp70/Hsc70 binding partner, has been implicated as a mediator of neuronal function. In this work we show that BAG-1 associates with Tau protein in an Hsc70-dependent manner. Overexpression of BAG-1 induced an increase in Tau levels, which is shown to be due to an inhibition of protein degradation.",
      "key": "117e61c13e6383858e29fbd1ebf205bf",
      "line": 451,
      "relation": "association",
      "source": 10,
      "subject": {
        "modifier": "Activity"
      },
      "target": 104
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Degradation Assay, 20S Proteasomal": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ],
        "date": "2007-12-21",
        "db": "PubMed",
        "db_id": "17954934",
        "db_name": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "first": "Elliott E",
        "journal": "The Journal of biological chemistry",
        "last": "Ginzburg I",
        "pages": "37276-84",
        "volume": "282"
      },
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "key": "7c57cfe3efdb06b408d73703a3296f70",
      "line": 460,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 28,
      "subject": {
        "modifier": "Activity"
      },
      "target": 125
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Degradation Assay, 20S Proteasomal": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ],
        "date": "2007-12-21",
        "db": "PubMed",
        "db_id": "17954934",
        "db_name": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "first": "Elliott E",
        "journal": "The Journal of biological chemistry",
        "last": "Ginzburg I",
        "pages": "37276-84",
        "volume": "282"
      },
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "key": "7fa5cd0a47ea738b622519095afb2223",
      "line": 461,
      "relation": "isA",
      "source": 28,
      "subject": {
        "modifier": "Activity"
      },
      "target": 28
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Degradation Assay, 20S Proteasomal": true,
          "Immunohistochemistry": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ],
        "date": "2007-12-21",
        "db": "PubMed",
        "db_id": "17954934",
        "db_name": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "first": "Elliott E",
        "journal": "The Journal of biological chemistry",
        "last": "Ginzburg I",
        "pages": "37276-84",
        "volume": "282"
      },
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "key": "ceb6f8ea6555dc13f18abb32eec7e37f",
      "line": 463,
      "relation": "negativeCorrelation",
      "source": 28,
      "subject": {
        "modifier": "Activity"
      },
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunoblotting": true,
          "Mass Spectrometry": true,
          "RP HPLC": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ],
        "date": "1993-06-01",
        "db": "PubMed",
        "db_id": "8391280",
        "db_name": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "first": "Morishima-Kawashima M",
        "journal": "Neuron",
        "last": "Ihara Y",
        "pages": "1151-60",
        "volume": "10"
      },
      "evidence": "The ubiquitin-targeted protein was identified as tau in paired helical filaments, and the conjugation sites were localized to the microtubule-binding region.",
      "key": "57406e600e1980068657df5b79462f29",
      "line": 479,
      "relation": "association",
      "source": 98,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunoblotting": true,
          "Mass Spectrometry": true,
          "RP HPLC": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ],
        "date": "1993-06-01",
        "db": "PubMed",
        "db_id": "8391280",
        "db_name": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "first": "Morishima-Kawashima M",
        "journal": "Neuron",
        "last": "Ihara Y",
        "pages": "1151-60",
        "volume": "10"
      },
      "evidence": "The ubiquitin-targeted protein was identified as tau in paired helical filaments, and the conjugation sites were localized to the microtubule-binding region.",
      "key": "8cd03e0027f2959a875c1a7b7cebfd6b",
      "line": 480,
      "relation": "directlyIncreases",
      "source": 98,
      "target": 141
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Electron Microscopy": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ],
        "date": "1993-06-01",
        "db": "PubMed",
        "db_id": "8391280",
        "db_name": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "first": "Morishima-Kawashima M",
        "journal": "Neuron",
        "last": "Ihara Y",
        "pages": "1151-60",
        "volume": "10"
      },
      "evidence": "We show here for the first time that the N-terminal projection domain of tau binds to the C-terminus of the p150 subunit of the dynactin complex. The sequences of tau encoded by exons 1 and 4, which lie at the tip of the N-terminal projection domain, interact with the C-terminal region of p150.",
      "key": "2d29bebd66322980e33e8160d7413a87",
      "line": 491,
      "relation": "association",
      "source": 164,
      "target": 108
    },
    {
      "annotations": {
        "CellLine": {
          "PC12": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Electron Microscopy, Immunological": true,
          "Immunoblotting": true,
          "Immunofluorescence": true,
          "Immunoprecipitation": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ],
        "date": "2003-04-11",
        "db": "PubMed",
        "db_id": "12551948",
        "db_name": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "first": "Agarwal-Mawal A",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "12722-8",
        "volume": "278"
      },
      "evidence": "The results suggest that the amino-terminal fragment suppresses neurite outgrowth by competing for plasma membrane binding.",
      "key": "138729491e0be7c498627902cdaccdf6",
      "line": 871,
      "relation": "decreases",
      "source": 164,
      "target": 17
    },
    {
      "annotations": {
        "CellLine": {
          "PC12": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Electron Microscopy, Immunological": true,
          "Immunoblotting": true,
          "Immunofluorescence": true,
          "Immunoprecipitation": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ],
        "date": "2003-04-11",
        "db": "PubMed",
        "db_id": "12551948",
        "db_name": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "first": "Agarwal-Mawal A",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "12722-8",
        "volume": "278"
      },
      "evidence": "The results suggest that the amino-terminal fragment suppresses neurite outgrowth by competing for plasma membrane binding.",
      "key": "1b6243a6d91b7e4ad5f61c5914243946",
      "line": 872,
      "object": {
        "location": {
          "name": "plasma membrane",
          "namespace": "GO"
        }
      },
      "relation": "isA",
      "source": 164,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Electron Microscopy": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ],
        "date": "1993-06-01",
        "db": "PubMed",
        "db_id": "8391280",
        "db_name": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "first": "Morishima-Kawashima M",
        "journal": "Neuron",
        "last": "Ihara Y",
        "pages": "1151-60",
        "volume": "10"
      },
      "evidence": "We show here for the first time that the N-terminal projection domain of tau binds to the C-terminus of the p150 subunit of the dynactin complex. The sequences of tau encoded by exons 1 and 4, which lie at the tip of the N-terminal projection domain, interact with the C-terminal region of p150.",
      "key": "5ba6bd4b71db61bd4f23e44ddf1fa830",
      "line": 491,
      "relation": "association",
      "source": 108,
      "target": 164
    },
    {
      "key": "ca0e29ff2f57a44a7e8571ff92db7700",
      "relation": "partOf",
      "source": 108,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Electron Microscopy": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ],
        "date": "1993-06-01",
        "db": "PubMed",
        "db_id": "8391280",
        "db_name": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "first": "Morishima-Kawashima M",
        "journal": "Neuron",
        "last": "Ihara Y",
        "pages": "1151-60",
        "volume": "10"
      },
      "evidence": "We show here for the first time that the N-terminal projection domain of tau binds to the C-terminus of the p150 subunit of the dynactin complex. The sequences of tau encoded by exons 1 and 4, which lie at the tip of the N-terminal projection domain, interact with the C-terminal region of p150.",
      "key": "f1a5a458b4299207e3576dba29505aff",
      "line": 494,
      "relation": "isA",
      "source": 108,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Electron Microscopy": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ],
        "date": "1993-06-01",
        "db": "PubMed",
        "db_id": "8391280",
        "db_name": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "first": "Morishima-Kawashima M",
        "journal": "Neuron",
        "last": "Ihara Y",
        "pages": "1151-60",
        "volume": "10"
      },
      "evidence": "We show here for the first time that the N-terminal projection domain of tau binds to the C-terminus of the p150 subunit of the dynactin complex. The sequences of tau encoded by exons 1 and 4, which lie at the tip of the N-terminal projection domain, interact with the C-terminal region of p150.",
      "key": "53f66e35b0d8dd31f6503a697cfcf9e0",
      "line": 495,
      "relation": "isA",
      "source": 108,
      "target": 159
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Electron Microscopy": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ],
        "date": "1993-06-01",
        "db": "PubMed",
        "db_id": "8391280",
        "db_name": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "first": "Morishima-Kawashima M",
        "journal": "Neuron",
        "last": "Ihara Y",
        "pages": "1151-60",
        "volume": "10"
      },
      "evidence": "We show here for the first time that the N-terminal projection domain of tau binds to the C-terminus of the p150 subunit of the dynactin complex. The sequences of tau encoded by exons 1 and 4, which lie at the tip of the N-terminal projection domain, interact with the C-terminal region of p150.",
      "key": "18d6a07bb9b613dc58413e6ead7c92aa",
      "line": 496,
      "relation": "isA",
      "source": 53,
      "target": 159
    },
    {
      "annotations": {
        "Anatomy": {
          "ganglionic layer of retina": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Electron Microscopy": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ],
        "date": "1993-06-01",
        "db": "PubMed",
        "db_id": "8391280",
        "db_name": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "first": "Morishima-Kawashima M",
        "journal": "Neuron",
        "last": "Ihara Y",
        "pages": "1151-60",
        "volume": "10"
      },
      "evidence": "Mutations of a conserved arginine residue in the Nterminus of tau, found in patients with FTDP-17, affect its binding to dynactin, which is abnormally distributed in the retinal ganglion cell axons of transgenic mice expressing human tau with a mutation in the microtubule-binding domain.",
      "key": "5d01cb5f30b0cc572897192afcfb49d7",
      "line": 511,
      "relation": "negativeCorrelation",
      "source": 53,
      "target": 81
    },
    {
      "key": "0ab0a86b2e96189632ba5df7b384f740",
      "relation": "partOf",
      "source": 159,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Electron Microscopy": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ],
        "date": "1993-06-01",
        "db": "PubMed",
        "db_id": "8391280",
        "db_name": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "first": "Morishima-Kawashima M",
        "journal": "Neuron",
        "last": "Ihara Y",
        "pages": "1151-60",
        "volume": "10"
      },
      "evidence": "Tau and dynactin show extensive colocalization, and the attachment of the dynactin complex to microtubules is enhanced by tau.",
      "key": "eaa5a9a673de4c499d170f4af8c22f8a",
      "line": 501,
      "relation": "positiveCorrelation",
      "source": 159,
      "subject": {
        "modifier": "Activity"
      },
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Electron Microscopy": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ],
        "date": "1993-06-01",
        "db": "PubMed",
        "db_id": "8391280",
        "db_name": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "first": "Morishima-Kawashima M",
        "journal": "Neuron",
        "last": "Ihara Y",
        "pages": "1151-60",
        "volume": "10"
      },
      "evidence": "Tau and dynactin show extensive colocalization, and the attachment of the dynactin complex to microtubules is enhanced by tau.",
      "key": "bea10e7677bc692880577946b9604306",
      "line": 501,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 38,
      "target": 159
    },
    {
      "annotations": {
        "Anatomy": {
          "ganglionic layer of retina": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Electron Microscopy": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ],
        "date": "1993-06-01",
        "db": "PubMed",
        "db_id": "8391280",
        "db_name": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "first": "Morishima-Kawashima M",
        "journal": "Neuron",
        "last": "Ihara Y",
        "pages": "1151-60",
        "volume": "10"
      },
      "evidence": "Mutations of a conserved arginine residue in the Nterminus of tau, found in patients with FTDP-17, affect its binding to dynactin, which is abnormally distributed in the retinal ganglion cell axons of transgenic mice expressing human tau with a mutation in the microtubule-binding domain.",
      "key": "cad3bc569c4acce56e34f18d770e716a",
      "line": 510,
      "relation": "positiveCorrelation",
      "source": 81,
      "target": 182
    },
    {
      "annotations": {
        "Anatomy": {
          "ganglionic layer of retina": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Electron Microscopy": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ],
        "date": "1993-06-01",
        "db": "PubMed",
        "db_id": "8391280",
        "db_name": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "first": "Morishima-Kawashima M",
        "journal": "Neuron",
        "last": "Ihara Y",
        "pages": "1151-60",
        "volume": "10"
      },
      "evidence": "Mutations of a conserved arginine residue in the Nterminus of tau, found in patients with FTDP-17, affect its binding to dynactin, which is abnormally distributed in the retinal ganglion cell axons of transgenic mice expressing human tau with a mutation in the microtubule-binding domain.",
      "key": "dd3d3f2f92421e18eff5ef8d2e65372a",
      "line": 511,
      "relation": "negativeCorrelation",
      "source": 81,
      "target": 53
    },
    {
      "annotations": {
        "Anatomy": {
          "ganglionic layer of retina": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Electron Microscopy": true,
          "Immunoblotting": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true,
          "SDS-PAGE": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ],
        "date": "1993-06-01",
        "db": "PubMed",
        "db_id": "8391280",
        "db_name": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "first": "Morishima-Kawashima M",
        "journal": "Neuron",
        "last": "Ihara Y",
        "pages": "1151-60",
        "volume": "10"
      },
      "evidence": "Mutations of a conserved arginine residue in the Nterminus of tau, found in patients with FTDP-17, affect its binding to dynactin, which is abnormally distributed in the retinal ganglion cell axons of transgenic mice expressing human tau with a mutation in the microtubule-binding domain.",
      "key": "dad649a1fe4f8ae5f979ea4890a87b2d",
      "line": 510,
      "relation": "positiveCorrelation",
      "source": 182,
      "target": 81
    },
    {
      "key": "0b5a26907b590a4061adac50f71b4596",
      "relation": "partOf",
      "source": 175,
      "target": 76
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ],
        "date": "2005-10-15",
        "db": "PubMed",
        "db_id": "16176937",
        "db_name": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "first": "Utton MA",
        "journal": "Journal of cell science",
        "last": "Hanger DP",
        "pages": "4645-54",
        "volume": "118"
      },
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "key": "02d226ec72d235e4d448a51c388c28f3",
      "line": 529,
      "relation": "isA",
      "source": 175,
      "target": 76
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ],
        "date": "2005-10-15",
        "db": "PubMed",
        "db_id": "16176937",
        "db_name": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "first": "Utton MA",
        "journal": "Journal of cell science",
        "last": "Hanger DP",
        "pages": "4645-54",
        "volume": "118"
      },
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "key": "cbdd6a191a02dad4fe4d9bca79b310af",
      "line": 532,
      "relation": "isA",
      "source": 175,
      "target": 163
    },
    {
      "key": "730459086bf2ae26857f783d3d7821ca",
      "relation": "partOf",
      "source": 176,
      "target": 77
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ],
        "date": "2005-10-15",
        "db": "PubMed",
        "db_id": "16176937",
        "db_name": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "first": "Utton MA",
        "journal": "Journal of cell science",
        "last": "Hanger DP",
        "pages": "4645-54",
        "volume": "118"
      },
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "key": "c1b1059e64a1181f6f80c30a1ab06db5",
      "line": 531,
      "relation": "isA",
      "source": 176,
      "target": 77
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ],
        "date": "2005-10-15",
        "db": "PubMed",
        "db_id": "16176937",
        "db_name": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "first": "Utton MA",
        "journal": "Journal of cell science",
        "last": "Hanger DP",
        "pages": "4645-54",
        "volume": "118"
      },
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "key": "8186f4e9aad4f795139f1eb6e7ab0ec3",
      "line": 533,
      "relation": "isA",
      "source": 176,
      "target": 163
    },
    {
      "key": "9832bc4da258030a472e5a5899942d6e",
      "relation": "partOf",
      "source": 176,
      "target": 78
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ],
        "date": "2005-10-15",
        "db": "PubMed",
        "db_id": "16176937",
        "db_name": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "first": "Utton MA",
        "journal": "Journal of cell science",
        "last": "Hanger DP",
        "pages": "4645-54",
        "volume": "118"
      },
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "key": "76cffba589df03ad4aa8af0c1631900e",
      "line": 535,
      "relation": "association",
      "source": 163,
      "target": 180
    },
    {
      "key": "722136aaa4297e616e08fb4e7870dd92",
      "relation": "partOf",
      "source": 180,
      "target": 45
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ],
        "date": "2005-10-15",
        "db": "PubMed",
        "db_id": "16176937",
        "db_name": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "first": "Utton MA",
        "journal": "Journal of cell science",
        "last": "Hanger DP",
        "pages": "4645-54",
        "volume": "118"
      },
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "key": "f9076464c5e2090139d59930302fe6af",
      "line": 534,
      "relation": "isA",
      "source": 180,
      "target": 45
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ],
        "date": "2005-10-15",
        "db": "PubMed",
        "db_id": "16176937",
        "db_name": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "first": "Utton MA",
        "journal": "Journal of cell science",
        "last": "Hanger DP",
        "pages": "4645-54",
        "volume": "118"
      },
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "key": "e2f276ecfa28e77c07cc0dec12cb3b1c",
      "line": 535,
      "relation": "association",
      "source": 180,
      "target": 163
    },
    {
      "key": "ea0677be1bda65e639999e7910463dad",
      "relation": "partOf",
      "source": 180,
      "target": 78
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ],
        "date": "2005-10-15",
        "db": "PubMed",
        "db_id": "16176937",
        "db_name": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "first": "Utton MA",
        "journal": "Journal of cell science",
        "last": "Hanger DP",
        "pages": "4645-54",
        "volume": "118"
      },
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "key": "50d6cd535917d86d69e277750fa4d8d2",
      "line": 537,
      "relation": "decreases",
      "source": 180,
      "target": 78
    },
    {
      "key": "2e988921e927062364e86a0268e01aee",
      "relation": "partOf",
      "source": 93,
      "target": 45
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunofluorescence": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ],
        "date": "2005-10-15",
        "db": "PubMed",
        "db_id": "16176937",
        "db_name": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "first": "Utton MA",
        "journal": "Journal of cell science",
        "last": "Hanger DP",
        "pages": "4645-54",
        "volume": "118"
      },
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "key": "c241ffb2c810c040494ab2113964042b",
      "line": 536,
      "relation": "isA",
      "source": 93,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "ELISA": true,
          "Immunocytochemistry": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true
        }
      },
      "citation": {
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ],
        "date": "1999-06-24",
        "db": "PubMed",
        "db_id": "10391244",
        "db_name": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "first": "Lu PJ",
        "journal": "Nature",
        "last": "Lu KP",
        "pages": "784-8",
        "volume": "399"
      },
      "evidence": "In contrast, no binding was observed between Pin1 and the nonphosphorylated tau (Fig. 4a), demonstrating that T231 phosphorylation is required for Pin1 binding of tau. To determine whether the WW domain of Pin1 is responsible for binding, the mutant Pin1Y23A was used, which contains a single alanine substitution at the critical Tyr 23 in the WW-domain, resulting in a loss of the phosphoserine-binding activity [13]. Pin1Y23A showed much less binding to pT231 peptide (Table 1). The residual binding might be due to binding of the pT231 peptide to the much lower affinity isomerase domain of Pin113. These results indicate that the WW domain mediates Pin1 binding to the pT231 sequence of tau.",
      "key": "ee3be8ed758e90e0df1199922eed427b",
      "line": 554,
      "relation": "association",
      "source": 146,
      "target": 140
    },
    {
      "key": "c56083e7d0d1f560c081d925b755251a",
      "relation": "partOf",
      "source": 146,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "ELISA": true,
          "Immunocytochemistry": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true
        }
      },
      "citation": {
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ],
        "date": "1999-06-24",
        "db": "PubMed",
        "db_id": "10391244",
        "db_name": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "first": "Lu PJ",
        "journal": "Nature",
        "last": "Lu KP",
        "pages": "784-8",
        "volume": "399"
      },
      "evidence": "In contrast, no binding was observed between Pin1 and the nonphosphorylated tau (Fig. 4a), demonstrating that T231 phosphorylation is required for Pin1 binding of tau. To determine whether the WW domain of Pin1 is responsible for binding, the mutant Pin1Y23A was used, which contains a single alanine substitution at the critical Tyr 23 in the WW-domain, resulting in a loss of the phosphoserine-binding activity [13]. Pin1Y23A showed much less binding to pT231 peptide (Table 1). The residual binding might be due to binding of the pT231 peptide to the much lower affinity isomerase domain of Pin113. These results indicate that the WW domain mediates Pin1 binding to the pT231 sequence of tau.",
      "key": "78374e52ba3d8c3083f57e2d9f7872d6",
      "line": 555,
      "relation": "positiveCorrelation",
      "source": 146,
      "subject": {
        "modifier": "Activity"
      },
      "target": 73
    },
    {
      "key": "86804ba881f5360336543e19d4e261f7",
      "relation": "hasVariant",
      "source": 145,
      "target": 146
    },
    {
      "key": "b8cc14ea60734d1d5a6f7828a9c7f14f",
      "relation": "hasVariant",
      "source": 145,
      "target": 147
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "ELISA": true,
          "Immunocytochemistry": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true
        }
      },
      "citation": {
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ],
        "date": "1999-06-24",
        "db": "PubMed",
        "db_id": "10391244",
        "db_name": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "first": "Lu PJ",
        "journal": "Nature",
        "last": "Lu KP",
        "pages": "784-8",
        "volume": "399"
      },
      "evidence": "In contrast, no binding was observed between Pin1 and the nonphosphorylated tau (Fig. 4a), demonstrating that T231 phosphorylation is required for Pin1 binding of tau. To determine whether the WW domain of Pin1 is responsible for binding, the mutant Pin1Y23A was used, which contains a single alanine substitution at the critical Tyr 23 in the WW-domain, resulting in a loss of the phosphoserine-binding activity [13]. Pin1Y23A showed much less binding to pT231 peptide (Table 1). The residual binding might be due to binding of the pT231 peptide to the much lower affinity isomerase domain of Pin113. These results indicate that the WW domain mediates Pin1 binding to the pT231 sequence of tau.",
      "key": "ee1c757249f8a81e82d29cfd467a6fec",
      "line": 554,
      "relation": "association",
      "source": 140,
      "target": 146
    },
    {
      "key": "2b37f3e5bd2ddf2730c4eb4986dc8d95",
      "relation": "partOf",
      "source": 140,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "ELISA": true,
          "Immunocytochemistry": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true
        }
      },
      "citation": {
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ],
        "date": "1999-06-24",
        "db": "PubMed",
        "db_id": "10391244",
        "db_name": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "first": "Lu PJ",
        "journal": "Nature",
        "last": "Lu KP",
        "pages": "784-8",
        "volume": "399"
      },
      "evidence": "To examine whether Pin1 affects the ability of pTau to bind microtubules, we generated pTau in vitro using purified Cdc2 (refs 17, 18), and determined its ability to bind Taxol-stabilized microtubules with or without Pin1. Although Cdc2 phosphorylation disrupted the ability of tau to bind microtubules; the binding was fully restored by preincubation with Pin1 (Fig. 5a). Furthermore, Pin1 was detected in the fraction of tau-bound microtubules (Fig. 5a). However, no Pin1 was detected in the microtubule fraction if pTau was not added (Fig. 5a), indicating that Pin1 does not bind microtubules directly. Thus, Pin1 binds pTau and restores its ability to bind microtubules.",
      "key": "6dc84c1d16572d00d66ccf927ac5c8f8",
      "line": 574,
      "object": {
        "effect": {
          "name": "microtubule binding",
          "namespace": "GO"
        },
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 140,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "key": "836753d97654fb6cef0164b8460ba266",
      "line": 684,
      "relation": "positiveCorrelation",
      "source": 140,
      "target": 105
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "ELISA": true,
          "Immunocytochemistry": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true
        }
      },
      "citation": {
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ],
        "date": "1999-06-24",
        "db": "PubMed",
        "db_id": "10391244",
        "db_name": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "first": "Lu PJ",
        "journal": "Nature",
        "last": "Lu KP",
        "pages": "784-8",
        "volume": "399"
      },
      "evidence": "In contrast, no binding was observed between Pin1 and the nonphosphorylated tau (Fig. 4a), demonstrating that T231 phosphorylation is required for Pin1 binding of tau. To determine whether the WW domain of Pin1 is responsible for binding, the mutant Pin1Y23A was used, which contains a single alanine substitution at the critical Tyr 23 in the WW-domain, resulting in a loss of the phosphoserine-binding activity [13]. Pin1Y23A showed much less binding to pT231 peptide (Table 1). The residual binding might be due to binding of the pT231 peptide to the much lower affinity isomerase domain of Pin113. These results indicate that the WW domain mediates Pin1 binding to the pT231 sequence of tau.",
      "key": "b940a023af34d65f979d091295a9807d",
      "line": 555,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 73,
      "target": 146
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "ELISA": true,
          "Immunocytochemistry": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true
        }
      },
      "citation": {
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ],
        "date": "1999-06-24",
        "db": "PubMed",
        "db_id": "10391244",
        "db_name": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "first": "Lu PJ",
        "journal": "Nature",
        "last": "Lu KP",
        "pages": "784-8",
        "volume": "399"
      },
      "evidence": "This result confirms previous findings that T231 is an important Cdc2 phosphorylation site in tau, and is also consistent with Pin1 binding mitotically pTau (Fig. 1a) and being sequestered on to PHFs in AD brains, where Cdc2 is upregulated (Fig. 3).",
      "key": "d28cac5a3248c08edfe9af6b653e5a40",
      "line": 564,
      "relation": "association",
      "source": 73,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "ELISA": true,
          "Immunocytochemistry": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true
        }
      },
      "citation": {
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ],
        "date": "1999-06-24",
        "db": "PubMed",
        "db_id": "10391244",
        "db_name": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "first": "Lu PJ",
        "journal": "Nature",
        "last": "Lu KP",
        "pages": "784-8",
        "volume": "399"
      },
      "evidence": "To examine whether Pin1 affects the ability of pTau to bind microtubules, we generated pTau in vitro using purified Cdc2 (refs 17, 18), and determined its ability to bind Taxol-stabilized microtubules with or without Pin1. Although Cdc2 phosphorylation disrupted the ability of tau to bind microtubules; the binding was fully restored by preincubation with Pin1 (Fig. 5a). Furthermore, Pin1 was detected in the fraction of tau-bound microtubules (Fig. 5a). However, no Pin1 was detected in the microtubule fraction if pTau was not added (Fig. 5a), indicating that Pin1 does not bind microtubules directly. Thus, Pin1 binds pTau and restores its ability to bind microtubules.",
      "key": "60f9ccf4b2d99c5eaae2520f97ddf6c5",
      "line": 575,
      "object": {
        "effect": {
          "name": "microtubule binding",
          "namespace": "GO"
        },
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 73,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "ELISA": true,
          "Immunocytochemistry": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true
        }
      },
      "citation": {
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ],
        "date": "1999-06-24",
        "db": "PubMed",
        "db_id": "10391244",
        "db_name": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "first": "Lu PJ",
        "journal": "Nature",
        "last": "Lu KP",
        "pages": "784-8",
        "volume": "399"
      },
      "evidence": "In contrast, no binding was observed between Pin1 and the nonphosphorylated tau (Fig. 4a), demonstrating that T231 phosphorylation is required for Pin1 binding of tau. To determine whether the WW domain of Pin1 is responsible for binding, the mutant Pin1Y23A was used, which contains a single alanine substitution at the critical Tyr 23 in the WW-domain, resulting in a loss of the phosphoserine-binding activity [13]. Pin1Y23A showed much less binding to pT231 peptide (Table 1). The residual binding might be due to binding of the pT231 peptide to the much lower affinity isomerase domain of Pin113. These results indicate that the WW domain mediates Pin1 binding to the pT231 sequence of tau.",
      "key": "717f1c049b7d986b50da80d105c50f74",
      "line": 556,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 147,
      "target": 146
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "ELISA": true,
          "Immunocytochemistry": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true
        }
      },
      "citation": {
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ],
        "date": "1999-06-24",
        "db": "PubMed",
        "db_id": "10391244",
        "db_name": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "first": "Lu PJ",
        "journal": "Nature",
        "last": "Lu KP",
        "pages": "784-8",
        "volume": "399"
      },
      "evidence": "In contrast, no binding was observed between Pin1 and the nonphosphorylated tau (Fig. 4a), demonstrating that T231 phosphorylation is required for Pin1 binding of tau. To determine whether the WW domain of Pin1 is responsible for binding, the mutant Pin1Y23A was used, which contains a single alanine substitution at the critical Tyr 23 in the WW-domain, resulting in a loss of the phosphoserine-binding activity [13]. Pin1Y23A showed much less binding to pT231 peptide (Table 1). The residual binding might be due to binding of the pT231 peptide to the much lower affinity isomerase domain of Pin113. These results indicate that the WW domain mediates Pin1 binding to the pT231 sequence of tau.",
      "key": "31af315e21c31a6dadf7d0bf55109465",
      "line": 557,
      "relation": "decreases",
      "source": 147,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "ELISA": true,
          "Immunocytochemistry": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true
        }
      },
      "citation": {
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ],
        "date": "1999-06-24",
        "db": "PubMed",
        "db_id": "10391244",
        "db_name": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "first": "Lu PJ",
        "journal": "Nature",
        "last": "Lu KP",
        "pages": "784-8",
        "volume": "399"
      },
      "evidence": "This result confirms previous findings that T231 is an important Cdc2 phosphorylation site in tau, and is also consistent with Pin1 binding mitotically pTau (Fig. 1a) and being sequestered on to PHFs in AD brains, where Cdc2 is upregulated (Fig. 3).",
      "key": "765d2a907cbfec58f87322bbc0408b5b",
      "line": 563,
      "relation": "increases",
      "source": 106,
      "subject": {
        "effect": {
          "name": "kin",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "ELISA": true,
          "Immunocytochemistry": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true
        }
      },
      "citation": {
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ],
        "date": "1999-06-24",
        "db": "PubMed",
        "db_id": "10391244",
        "db_name": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "first": "Lu PJ",
        "journal": "Nature",
        "last": "Lu KP",
        "pages": "784-8",
        "volume": "399"
      },
      "evidence": "This result confirms previous findings that T231 is an important Cdc2 phosphorylation site in tau, and is also consistent with Pin1 binding mitotically pTau (Fig. 1a) and being sequestered on to PHFs in AD brains, where Cdc2 is upregulated (Fig. 3).",
      "key": "356b99bd473a622e4cdd237de3fa5479",
      "line": 565,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "ELISA": true,
          "Immunocytochemistry": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true
        }
      },
      "citation": {
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ],
        "date": "1999-06-24",
        "db": "PubMed",
        "db_id": "10391244",
        "db_name": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "first": "Lu PJ",
        "journal": "Nature",
        "last": "Lu KP",
        "pages": "784-8",
        "volume": "399"
      },
      "evidence": "This result confirms previous findings that T231 is an important Cdc2 phosphorylation site in tau, and is also consistent with Pin1 binding mitotically pTau (Fig. 1a) and being sequestered on to PHFs in AD brains, where Cdc2 is upregulated (Fig. 3).",
      "key": "7195c233fa4e8a5a1dd638463ceac30e",
      "line": 564,
      "relation": "association",
      "source": 26,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "ELISA": true,
          "Immunocytochemistry": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "Pull-down Assay, His-tagged": true
        }
      },
      "citation": {
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ],
        "date": "1999-06-24",
        "db": "PubMed",
        "db_id": "10391244",
        "db_name": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "first": "Lu PJ",
        "journal": "Nature",
        "last": "Lu KP",
        "pages": "784-8",
        "volume": "399"
      },
      "evidence": "This result confirms previous findings that T231 is an important Cdc2 phosphorylation site in tau, and is also consistent with Pin1 binding mitotically pTau (Fig. 1a) and being sequestered on to PHFs in AD brains, where Cdc2 is upregulated (Fig. 3).",
      "key": "328e16ca1905d4950f983cef6a277efc",
      "line": 565,
      "relation": "positiveCorrelation",
      "source": 26,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Disease": {
          "Parkinson's disease": true
        }
      },
      "citation": {
        "authors": [
          "Forman MS",
          "Giasson BI",
          "Golbe LI",
          "Graves CL",
          "Higuchi M",
          "Kotzbauer PT",
          "Lee VM",
          "Trojanowski JQ"
        ],
        "date": "2003-04-25",
        "db": "PubMed",
        "db_id": "12714745",
        "db_name": "Initiation and synergistic fibrillization of tau and alpha-synuclein.",
        "first": "Giasson BI",
        "journal": "Science (New York, N.Y.)",
        "last": "Lee VM",
        "pages": "636-40",
        "volume": "300"
      },
      "evidence": "Recent studies of an individual with Parkinson’s disease (IX-47) of the Contursi kindred with the rare A53T alpha-synuclein mutation revealed widespread alpha-syn and tau inclusions (15). Post-mortem examination of another affected member (IX-51) of this kindred also demonstrated abundant alpha-syn and tau inclusions(figs. S1 and S2). Thus, a pathogenic mutation in alpha-synuclein that is known to increase the propensity of alpha-synuclein to fibrillize (8, 9) also promotes formation of tau inclusions in humans.",
      "key": "d9ebcbc4c35c56a63417329b6624a5d7",
      "line": 817,
      "relation": "positiveCorrelation",
      "source": 26,
      "target": 80
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ],
        "date": "2010-02-09",
        "db": "PubMed",
        "db_id": "20133804",
        "db_name": "A role for FKBP52 in Tau protein function.",
        "first": "Chambraud B",
        "journal": "Proceedings of the National Academy of Sciences of the United States of America",
        "last": "Baulieu EE",
        "pages": "2658-63",
        "volume": "107"
      },
      "evidence": "Thus, Tau and FKBP52 form a complex in rat brain. These findings indicate a direct interaction between FKBP52 and Tau. As shown in Fig. 3B, the amount of FKBP52 recruited by Tau depends on its phosphorylation state.In any case, these results underline the importance of Tau phosphorylation for its binding to FKBP52.",
      "key": "b76d1db47f197c403cbc7fadb3978712",
      "line": 589,
      "relation": "positiveCorrelation",
      "source": 174,
      "target": 179
    },
    {
      "key": "eaab4b8523aacb371cc9ff0c972dfedf",
      "relation": "partOf",
      "source": 174,
      "target": 75
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ],
        "date": "2010-02-09",
        "db": "PubMed",
        "db_id": "20133804",
        "db_name": "A role for FKBP52 in Tau protein function.",
        "first": "Chambraud B",
        "journal": "Proceedings of the National Academy of Sciences of the United States of America",
        "last": "Baulieu EE",
        "pages": "2658-63",
        "volume": "107"
      },
      "evidence": "Thus, Tau and FKBP52 form a complex in rat brain. These findings indicate a direct interaction between FKBP52 and Tau. As shown in Fig. 3B, the amount of FKBP52 recruited by Tau depends on its phosphorylation state.In any case, these results underline the importance of Tau phosphorylation for its binding to FKBP52.",
      "key": "c261cdb38c30f483dc7ce3512122772b",
      "line": 590,
      "relation": "isA",
      "source": 174,
      "target": 75
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ],
        "date": "2010-02-09",
        "db": "PubMed",
        "db_id": "20133804",
        "db_name": "A role for FKBP52 in Tau protein function.",
        "first": "Chambraud B",
        "journal": "Proceedings of the National Academy of Sciences of the United States of America",
        "last": "Baulieu EE",
        "pages": "2658-63",
        "volume": "107"
      },
      "evidence": "We concluded that FKBP52 inhibits the promotion of microtubule assembly by Tau.",
      "key": "d302539a4f5d40a03f0cf4ba2e335f35",
      "line": 595,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 174,
      "target": 177
    },
    {
      "annotations": {
        "CellLine": {
          "PC12": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ],
        "date": "2010-02-09",
        "db": "PubMed",
        "db_id": "20133804",
        "db_name": "A role for FKBP52 in Tau protein function.",
        "first": "Chambraud B",
        "journal": "Proceedings of the National Academy of Sciences of the United States of America",
        "last": "Baulieu EE",
        "pages": "2658-63",
        "volume": "107"
      },
      "evidence": "Because one role of Tau is to stimulate neurite outgrowth (12), we investigated the consequence of FKBP52 overexpression on neurite length in both PC12 and H7C2 cells. The inhibition of neurite outgrowth resulting from FKBP52 overexpression is in agreement with our previous report showing that the loss of FKBP52 in PC12 cells results in the formation of neurite extensions (9). The FKBP52 effect on neurite length could be explained by the binding of Tau to FKBP52, removing Tau from microtubules.",
      "key": "2ff0cb954473b19b246f791dcf210bd3",
      "line": 608,
      "relation": "negativeCorrelation",
      "source": 174,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ],
        "date": "2010-02-09",
        "db": "PubMed",
        "db_id": "20133804",
        "db_name": "A role for FKBP52 in Tau protein function.",
        "first": "Chambraud B",
        "journal": "Proceedings of the National Academy of Sciences of the United States of America",
        "last": "Baulieu EE",
        "pages": "2658-63",
        "volume": "107"
      },
      "evidence": "Thus, Tau and FKBP52 form a complex in rat brain. These findings indicate a direct interaction between FKBP52 and Tau. As shown in Fig. 3B, the amount of FKBP52 recruited by Tau depends on its phosphorylation state.In any case, these results underline the importance of Tau phosphorylation for its binding to FKBP52.",
      "key": "a83477b6ffb58d8cb81ea4bcbe0505d6",
      "line": 589,
      "relation": "positiveCorrelation",
      "source": 179,
      "target": 174
    },
    {
      "key": "601351e1a0511339591b6b9a940354f7",
      "relation": "partOf",
      "source": 179,
      "target": 75
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ],
        "date": "2010-02-09",
        "db": "PubMed",
        "db_id": "20133804",
        "db_name": "A role for FKBP52 in Tau protein function.",
        "first": "Chambraud B",
        "journal": "Proceedings of the National Academy of Sciences of the United States of America",
        "last": "Baulieu EE",
        "pages": "2658-63",
        "volume": "107"
      },
      "evidence": "We concluded that FKBP52 inhibits the promotion of microtubule assembly by Tau.",
      "key": "363f2c28c5e70e242b3a85018263b9cc",
      "line": 597,
      "relation": "positiveCorrelation",
      "source": 13,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ],
        "date": "1990-09-03",
        "db": "PubMed",
        "db_id": "2123288",
        "db_name": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "first": "Padilla R",
        "journal": "Molecular and cellular biochemistry",
        "last": "Avila J",
        "pages": "35-41",
        "volume": "97"
      },
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "key": "edb17d0c40522d445006d09e89a42423",
      "line": 737,
      "relation": "increases",
      "source": 13,
      "target": 9
    },
    {
      "annotations": {
        "CellLine": {
          "PC12": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ],
        "date": "2010-02-09",
        "db": "PubMed",
        "db_id": "20133804",
        "db_name": "A role for FKBP52 in Tau protein function.",
        "first": "Chambraud B",
        "journal": "Proceedings of the National Academy of Sciences of the United States of America",
        "last": "Baulieu EE",
        "pages": "2658-63",
        "volume": "107"
      },
      "evidence": "Because one role of Tau is to stimulate neurite outgrowth (12), we investigated the consequence of FKBP52 overexpression on neurite length in both PC12 and H7C2 cells. The inhibition of neurite outgrowth resulting from FKBP52 overexpression is in agreement with our previous report showing that the loss of FKBP52 in PC12 cells results in the formation of neurite extensions (9). The FKBP52 effect on neurite length could be explained by the binding of Tau to FKBP52, removing Tau from microtubules.",
      "key": "5199f72fbf38162bd111ee20188cf7ca",
      "line": 608,
      "relation": "negativeCorrelation",
      "source": 17,
      "target": 174
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true
        }
      },
      "citation": {
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ],
        "date": "2010-02-09",
        "db": "PubMed",
        "db_id": "20133804",
        "db_name": "A role for FKBP52 in Tau protein function.",
        "first": "Chambraud B",
        "journal": "Proceedings of the National Academy of Sciences of the United States of America",
        "last": "Baulieu EE",
        "pages": "2658-63",
        "volume": "107"
      },
      "evidence": "In addition to its peptidyl–prolyl isomerase activity, FKBP52 serves as a molecular chaperone. This activity depends on its tetratricopeptide repeat domain (27) to which the molecular chaperone HSP90 and other proteins bind.",
      "key": "d72b206d861da71091a490073150d363",
      "line": 616,
      "relation": "association",
      "source": 111,
      "target": 95
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true
        }
      },
      "citation": {
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ],
        "date": "2010-02-09",
        "db": "PubMed",
        "db_id": "20133804",
        "db_name": "A role for FKBP52 in Tau protein function.",
        "first": "Chambraud B",
        "journal": "Proceedings of the National Academy of Sciences of the United States of America",
        "last": "Baulieu EE",
        "pages": "2658-63",
        "volume": "107"
      },
      "evidence": "In addition to its peptidyl–prolyl isomerase activity, FKBP52 serves as a molecular chaperone. This activity depends on its tetratricopeptide repeat domain (27) to which the molecular chaperone HSP90 and other proteins bind.",
      "key": "349faa215687f0f7789c9b288a2d90d5",
      "line": 617,
      "relation": "isA",
      "source": 111,
      "target": 110
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Co-Immunoprecipitation": true,
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true
        }
      },
      "citation": {
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ],
        "date": "2010-02-09",
        "db": "PubMed",
        "db_id": "20133804",
        "db_name": "A role for FKBP52 in Tau protein function.",
        "first": "Chambraud B",
        "journal": "Proceedings of the National Academy of Sciences of the United States of America",
        "last": "Baulieu EE",
        "pages": "2658-63",
        "volume": "107"
      },
      "evidence": "In addition to its peptidyl–prolyl isomerase activity, FKBP52 serves as a molecular chaperone. This activity depends on its tetratricopeptide repeat domain (27) to which the molecular chaperone HSP90 and other proteins bind.",
      "key": "5b4d92184dff4a0eaf0e9402383bbda3",
      "line": 618,
      "relation": "isA",
      "source": 111,
      "target": 48
    },
    {
      "key": "10d7b1aac0334cc0166913028b6b183e",
      "relation": "hasVariant",
      "source": 110,
      "target": 111
    },
    {
      "key": "b7c81c8f0a6add7a30105eec087f445a",
      "relation": "partOf",
      "source": 110,
      "target": 48
    },
    {
      "key": "e520b09e7f0c0a6ec64ce833c887be44",
      "relation": "hasVariant",
      "source": 110,
      "target": 112
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "8b32c4b1a8f8e183fcb3d66902a95940",
      "line": 634,
      "relation": "increases",
      "source": 113,
      "target": 125
    },
    {
      "key": "cad947ff9fd93f9b32c757b04226f17e",
      "relation": "partOf",
      "source": 113,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "f396ec8d0847cd1f99b7a2e106d12f64",
      "line": 635,
      "relation": "isA",
      "source": 113,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "8b607718d39af146d31573d5f0e3cb24",
      "line": 643,
      "relation": "positiveCorrelation",
      "source": 113,
      "target": 136
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "b77bf9985104600e9d86bad173d9547a",
      "line": 644,
      "relation": "positiveCorrelation",
      "source": 113,
      "target": 132
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "d720591c1a16c024fb4251f0840d6213",
      "line": 645,
      "relation": "positiveCorrelation",
      "source": 113,
      "target": 133
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We then investigated what effect over-expression or knockdown of FKBP51 might have on the interaction of tau with other Hsp90 cochaperones that comprise a mature Hsp90 complex. Surprisingly, we found that FKBP51 over-expression decreased the endogenous association of another Hsp90 pro-folding cochaperone, Aha1, with tau despite increasing Hsp90 binding (Fig. 4C). Endogenous p23 binding to tau however was not detected. Conversely, knockdown of FKBP51 with siRNA increased the association of endogenous Aha1 with tau despite decreasing the number of Hsp90 tau complexes. Moreover, endogenous p23 binding to tau was only detectable when FKBP51 was knocked down (Fig. 4C).",
      "key": "6e79b8529f62e25a6ad01783328a4486",
      "line": 654,
      "relation": "negativeCorrelation",
      "source": 113,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We then investigated what effect over-expression or knockdown of FKBP51 might have on the interaction of tau with other Hsp90 cochaperones that comprise a mature Hsp90 complex. Surprisingly, we found that FKBP51 over-expression decreased the endogenous association of another Hsp90 pro-folding cochaperone, Aha1, with tau despite increasing Hsp90 binding (Fig. 4C). Endogenous p23 binding to tau however was not detected. Conversely, knockdown of FKBP51 with siRNA increased the association of endogenous Aha1 with tau despite decreasing the number of Hsp90 tau complexes. Moreover, endogenous p23 binding to tau was only detectable when FKBP51 was knocked down (Fig. 4C).",
      "key": "b0719a2cd3cd616044d4a238e0447cd4",
      "line": 655,
      "relation": "positiveCorrelation",
      "source": 113,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We then investigated what effect over-expression or knockdown of FKBP51 might have on the interaction of tau with other Hsp90 cochaperones that comprise a mature Hsp90 complex. Surprisingly, we found that FKBP51 over-expression decreased the endogenous association of another Hsp90 pro-folding cochaperone, Aha1, with tau despite increasing Hsp90 binding (Fig. 4C). Endogenous p23 binding to tau however was not detected. Conversely, knockdown of FKBP51 with siRNA increased the association of endogenous Aha1 with tau despite decreasing the number of Hsp90 tau complexes. Moreover, endogenous p23 binding to tau was only detectable when FKBP51 was knocked down (Fig. 4C).",
      "key": "0f904950cd608cac9a753ee365df7a08",
      "line": 656,
      "relation": "decreases",
      "source": 113,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "Fluorescent imaging of these extracts revealed that wildtype FKBP51 promoted microtubule polymerization relative to extracts treated with buffer only (Fig 7A and S2). Conversely, neither mutant F130A FKBP51 nor FKBP52 stimulated microtubule formation.",
      "key": "b1601987b6d403eefc4bfecbb583b2b6",
      "line": 663,
      "relation": "increases",
      "source": 113,
      "target": 13
    },
    {
      "key": "d6eca8b645e7ef946fc7a85749139cda",
      "relation": "hasVariant",
      "source": 113,
      "target": 114
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "93c0c71e71115d72747f8436ca992253",
      "line": 640,
      "relation": "association",
      "source": 54,
      "target": 136
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "afc7989390c7e92d67a942fd0d6e8f0d",
      "line": 641,
      "relation": "association",
      "source": 54,
      "target": 132
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "436f7ae6b2b805f1252917bf0030c12f",
      "line": 642,
      "relation": "association",
      "source": 54,
      "target": 133
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "ef7bd0e7366651e0b16b63b5d19b89fb",
      "line": 638,
      "relation": "isA",
      "source": 132,
      "target": 179
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "d93722910788be3099e3008cbeab3599",
      "line": 641,
      "relation": "association",
      "source": 132,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "key": "6b1b7ff1fa859db2cd6db3167f6d878e",
      "line": 644,
      "relation": "positiveCorrelation",
      "source": 132,
      "target": 113
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "key": "cc13b4e6d781ca0993c6bdf4a11bafc3",
      "line": 685,
      "relation": "positiveCorrelation",
      "source": 132,
      "target": 105
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "We then investigated what effect over-expression or knockdown of FKBP51 might have on the interaction of tau with other Hsp90 cochaperones that comprise a mature Hsp90 complex. Surprisingly, we found that FKBP51 over-expression decreased the endogenous association of another Hsp90 pro-folding cochaperone, Aha1, with tau despite increasing Hsp90 binding (Fig. 4C). Endogenous p23 binding to tau however was not detected. Conversely, knockdown of FKBP51 with siRNA increased the association of endogenous Aha1 with tau despite decreasing the number of Hsp90 tau complexes. Moreover, endogenous p23 binding to tau was only detectable when FKBP51 was knocked down (Fig. 4C).",
      "key": "2a64d3bcfce3df4df0dd9fecffdade1d",
      "line": 654,
      "relation": "negativeCorrelation",
      "source": 50,
      "target": 113
    },
    {
      "key": "86a3bc2700d137ac7e33d09b468ccd40",
      "relation": "partOf",
      "source": 101,
      "target": 50
    },
    {
      "key": "7b6bce158a0c6f8ae677e56517d22e7f",
      "relation": "partOf",
      "source": 151,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "Fluorescent imaging of these extracts revealed that wildtype FKBP51 promoted microtubule polymerization relative to extracts treated with buffer only (Fig 7A and S2). Conversely, neither mutant F130A FKBP51 nor FKBP52 stimulated microtubule formation.",
      "key": "d650e196eec3fc6ac205ccd644eb6652",
      "line": 664,
      "relation": "increases",
      "source": 114,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Chromatography, Gel filtration": true,
          "Chromatography, Ni-NTA-Sepharose": true,
          "Chymotrypsin Assay": true,
          "Co-Immunoprecipitation": true,
          "Immunofluorescence": true,
          "Immunohistochemistry": true,
          "Microtubule polzmerization Assay": true,
          "Protease-coupled Assay": true,
          "RNA Interference, siRNA": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ],
        "date": "2010-01-13",
        "db": "PubMed",
        "db_id": "20071522",
        "db_name": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "first": "Jinwal UK",
        "journal": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "last": "Dickey CA",
        "pages": "591-9",
        "volume": "30"
      },
      "evidence": "Fluorescent imaging of these extracts revealed that wildtype FKBP51 promoted microtubule polymerization relative to extracts treated with buffer only (Fig 7A and S2). Conversely, neither mutant F130A FKBP51 nor FKBP52 stimulated microtubule formation.",
      "key": "3f49416f64a188c57f7d69242db3b53c",
      "line": 665,
      "relation": "increases",
      "source": 112,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "This coordination of kinase triage decisions by Hsp90 requires the co-chaperone Cdc37 (cell division cycle protein 37). The Hsp90/Cdc37 machine is essential for the maturation of a number of kinases, including Akt",
      "key": "6c77ec0c0dce24a927b1004b67e6e2b9",
      "line": 676,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 105,
      "target": 95
    },
    {
      "key": "f08abe63aa6cd646d5f75c6c462aca2a",
      "relation": "partOf",
      "source": 105,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "This coordination of kinase triage decisions by Hsp90 requires the co-chaperone Cdc37 (cell division cycle protein 37). The Hsp90/Cdc37 machine is essential for the maturation of a number of kinases, including Akt",
      "key": "ca460f42ad830b9ec3731ee20e92f758",
      "line": 677,
      "relation": "isA",
      "source": 105,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "key": "27dc8af5a90f78e5d6c6ace2ad90a337",
      "line": 684,
      "relation": "positiveCorrelation",
      "source": 105,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "key": "109775762a7ce7b879b6fca531374826",
      "line": 685,
      "relation": "positiveCorrelation",
      "source": 105,
      "target": 132
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "key": "2e65f4940b357646e7e69ae6a0abd800",
      "line": 686,
      "relation": "positiveCorrelation",
      "source": 105,
      "target": 133
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "key": "98998d8d511a28dd3f36c93df1994e75",
      "line": 687,
      "relation": "positiveCorrelation",
      "source": 105,
      "target": 136
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "key": "77552fdcb7f904c4b4a0d29c34f4243e",
      "line": 688,
      "relation": "positiveCorrelation",
      "source": 105,
      "target": 137
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "key": "3987d0030cde908dbfddb3ff49b35ea0",
      "line": 689,
      "relation": "positiveCorrelation",
      "source": 105,
      "target": 134
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "key": "0c300e96f47e85703596e693c0eb3614",
      "line": 690,
      "relation": "positiveCorrelation",
      "source": 105,
      "target": 135
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Previous work showed that Hsp90 inhibition with 17-AAG reduced phospho-tau levels in vivo (16, 23). We speculated that Cdc37 might modulate Hsp90 inhibitor efficacy for phosphotau. M17 cells were transfected with Cdc37 siRNA and then treated with 1 μM 17-AAG for 24 h. Indeed, reducing Cdc37 synergized with Hsp90 inhibition to reduce tau levels more potently than either condition alone (Fig. 6A).",
      "key": "e4f23d6a769743833be64f9cce1a9079",
      "line": 700,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 105,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Western blot analysis for a panel of tau kinases showed that only the levels of endogenous Cdk5 and Akt were significantly reduced by Cdc37 siRNA; the levels of GSK3-Beta and Mark2 (microtubule affinity regulating kinase 2) were largely unchanged",
      "key": "5f36d97fcbc6cd7a04da973f5f3ad898",
      "line": 707,
      "object": {
        "effect": {
          "name": "kin",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 105,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Western blot analysis for a panel of tau kinases showed that only the levels of endogenous Cdk5 and Akt were significantly reduced by Cdc37 siRNA; the levels of GSK3-Beta and Mark2 (microtubule affinity regulating kinase 2) were largely unchanged",
      "key": "3725722d9830ad4f1e475f83b51da0ce",
      "line": 708,
      "object": {
        "effect": {
          "name": "kin",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 105,
      "target": 102
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Western blot analysis for a panel of tau kinases showed that only the levels of endogenous Cdk5 and Akt were significantly reduced by Cdc37 siRNA; the levels of GSK3-Beta and Mark2 (microtubule affinity regulating kinase 2) were largely unchanged",
      "key": "1e4fe1da53af0eea2eea3c0212422328",
      "line": 709,
      "relation": "causesNoChange",
      "source": 105,
      "target": 118
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Western blot analysis for a panel of tau kinases showed that only the levels of endogenous Cdk5 and Akt were significantly reduced by Cdc37 siRNA; the levels of GSK3-Beta and Mark2 (microtubule affinity regulating kinase 2) were largely unchanged",
      "key": "b9b08d4db022a303b5a8f6f7e7dc212b",
      "line": 710,
      "relation": "causesNoChange",
      "source": 105,
      "target": 142
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "This coordination of kinase triage decisions by Hsp90 requires the co-chaperone Cdc37 (cell division cycle protein 37). The Hsp90/Cdc37 machine is essential for the maturation of a number of kinases, including Akt",
      "key": "e0ea447fe0b38edc3b9a8cabe33e666b",
      "line": 678,
      "object": {
        "effect": {
          "name": "kin",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 47,
      "target": 102
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Previous work showed that Hsp90 inhibition with 17-AAG reduced phospho-tau levels in vivo (16, 23). We speculated that Cdc37 might modulate Hsp90 inhibitor efficacy for phosphotau. M17 cells were transfected with Cdc37 siRNA and then treated with 1 μM 17-AAG for 24 h. Indeed, reducing Cdc37 synergized with Hsp90 inhibition to reduce tau levels more potently than either condition alone (Fig. 6A).",
      "key": "25509c4356c06516795b24ba82cd1c54",
      "line": 699,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "negativeCorrelation",
      "source": 47,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "This coordination of kinase triage decisions by Hsp90 requires the co-chaperone Cdc37 (cell division cycle protein 37). The Hsp90/Cdc37 machine is essential for the maturation of a number of kinases, including Akt",
      "key": "4d02cbb4acd6cccb621f754fd32ec74b",
      "line": 678,
      "relation": "positiveCorrelation",
      "source": 102,
      "subject": {
        "effect": {
          "name": "kin",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Western blot analysis for a panel of tau kinases showed that only the levels of endogenous Cdk5 and Akt were significantly reduced by Cdc37 siRNA; the levels of GSK3-Beta and Mark2 (microtubule affinity regulating kinase 2) were largely unchanged",
      "key": "c34dedd7c3554e022a580f4a355e8791",
      "line": 708,
      "relation": "negativeCorrelation",
      "source": 102,
      "subject": {
        "effect": {
          "name": "kin",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "target": 105
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "key": "084f01cb2fcc9b6d31c5c6a29032d426",
      "line": 689,
      "relation": "positiveCorrelation",
      "source": 134,
      "target": 105
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "key": "8986ba21a1b48b2ca9fbd286cbaeeff3",
      "line": 690,
      "relation": "positiveCorrelation",
      "source": 135,
      "target": 105
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Previous work showed that Hsp90 inhibition with 17-AAG reduced phospho-tau levels in vivo (16, 23). We speculated that Cdc37 might modulate Hsp90 inhibitor efficacy for phosphotau. M17 cells were transfected with Cdc37 siRNA and then treated with 1 μM 17-AAG for 24 h. Indeed, reducing Cdc37 synergized with Hsp90 inhibition to reduce tau levels more potently than either condition alone (Fig. 6A).",
      "key": "a9ccd3054b7b236f5709bec6f74822f6",
      "line": 698,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 7,
      "target": 95
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ],
        "date": "2011-05-13",
        "db": "PubMed",
        "db_id": "21367866",
        "db_name": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "first": "Jinwal UK",
        "journal": "The Journal of biological chemistry",
        "last": "Dickey CA",
        "pages": "16976-83",
        "volume": "286"
      },
      "evidence": "Western blot analysis for a panel of tau kinases showed that only the levels of endogenous Cdk5 and Akt were significantly reduced by Cdc37 siRNA; the levels of GSK3-Beta and Mark2 (microtubule affinity regulating kinase 2) were largely unchanged",
      "key": "56601d89d311053d8aba41d00ebdfcc4",
      "line": 707,
      "relation": "negativeCorrelation",
      "source": 107,
      "subject": {
        "effect": {
          "name": "kin",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "target": 105
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ],
        "date": "1990-09-03",
        "db": "PubMed",
        "db_id": "2123288",
        "db_name": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "first": "Padilla R",
        "journal": "Molecular and cellular biochemistry",
        "last": "Avila J",
        "pages": "35-41",
        "volume": "97"
      },
      "evidence": "The present studies show that the calcium-binding protein calmodulin interacts with a tubulin binding site on tau defined by the second repetitive sequence",
      "key": "82a71ba4584ba635536d613bfa25b156",
      "line": 721,
      "relation": "association",
      "source": 94,
      "target": 90
    },
    {
      "key": "a4a5ab3dd4cb84a5b67e06ce07616085",
      "relation": "partOf",
      "source": 94,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ],
        "date": "1990-09-03",
        "db": "PubMed",
        "db_id": "2123288",
        "db_name": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "first": "Padilla R",
        "journal": "Molecular and cellular biochemistry",
        "last": "Avila J",
        "pages": "35-41",
        "volume": "97"
      },
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "key": "4e1909fdb92c6f2d6b8b038598ef94ca",
      "line": 730,
      "relation": "increases",
      "source": 94,
      "subject": {
        "modifier": "Activity"
      },
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ],
        "date": "1990-09-03",
        "db": "PubMed",
        "db_id": "2123288",
        "db_name": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "first": "Padilla R",
        "journal": "Molecular and cellular biochemistry",
        "last": "Avila J",
        "pages": "35-41",
        "volume": "97"
      },
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "key": "0030f7efd4dda2743a89217822915068",
      "line": 731,
      "relation": "decreases",
      "source": 94,
      "subject": {
        "modifier": "Activity"
      },
      "target": 13
    },
    {
      "key": "a051f61c534b48db4e33598d5760a22b",
      "relation": "partOf",
      "source": 94,
      "target": 46
    },
    {
      "key": "c582954d4bf00f1c35886aea684a0aec",
      "relation": "partOf",
      "source": 94,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ],
        "date": "1990-09-03",
        "db": "PubMed",
        "db_id": "2123288",
        "db_name": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "first": "Padilla R",
        "journal": "Molecular and cellular biochemistry",
        "last": "Avila J",
        "pages": "35-41",
        "volume": "97"
      },
      "evidence": "The present studies show that the calcium-binding protein calmodulin interacts with a tubulin binding site on tau defined by the second repetitive sequence",
      "key": "0749f4f463b6a83c0fe10133ca65212d",
      "line": 721,
      "relation": "association",
      "source": 90,
      "target": 94
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ],
        "date": "1990-09-03",
        "db": "PubMed",
        "db_id": "2123288",
        "db_name": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "first": "Padilla R",
        "journal": "Molecular and cellular biochemistry",
        "last": "Avila J",
        "pages": "35-41",
        "volume": "97"
      },
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "key": "f62965f230a533efb17b95356cc5c2a9",
      "line": 729,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 1,
      "target": 94
    },
    {
      "key": "aacd35523385173143720ab90c17d500",
      "relation": "partOf",
      "source": 1,
      "target": 33
    },
    {
      "key": "813a136754044c4ea8ebfef679bf60ab",
      "relation": "partOf",
      "source": 1,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Affinity": true,
          "Chromatography, FPLC": true,
          "Phosphorylation Assay": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Baudier J",
          "Cole RD"
        ],
        "date": "1988-04-25",
        "db": "PubMed",
        "db_id": "2833519",
        "db_name": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "first": "Baudier J",
        "journal": "The Journal of biological chemistry",
        "last": "Cole RD",
        "pages": "5876-83",
        "volume": "263"
      },
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+ concentration to the 100 μM range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "key": "a4ac48d167b07da0381fbbfd239d6169",
      "line": 754,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 1,
      "target": 152
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ],
        "date": "1990-09-03",
        "db": "PubMed",
        "db_id": "2123288",
        "db_name": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "first": "Padilla R",
        "journal": "Molecular and cellular biochemistry",
        "last": "Avila J",
        "pages": "35-41",
        "volume": "97"
      },
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "key": "0a3945857e82aeb0608b0d01ee36dbd8",
      "line": 734,
      "relation": "isA",
      "source": 33,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ],
        "date": "1990-09-03",
        "db": "PubMed",
        "db_id": "2123288",
        "db_name": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "first": "Padilla R",
        "journal": "Molecular and cellular biochemistry",
        "last": "Avila J",
        "pages": "35-41",
        "volume": "97"
      },
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "key": "a6ca5b5661b54d6e13486ccfc28d88cb",
      "line": 733,
      "relation": "isA",
      "source": 46,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "citation": {
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ],
        "date": "1990-09-03",
        "db": "PubMed",
        "db_id": "2123288",
        "db_name": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "first": "Padilla R",
        "journal": "Molecular and cellular biochemistry",
        "last": "Avila J",
        "pages": "35-41",
        "volume": "97"
      },
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "key": "05e40e57bc9fa262901386fa41546d64",
      "line": 735,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 34,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Affinity": true,
          "Chromatography, FPLC": true,
          "Phosphorylation Assay": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Baudier J",
          "Cole RD"
        ],
        "date": "1988-04-25",
        "db": "PubMed",
        "db_id": "2833519",
        "db_name": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "first": "Baudier J",
        "journal": "The Journal of biological chemistry",
        "last": "Cole RD",
        "pages": "5876-83",
        "volume": "263"
      },
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+ concentration to the 100 μM range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "key": "a00bdd9a6a35fba096f64e5ad80e6e24",
      "line": 753,
      "relation": "association",
      "source": 152,
      "target": 125
    },
    {
      "key": "24fbff70f343ab2cee0dff9e3d262b2e",
      "relation": "partOf",
      "source": 152,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Affinity": true,
          "Chromatography, FPLC": true,
          "Phosphorylation Assay": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Baudier J",
          "Cole RD"
        ],
        "date": "1988-04-25",
        "db": "PubMed",
        "db_id": "2833519",
        "db_name": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "first": "Baudier J",
        "journal": "The Journal of biological chemistry",
        "last": "Cole RD",
        "pages": "5876-83",
        "volume": "263"
      },
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+ concentration to the 100 μM range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "key": "c72a4a21bb4272c2ec60766d44612930",
      "line": 755,
      "relation": "isA",
      "source": 152,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Affinity": true,
          "Chromatography, FPLC": true,
          "Phosphorylation Assay": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Baudier J",
          "Cole RD"
        ],
        "date": "1988-04-25",
        "db": "PubMed",
        "db_id": "2833519",
        "db_name": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "first": "Baudier J",
        "journal": "The Journal of biological chemistry",
        "last": "Cole RD",
        "pages": "5876-83",
        "volume": "263"
      },
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+ concentration to the 100 μM range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "key": "08f5f542f812069c4d2acdb897fe2ee1",
      "line": 759,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 152,
      "subject": {
        "modifier": "Activity"
      },
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3β phosphorylation and β-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "key": "9a6e3a32e6710df0951e18a61fc608a0",
      "line": 793,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 152,
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3β phosphorylation and β-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "key": "14d190371dabbda377fd36fc935e8ca9",
      "line": 796,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 152,
      "target": 96
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3β phosphorylation and β-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "key": "91268b6c68b606935affab16d345cc42",
      "line": 802,
      "relation": "increases",
      "source": 152,
      "target": 99
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3β phosphorylation and β-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "key": "14d5ffffa986bf48d8de0a31be223cf8",
      "line": 804,
      "relation": "positiveCorrelation",
      "source": 152,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Affinity": true,
          "Chromatography, FPLC": true,
          "Phosphorylation Assay": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Baudier J",
          "Cole RD"
        ],
        "date": "1988-04-25",
        "db": "PubMed",
        "db_id": "2833519",
        "db_name": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "first": "Baudier J",
        "journal": "The Journal of biological chemistry",
        "last": "Cole RD",
        "pages": "5876-83",
        "volume": "263"
      },
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+ concentration to the 100 μM range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "key": "4059796f0081960347064f4ac2b89046",
      "line": 758,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 69,
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Affinity": true,
          "Chromatography, FPLC": true,
          "Phosphorylation Assay": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Baudier J",
          "Cole RD"
        ],
        "date": "1988-04-25",
        "db": "PubMed",
        "db_id": "2833519",
        "db_name": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "first": "Baudier J",
        "journal": "The Journal of biological chemistry",
        "last": "Cole RD",
        "pages": "5876-83",
        "volume": "263"
      },
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+ concentration to the 100 μM range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "key": "c7f6b6720e9a8676b4f63ec8d36e73b3",
      "line": 757,
      "relation": "increases",
      "source": 92,
      "subject": {
        "modifier": "Activity"
      },
      "target": 131
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, Affinity": true,
          "Chromatography, FPLC": true,
          "Phosphorylation Assay": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Baudier J",
          "Cole RD"
        ],
        "date": "1988-04-25",
        "db": "PubMed",
        "db_id": "2833519",
        "db_name": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "first": "Baudier J",
        "journal": "The Journal of biological chemistry",
        "last": "Cole RD",
        "pages": "5876-83",
        "volume": "263"
      },
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+ concentration to the 100 μM range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "key": "9eb1290f40cf0caa7ec5d4409864b496",
      "line": 760,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 5,
      "target": 152
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "In general, GSK-3β phosphorylation is inhibited through the canonical Wnt signalling pathway [5]. Wnt, binding to frizzled receptor, recruits dishevelled protein, which in turn antagonizes GSK-3β activity.",
      "key": "e9fe9508bf4d9304c70b11a53c1d3931",
      "line": 768,
      "relation": "increases",
      "source": 11,
      "target": 119
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "In general, GSK-3β phosphorylation is inhibited through the canonical Wnt signalling pathway [5]. Wnt, binding to frizzled receptor, recruits dishevelled protein, which in turn antagonizes GSK-3β activity.",
      "key": "720c544204296134fee65ff2548301b5",
      "line": 770,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 11,
      "target": 118
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "In general, GSK-3β phosphorylation is inhibited through the canonical Wnt signalling pathway [5]. Wnt, binding to frizzled receptor, recruits dishevelled protein, which in turn antagonizes GSK-3β activity.",
      "key": "39fa5a5e88e748d672b78ee4c7d0ebb7",
      "line": 769,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 119,
      "target": 118
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "For example, ongoing inflammation can trigger various cell stress-response pathways, including overexpression of the secreted glycoprotein Dickopff-1 (DKK-1). DKK-1 up-regulates GSK-3β activity, promotes tau hyper-phosphorylation, NFT formation and neuronal degeneration. Thus, DKK-1 inhibits Wnt signalling in a manner similar to Aβ, and thereby fosters a self-sustaining feedback loop resulting in cellular injury",
      "key": "6ff4ec43fb7668983e875eb73ec88dd7",
      "line": 777,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 12,
      "target": 109
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3β phosphorylation and β-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "key": "3bd52eb12cd0153557f0c6363cf1c82c",
      "line": 804,
      "relation": "positiveCorrelation",
      "source": 12,
      "target": 152
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "For example, ongoing inflammation can trigger various cell stress-response pathways, including overexpression of the secreted glycoprotein Dickopff-1 (DKK-1). DKK-1 up-regulates GSK-3β activity, promotes tau hyper-phosphorylation, NFT formation and neuronal degeneration. Thus, DKK-1 inhibits Wnt signalling in a manner similar to Aβ, and thereby fosters a self-sustaining feedback loop resulting in cellular injury",
      "key": "04b496b6174a22c69dcaae409999a201",
      "line": 778,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 109,
      "target": 118
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "For example, ongoing inflammation can trigger various cell stress-response pathways, including overexpression of the secreted glycoprotein Dickopff-1 (DKK-1). DKK-1 up-regulates GSK-3β activity, promotes tau hyper-phosphorylation, NFT formation and neuronal degeneration. Thus, DKK-1 inhibits Wnt signalling in a manner similar to Aβ, and thereby fosters a self-sustaining feedback loop resulting in cellular injury",
      "key": "82765397500290a8d89c2cc20b7fc042",
      "line": 779,
      "relation": "decreases",
      "source": 109,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3β phosphorylation and β-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "key": "db850f01c1b6cfe30fca12cface224f8",
      "line": 798,
      "relation": "increases",
      "source": 109,
      "target": 119
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3β phosphorylation and β-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "key": "578fc36ca10e07fc6aab0c01ac6c0ef4",
      "line": 799,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 109,
      "target": 167
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "For example, ongoing inflammation can trigger various cell stress-response pathways, including overexpression of the secreted glycoprotein Dickopff-1 (DKK-1). DKK-1 up-regulates GSK-3β activity, promotes tau hyper-phosphorylation, NFT formation and neuronal degeneration. Thus, DKK-1 inhibits Wnt signalling in a manner similar to Aβ, and thereby fosters a self-sustaining feedback loop resulting in cellular injury",
      "key": "41a2dd8d9787d388de44ae6e307e801e",
      "line": 782,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 16,
      "target": 118
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3β phosphorylation and β-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "key": "b8dbfc54f41ffb9d1e523db1eca845e8",
      "line": 794,
      "relation": "positiveCorrelation",
      "source": 100,
      "subject": {
        "modifier": "Activity"
      },
      "target": 97
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3β phosphorylation and β-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "key": "38949779eff6862b3bbe355cda429324",
      "line": 794,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 97,
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3β phosphorylation and β-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "key": "a6becb39ed02d0ed4067e9870d319b80",
      "line": 795,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 97,
      "target": 96
    },
    {
      "key": "2f5ac5955c1f8378aa2b5ab4aa4f0266",
      "relation": "hasVariant",
      "source": 96,
      "target": 97
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3β phosphorylation and β-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "key": "efcefe34d6e56f4177fda10182b6cae1",
      "line": 797,
      "relation": "increases",
      "source": 96,
      "subject": {
        "modifier": "Activity"
      },
      "target": 109
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3β phosphorylation and β-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "key": "cd77f541c700a9b2ac9644f03480f37c",
      "line": 800,
      "relation": "regulates",
      "source": 167,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ],
        "date": "2008-06-01",
        "db": "PubMed",
        "db_id": "18494933",
        "db_name": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "first": "Esposito G",
        "journal": "Journal of cellular and molecular medicine",
        "last": "Steardo L",
        "pages": "914-27",
        "volume": "12"
      },
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3β phosphorylation and β-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "key": "4c19f605d77ed96089dedf6a39568167",
      "line": 801,
      "relation": "decreases",
      "source": 167,
      "target": 130
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Disease": {
          "Parkinson's disease": true
        }
      },
      "citation": {
        "authors": [
          "Forman MS",
          "Giasson BI",
          "Golbe LI",
          "Graves CL",
          "Higuchi M",
          "Kotzbauer PT",
          "Lee VM",
          "Trojanowski JQ"
        ],
        "date": "2003-04-25",
        "db": "PubMed",
        "db_id": "12714745",
        "db_name": "Initiation and synergistic fibrillization of tau and alpha-synuclein.",
        "first": "Giasson BI",
        "journal": "Science (New York, N.Y.)",
        "last": "Lee VM",
        "pages": "636-40",
        "volume": "300"
      },
      "evidence": "Recent studies of an individual with Parkinson’s disease (IX-47) of the Contursi kindred with the rare A53T alpha-synuclein mutation revealed widespread alpha-syn and tau inclusions (15). Post-mortem examination of another affected member (IX-51) of this kindred also demonstrated abundant alpha-syn and tau inclusions(figs. S1 and S2). Thus, a pathogenic mutation in alpha-synuclein that is known to increase the propensity of alpha-synuclein to fibrillize (8, 9) also promotes formation of tau inclusions in humans.",
      "key": "8903d530a3d06e5a4e112d7d871a43dc",
      "line": 816,
      "relation": "positiveCorrelation",
      "source": 80,
      "target": 87
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Disease": {
          "Parkinson's disease": true
        }
      },
      "citation": {
        "authors": [
          "Forman MS",
          "Giasson BI",
          "Golbe LI",
          "Graves CL",
          "Higuchi M",
          "Kotzbauer PT",
          "Lee VM",
          "Trojanowski JQ"
        ],
        "date": "2003-04-25",
        "db": "PubMed",
        "db_id": "12714745",
        "db_name": "Initiation and synergistic fibrillization of tau and alpha-synuclein.",
        "first": "Giasson BI",
        "journal": "Science (New York, N.Y.)",
        "last": "Lee VM",
        "pages": "636-40",
        "volume": "300"
      },
      "evidence": "Recent studies of an individual with Parkinson’s disease (IX-47) of the Contursi kindred with the rare A53T alpha-synuclein mutation revealed widespread alpha-syn and tau inclusions (15). Post-mortem examination of another affected member (IX-51) of this kindred also demonstrated abundant alpha-syn and tau inclusions(figs. S1 and S2). Thus, a pathogenic mutation in alpha-synuclein that is known to increase the propensity of alpha-synuclein to fibrillize (8, 9) also promotes formation of tau inclusions in humans.",
      "key": "e40840be80185e9830d02cf5028feffb",
      "line": 817,
      "relation": "positiveCorrelation",
      "source": 80,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Disease": {
          "Parkinson's disease": true
        }
      },
      "citation": {
        "authors": [
          "Forman MS",
          "Giasson BI",
          "Golbe LI",
          "Graves CL",
          "Higuchi M",
          "Kotzbauer PT",
          "Lee VM",
          "Trojanowski JQ"
        ],
        "date": "2003-04-25",
        "db": "PubMed",
        "db_id": "12714745",
        "db_name": "Initiation and synergistic fibrillization of tau and alpha-synuclein.",
        "first": "Giasson BI",
        "journal": "Science (New York, N.Y.)",
        "last": "Lee VM",
        "pages": "636-40",
        "volume": "300"
      },
      "evidence": "Recent studies of an individual with Parkinson’s disease (IX-47) of the Contursi kindred with the rare A53T alpha-synuclein mutation revealed widespread alpha-syn and tau inclusions (15). Post-mortem examination of another affected member (IX-51) of this kindred also demonstrated abundant alpha-syn and tau inclusions(figs. S1 and S2). Thus, a pathogenic mutation in alpha-synuclein that is known to increase the propensity of alpha-synuclein to fibrillize (8, 9) also promotes formation of tau inclusions in humans.",
      "key": "9ab4c6055ce75e29b15414923b0fdfff",
      "line": 818,
      "relation": "positiveCorrelation",
      "source": 80,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Disease": {
          "Parkinson's disease": true
        }
      },
      "citation": {
        "authors": [
          "Forman MS",
          "Giasson BI",
          "Golbe LI",
          "Graves CL",
          "Higuchi M",
          "Kotzbauer PT",
          "Lee VM",
          "Trojanowski JQ"
        ],
        "date": "2003-04-25",
        "db": "PubMed",
        "db_id": "12714745",
        "db_name": "Initiation and synergistic fibrillization of tau and alpha-synuclein.",
        "first": "Giasson BI",
        "journal": "Science (New York, N.Y.)",
        "last": "Lee VM",
        "pages": "636-40",
        "volume": "300"
      },
      "evidence": "Recent studies of an individual with Parkinson’s disease (IX-47) of the Contursi kindred with the rare A53T alpha-synuclein mutation revealed widespread alpha-syn and tau inclusions (15). Post-mortem examination of another affected member (IX-51) of this kindred also demonstrated abundant alpha-syn and tau inclusions(figs. S1 and S2). Thus, a pathogenic mutation in alpha-synuclein that is known to increase the propensity of alpha-synuclein to fibrillize (8, 9) also promotes formation of tau inclusions in humans.",
      "key": "a2ff3caf389586b32e9eda13a60ad25a",
      "line": 816,
      "relation": "positiveCorrelation",
      "source": 87,
      "target": 80
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Disease": {
          "Parkinson's disease": true
        }
      },
      "citation": {
        "authors": [
          "Forman MS",
          "Giasson BI",
          "Golbe LI",
          "Graves CL",
          "Higuchi M",
          "Kotzbauer PT",
          "Lee VM",
          "Trojanowski JQ"
        ],
        "date": "2003-04-25",
        "db": "PubMed",
        "db_id": "12714745",
        "db_name": "Initiation and synergistic fibrillization of tau and alpha-synuclein.",
        "first": "Giasson BI",
        "journal": "Science (New York, N.Y.)",
        "last": "Lee VM",
        "pages": "636-40",
        "volume": "300"
      },
      "evidence": "Recent studies of an individual with Parkinson’s disease (IX-47) of the Contursi kindred with the rare A53T alpha-synuclein mutation revealed widespread alpha-syn and tau inclusions (15). Post-mortem examination of another affected member (IX-51) of this kindred also demonstrated abundant alpha-syn and tau inclusions(figs. S1 and S2). Thus, a pathogenic mutation in alpha-synuclein that is known to increase the propensity of alpha-synuclein to fibrillize (8, 9) also promotes formation of tau inclusions in humans.",
      "key": "080a58330e04a03f34b4a5bb57e13178",
      "line": 818,
      "relation": "positiveCorrelation",
      "source": 22,
      "target": 80
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Electron Microscopy, Immunological": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Forman MS",
          "Giasson BI",
          "Golbe LI",
          "Graves CL",
          "Higuchi M",
          "Kotzbauer PT",
          "Lee VM",
          "Trojanowski JQ"
        ],
        "date": "2003-04-25",
        "db": "PubMed",
        "db_id": "12714745",
        "db_name": "Initiation and synergistic fibrillization of tau and alpha-synuclein.",
        "first": "Giasson BI",
        "journal": "Science (New York, N.Y.)",
        "last": "Lee VM",
        "pages": "636-40",
        "volume": "300"
      },
      "evidence": "We also observed that tau and alpha-synuclein synergistically promote and propagate each other’s polymerization into fibrils",
      "key": "b690de05ac4fca66d6fb0f6dd7bca1ac",
      "line": 826,
      "relation": "increases",
      "source": 79,
      "target": 87
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Electron Microscopy, Immunological": true,
          "Western Blot": true
        }
      },
      "citation": {
        "authors": [
          "Forman MS",
          "Giasson BI",
          "Golbe LI",
          "Graves CL",
          "Higuchi M",
          "Kotzbauer PT",
          "Lee VM",
          "Trojanowski JQ"
        ],
        "date": "2003-04-25",
        "db": "PubMed",
        "db_id": "12714745",
        "db_name": "Initiation and synergistic fibrillization of tau and alpha-synuclein.",
        "first": "Giasson BI",
        "journal": "Science (New York, N.Y.)",
        "last": "Lee VM",
        "pages": "636-40",
        "volume": "300"
      },
      "evidence": "We also observed that tau and alpha-synuclein synergistically promote and propagate each other’s polymerization into fibrils",
      "key": "308538dc774c0a3126be36cb5fafc354",
      "line": 827,
      "relation": "increases",
      "source": 79,
      "target": 82
    },
    {
      "key": "21ea7fbb4e6de86d1caef9678000939b",
      "relation": "partOf",
      "source": 153,
      "target": 79
    },
    {
      "key": "1084a268007b230d5f149ba14a7bebed",
      "relation": "partOf",
      "source": 158,
      "target": 58
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, FPLC": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ],
        "date": "2003-04-11",
        "db": "PubMed",
        "db_id": "12551948",
        "db_name": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "first": "Agarwal-Mawal A",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "12722-8",
        "volume": "278"
      },
      "evidence": "These observations suggested that 14-3-3zeta may be bound to GSK3Beta and/or tau within brain microtubules and may be a component of tau phosphorylation complex.Therefore, 14-3-3 must be the central molecule that holds tau and GSK3Beta within the complex. Indeed, FLAG-tau co-immunoprecipitated with HA-GSK3Beta from cells overexpressing FLAG-tau and HA-GSK3Beta only when these cells also overexpressed Xpress-14-3-3zeta (Fig. 6A, lanes 8 and 9), indicating that GSK3Beta associates with tau only in the presence of 14-3-3zeta. As discussed above, 14-3-3zeta binds to tau (36) and GSK3Beta (Fig. 5) directly. Taken together, these observations indicated that 14-3-3zeta connects GSK3Beta to tau in vivo.",
      "key": "3965499c540649db68124ccd2201fa43",
      "line": 843,
      "relation": "isA",
      "source": 158,
      "target": 58
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, FPLC": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ],
        "date": "2003-04-11",
        "db": "PubMed",
        "db_id": "12551948",
        "db_name": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "first": "Agarwal-Mawal A",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "12722-8",
        "volume": "278"
      },
      "evidence": "These observations suggested that 14-3-3zeta may be bound to GSK3Beta and/or tau within brain microtubules and may be a component of tau phosphorylation complex.Therefore, 14-3-3 must be the central molecule that holds tau and GSK3Beta within the complex. Indeed, FLAG-tau co-immunoprecipitated with HA-GSK3Beta from cells overexpressing FLAG-tau and HA-GSK3Beta only when these cells also overexpressed Xpress-14-3-3zeta (Fig. 6A, lanes 8 and 9), indicating that GSK3Beta associates with tau only in the presence of 14-3-3zeta. As discussed above, 14-3-3zeta binds to tau (36) and GSK3Beta (Fig. 5) directly. Taken together, these observations indicated that 14-3-3zeta connects GSK3Beta to tau in vivo.",
      "key": "1fe097a7714b00ff37826df77e0e438b",
      "line": 844,
      "relation": "association",
      "source": 158,
      "target": 125
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, FPLC": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ],
        "date": "2003-04-11",
        "db": "PubMed",
        "db_id": "12551948",
        "db_name": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "first": "Agarwal-Mawal A",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "12722-8",
        "volume": "278"
      },
      "evidence": "These observations suggested that 14-3-3zeta may be bound to GSK3Beta and/or tau within brain microtubules and may be a component of tau phosphorylation complex.Therefore, 14-3-3 must be the central molecule that holds tau and GSK3Beta within the complex. Indeed, FLAG-tau co-immunoprecipitated with HA-GSK3Beta from cells overexpressing FLAG-tau and HA-GSK3Beta only when these cells also overexpressed Xpress-14-3-3zeta (Fig. 6A, lanes 8 and 9), indicating that GSK3Beta associates with tau only in the presence of 14-3-3zeta. As discussed above, 14-3-3zeta binds to tau (36) and GSK3Beta (Fig. 5) directly. Taken together, these observations indicated that 14-3-3zeta connects GSK3Beta to tau in vivo.",
      "key": "2d55e355a84c57c6aee525fa0fb2a72d",
      "line": 845,
      "relation": "association",
      "source": 158,
      "target": 118
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        },
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatography, FPLC": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "SDS-PAGE": true
        }
      },
      "citation": {
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ],
        "date": "2003-04-11",
        "db": "PubMed",
        "db_id": "12551948",
        "db_name": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "first": "Agarwal-Mawal A",
        "journal": "The Journal of biological chemistry",
        "last": "Paudel HK",
        "pages": "12722-8",
        "volume": "278"
      },
      "evidence": "In cells that were co-transfected with fixed amounts of FLAG-tau and HA-GSK3Beta but different amounts of Xpress-14-3-3zeta, FLAG-tau phosphorylation increased progressively with the increase in the amount of Xpress-14-3-3zeta (lanes 7–9). This increase was evident not only by an increased immunoreactivity against all tau phosphorylation-sensitive antibodies tested but also by a retarded mobility of FLAG-tau on the SDS gel, a characteristic feature of hyperphosphorylated tau (2, 3). Thus, 14-3-3zeta profoundly stimulated GSK3Beta-catalyzed tau phosphorylation in vivo.",
      "key": "3fd734bfe2196d73a0e0cecacb928e9d",
      "line": 856,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 158,
      "target": 118
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy, Laser Scanning": true,
          "Immunocytochemistry": true,
          "Mass Spectrometry": true,
          "Pull-down Assay, GFP": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        }
      },
      "citation": {
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "Sebö-Lemke Z",
          "Weissmann C"
        ],
        "date": "2011-02-21",
        "db": "PubMed",
        "db_id": "21339331",
        "db_name": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "first": "Gauthier-Kemper A",
        "journal": "The Journal of cell biology",
        "last": "Brandt R",
        "pages": "647-61",
        "volume": "192"
      },
      "evidence": "The quantification of all immunoreactive bands revealed that the R406W mutation exhibits a decreased phosphorylation at T205, T212, and the PHF1 epitope (S396/S404; reductions of 40–65%) as compared with wt tau, whereas other sites were not affected or only slightly affected (T181, S199, S214, and S262).",
      "key": "b7016b051a56abd8439b5bad21a54a46",
      "line": 882,
      "relation": "decreases",
      "source": 84,
      "target": 138
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy, Laser Scanning": true,
          "Immunocytochemistry": true,
          "Mass Spectrometry": true,
          "Pull-down Assay, GFP": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        }
      },
      "citation": {
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "Sebö-Lemke Z",
          "Weissmann C"
        ],
        "date": "2011-02-21",
        "db": "PubMed",
        "db_id": "21339331",
        "db_name": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "first": "Gauthier-Kemper A",
        "journal": "The Journal of cell biology",
        "last": "Brandt R",
        "pages": "647-61",
        "volume": "192"
      },
      "evidence": "The quantification of all immunoreactive bands revealed that the R406W mutation exhibits a decreased phosphorylation at T205, T212, and the PHF1 epitope (S396/S404; reductions of 40–65%) as compared with wt tau, whereas other sites were not affected or only slightly affected (T181, S199, S214, and S262).",
      "key": "5820ea1333257fb0bcc931019c91daa6",
      "line": 883,
      "relation": "decreases",
      "source": 84,
      "target": 139
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy, Laser Scanning": true,
          "Immunocytochemistry": true,
          "Mass Spectrometry": true,
          "Pull-down Assay, GFP": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        }
      },
      "citation": {
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "Sebö-Lemke Z",
          "Weissmann C"
        ],
        "date": "2011-02-21",
        "db": "PubMed",
        "db_id": "21339331",
        "db_name": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "first": "Gauthier-Kemper A",
        "journal": "The Journal of cell biology",
        "last": "Brandt R",
        "pages": "647-61",
        "volume": "192"
      },
      "evidence": "The quantification of all immunoreactive bands revealed that the R406W mutation exhibits a decreased phosphorylation at T205, T212, and the PHF1 epitope (S396/S404; reductions of 40–65%) as compared with wt tau, whereas other sites were not affected or only slightly affected (T181, S199, S214, and S262).",
      "key": "36d7e2baf8db6d23a5d7290bf6855628",
      "line": 884,
      "relation": "decreases",
      "source": 84,
      "target": 136
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy, Laser Scanning": true,
          "Immunocytochemistry": true,
          "Mass Spectrometry": true,
          "Pull-down Assay, GFP": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        }
      },
      "citation": {
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "Sebö-Lemke Z",
          "Weissmann C"
        ],
        "date": "2011-02-21",
        "db": "PubMed",
        "db_id": "21339331",
        "db_name": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "first": "Gauthier-Kemper A",
        "journal": "The Journal of cell biology",
        "last": "Brandt R",
        "pages": "647-61",
        "volume": "192"
      },
      "evidence": "The quantification of all immunoreactive bands revealed that the R406W mutation exhibits a decreased phosphorylation at T205, T212, and the PHF1 epitope (S396/S404; reductions of 40–65%) as compared with wt tau, whereas other sites were not affected or only slightly affected (T181, S199, S214, and S262).",
      "key": "26c14a1a395406e9210fecd8cda4531a",
      "line": 885,
      "relation": "decreases",
      "source": 84,
      "target": 137
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy, Laser Scanning": true,
          "Immunocytochemistry": true,
          "Mass Spectrometry": true,
          "Pull-down Assay, GFP": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        }
      },
      "citation": {
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "Sebö-Lemke Z",
          "Weissmann C"
        ],
        "date": "2011-02-21",
        "db": "PubMed",
        "db_id": "21339331",
        "db_name": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "first": "Gauthier-Kemper A",
        "journal": "The Journal of cell biology",
        "last": "Brandt R",
        "pages": "647-61",
        "volume": "192"
      },
      "evidence": "The data suggest that tau’s membrane association causes retention of tau in the tip of neurites, which is compromised by the R406W mutation. Also, after BAPTA treatment, the difference in the retention of wt tau and R406W tau was abolished (Fig. 9 D), which again suggests that tau trapping is caused by an interaction with AnxA2 at the membrane.",
      "key": "ae7efd323fd83f78a9013c1b9e243ced",
      "line": 899,
      "relation": "decreases",
      "source": 84,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy, Laser Scanning": true,
          "Immunocytochemistry": true,
          "Mass Spectrometry": true,
          "Pull-down Assay, GFP": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        }
      },
      "citation": {
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "Sebö-Lemke Z",
          "Weissmann C"
        ],
        "date": "2011-02-21",
        "db": "PubMed",
        "db_id": "21339331",
        "db_name": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "first": "Gauthier-Kemper A",
        "journal": "The Journal of cell biology",
        "last": "Brandt R",
        "pages": "647-61",
        "volume": "192"
      },
      "evidence": "The data suggest that tau’s membrane association causes retention of tau in the tip of neurites, which is compromised by the R406W mutation. Also, after BAPTA treatment, the difference in the retention of wt tau and R406W tau was abolished (Fig. 9 D), which again suggests that tau trapping is caused by an interaction with AnxA2 at the membrane.",
      "key": "f5d10c58d687618f91af0871caa94fea",
      "line": 896,
      "relation": "association",
      "source": 103,
      "target": 125
    },
    {
      "key": "c7cc2efd1437dfede827fe591a39b24e",
      "relation": "partOf",
      "source": 103,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Method": {
          "Confocal Microscopy, Laser Scanning": true,
          "Immunocytochemistry": true,
          "Mass Spectrometry": true,
          "Pull-down Assay, GFP": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        }
      },
      "citation": {
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "Sebö-Lemke Z",
          "Weissmann C"
        ],
        "date": "2011-02-21",
        "db": "PubMed",
        "db_id": "21339331",
        "db_name": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "first": "Gauthier-Kemper A",
        "journal": "The Journal of cell biology",
        "last": "Brandt R",
        "pages": "647-61",
        "volume": "192"
      },
      "evidence": "The data suggest that tau’s membrane association causes retention of tau in the tip of neurites, which is compromised by the R406W mutation. Also, after BAPTA treatment, the difference in the retention of wt tau and R406W tau was abolished (Fig. 9 D), which again suggests that tau trapping is caused by an interaction with AnxA2 at the membrane.",
      "key": "307aab8c05f5e72a230901cecf582f8e",
      "line": 897,
      "relation": "isA",
      "source": 103,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Western Blot": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ],
        "date": "2008-05-01",
        "db": "PubMed",
        "db_id": "18096814",
        "db_name": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "first": "Williamson R",
        "journal": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "last": "Anderton BH",
        "pages": "1552-9",
        "volume": "22"
      },
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fyn’s localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "key": "af509fd9f17f3561872f0b4e9cefe2e9",
      "line": 913,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "cytoplasm",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "membrane raft",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 8,
      "target": 168
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Western Blot": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ],
        "date": "2008-05-01",
        "db": "PubMed",
        "db_id": "18096814",
        "db_name": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "first": "Williamson R",
        "journal": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "last": "Anderton BH",
        "pages": "1552-9",
        "volume": "22"
      },
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fyn’s localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "key": "f5ea152ea238e64f2e5ebd7488148239",
      "line": 914,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "cytoplasm",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "membrane raft",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 8,
      "target": 172
    },
    {
      "key": "c9d39d56c77572dd5b4eec8346f8fcff",
      "relation": "hasVariant",
      "source": 168,
      "target": 169
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Western Blot": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ],
        "date": "2008-05-01",
        "db": "PubMed",
        "db_id": "18096814",
        "db_name": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "first": "Williamson R",
        "journal": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "last": "Anderton BH",
        "pages": "1552-9",
        "volume": "22"
      },
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fyn’s localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "key": "f432f7256d63fb06d24ea717767f25b7",
      "line": 918,
      "relation": "negativeCorrelation",
      "source": 168,
      "subject": {
        "location": {
          "name": "membrane raft",
          "namespace": "GO"
        }
      },
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Western Blot": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ],
        "date": "2008-05-01",
        "db": "PubMed",
        "db_id": "18096814",
        "db_name": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "first": "Williamson R",
        "journal": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "last": "Anderton BH",
        "pages": "1552-9",
        "volume": "22"
      },
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fyn’s localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "key": "8cc57917c03cc2ef32b7f311fad43fa8",
      "line": 919,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "cytoplasm",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "membrane raft",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "regulates",
      "source": 168,
      "target": 172
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Western Blot": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ],
        "date": "2008-05-01",
        "db": "PubMed",
        "db_id": "18096814",
        "db_name": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "first": "Williamson R",
        "journal": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "last": "Anderton BH",
        "pages": "1552-9",
        "volume": "22"
      },
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fyn’s localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "key": "0afa8725aae3fcba9bcffcb45df2699c",
      "line": 915,
      "relation": "decreases",
      "source": 0,
      "target": 169
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Western Blot": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ],
        "date": "2008-05-01",
        "db": "PubMed",
        "db_id": "18096814",
        "db_name": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "first": "Williamson R",
        "journal": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "last": "Anderton BH",
        "pages": "1552-9",
        "volume": "22"
      },
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fyn’s localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "key": "bbfa1cf0343e1c340772e35a0646a1b7",
      "line": 917,
      "object": {
        "location": {
          "name": "membrane raft",
          "namespace": "GO"
        }
      },
      "relation": "negativeCorrelation",
      "source": 0,
      "target": 172
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Western Blot": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ],
        "date": "2008-05-01",
        "db": "PubMed",
        "db_id": "18096814",
        "db_name": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "first": "Williamson R",
        "journal": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "last": "Anderton BH",
        "pages": "1552-9",
        "volume": "22"
      },
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fyn’s localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "key": "1850ab499db05c895a2ebc9eaf9ccd58",
      "line": 918,
      "object": {
        "location": {
          "name": "membrane raft",
          "namespace": "GO"
        }
      },
      "relation": "negativeCorrelation",
      "source": 0,
      "target": 168
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Method": {
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Western Blot": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ],
        "date": "2008-05-01",
        "db": "PubMed",
        "db_id": "18096814",
        "db_name": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "first": "Williamson R",
        "journal": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "last": "Anderton BH",
        "pages": "1552-9",
        "volume": "22"
      },
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fyn’s localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "key": "2d4c35acea0f851d23138bced725c59e",
      "line": 916,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "cytoplasm",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "membrane raft",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 169,
      "target": 168
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Chromatin Immunoprecipitation": true
        }
      },
      "citation": {
        "authors": [
          "Bonnefoy E",
          "Buée L",
          "Bégard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ],
        "date": "2011-02-11",
        "db": "PubMed",
        "db_id": "21131359",
        "db_name": "Nuclear tau, a key player in neuronal DNA protection.",
        "first": "Sultan A",
        "journal": "The Journal of biological chemistry",
        "last": "Galas MC",
        "pages": "4566-75",
        "volume": "286"
      },
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "key": "79ce011d2d051a13bab30c5938274059",
      "line": 935,
      "relation": "increases",
      "source": 20,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Non-denaturing Fast Halo Assay": true
        }
      },
      "citation": {
        "authors": [
          "Bonnefoy E",
          "Buée L",
          "Bégard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ],
        "date": "2011-02-11",
        "db": "PubMed",
        "db_id": "21131359",
        "db_name": "Nuclear tau, a key player in neuronal DNA protection.",
        "first": "Sultan A",
        "journal": "The Journal of biological chemistry",
        "last": "Galas MC",
        "pages": "4566-75",
        "volume": "286"
      },
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "key": "4345f5163e4905a6cb59326c6273a3ab",
      "line": 941,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "cytoplasm",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "nucleus",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 20,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Non-denaturing Fast Halo Assay": true
        }
      },
      "citation": {
        "authors": [
          "Bonnefoy E",
          "Buée L",
          "Bégard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ],
        "date": "2011-02-11",
        "db": "PubMed",
        "db_id": "21131359",
        "db_name": "Nuclear tau, a key player in neuronal DNA protection.",
        "first": "Sultan A",
        "journal": "The Journal of biological chemistry",
        "last": "Galas MC",
        "pages": "4566-75",
        "volume": "286"
      },
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "key": "8d9797e18c19d2b30eb64bece7e66237",
      "line": 942,
      "relation": "negativeCorrelation",
      "source": 20,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Non-denaturing Fast Halo Assay": true
        }
      },
      "citation": {
        "authors": [
          "Bonnefoy E",
          "Buée L",
          "Bégard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ],
        "date": "2011-02-11",
        "db": "PubMed",
        "db_id": "21131359",
        "db_name": "Nuclear tau, a key player in neuronal DNA protection.",
        "first": "Sultan A",
        "journal": "The Journal of biological chemistry",
        "last": "Galas MC",
        "pages": "4566-75",
        "volume": "286"
      },
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "key": "e172e58af03ee395100ed93dc4181bf9",
      "line": 943,
      "relation": "decreases",
      "source": 20,
      "target": 2
    },
    {
      "key": "f5997dacadc332a21e1fde810269ac73",
      "relation": "partOf",
      "source": 2,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Non-denaturing Fast Halo Assay": true
        }
      },
      "citation": {
        "authors": [
          "Bonnefoy E",
          "Buée L",
          "Bégard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ],
        "date": "2011-02-11",
        "db": "PubMed",
        "db_id": "21131359",
        "db_name": "Nuclear tau, a key player in neuronal DNA protection.",
        "first": "Sultan A",
        "journal": "The Journal of biological chemistry",
        "last": "Galas MC",
        "pages": "4566-75",
        "volume": "286"
      },
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "key": "b2c219e6c85f5b1ba61161621af22394",
      "line": 939,
      "relation": "isA",
      "source": 2,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Non-denaturing Fast Halo Assay": true
        }
      },
      "citation": {
        "authors": [
          "Bonnefoy E",
          "Buée L",
          "Bégard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ],
        "date": "2011-02-11",
        "db": "PubMed",
        "db_id": "21131359",
        "db_name": "Nuclear tau, a key player in neuronal DNA protection.",
        "first": "Sultan A",
        "journal": "The Journal of biological chemistry",
        "last": "Galas MC",
        "pages": "4566-75",
        "volume": "286"
      },
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "key": "21d2265e5c3bc4499872b07b5ca79f41",
      "line": 937,
      "relation": "association",
      "source": 2,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true,
          "LDH Assay": true,
          "Non-denaturing Fast Halo Assay": true
        }
      },
      "citation": {
        "authors": [
          "Bonnefoy E",
          "Buée L",
          "Bégard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ],
        "date": "2011-02-11",
        "db": "PubMed",
        "db_id": "21131359",
        "db_name": "Nuclear tau, a key player in neuronal DNA protection.",
        "first": "Sultan A",
        "journal": "The Journal of biological chemistry",
        "last": "Galas MC",
        "pages": "4566-75",
        "volume": "286"
      },
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "key": "fa16ce6b7a03f6cc3fae9dba96417362",
      "line": 940,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "cytoplasm",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "nucleus",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 21,
      "target": 125
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Method": {
          "Electron Microscopy": true
        }
      },
      "citation": {
        "authors": [
          "Biernat J",
          "Friedhoff P",
          "Kampers T",
          "Mandelkow E",
          "Mandelkow EM"
        ],
        "date": "1996-12-16",
        "db": "PubMed",
        "db_id": "8985176",
        "db_name": "RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments.",
        "first": "Kampers T",
        "journal": "FEBS letters",
        "last": "Mandelkow E",
        "pages": "344-9",
        "volume": "399"
      },
      "evidence": "As noticed earler, it is difficult to obtain PHFs from constructs containing domains outside the repeats or the second repeat, at least under conditions where assembly is driven by high ionic strength and high protein concentration [5,26]. This would suggest that some non-repeat domains of tau prevent PHF formation. The same tendency is observed here again, but low we find that the inhibition can be easily overcome by RNA in most cases. Since dimers are building blocks of PHFs, the extra repeat (no. 2) effectively acted as a PHF inhibitor [22]. However, this inhibition can be overcome by tRNA.",
      "key": "d3d6f9ae211b943e1de78043be720af7",
      "line": 956,
      "relation": "increases",
      "source": 4,
      "target": 14
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"2-bromohexadecanoic acid\")",
      "concept": {
        "name": "2-bromohexadecanoic acid",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "b204b3e40b6d79183d069bd9eab50184"
    },
    {
      "bel": "a(CHEBI:\"calcium(2+)\")",
      "concept": {
        "name": "calcium(2+)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "94df77a2db8d9014b42535235da90e5d"
    },
    {
      "bel": "a(CHEBI:\"double-stranded DNA\")",
      "concept": {
        "name": "double-stranded DNA",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "f0e185eea212dc432ed0447543ad55fa"
    },
    {
      "bel": "a(CHEBI:\"phosphate(3-)\")",
      "concept": {
        "name": "phosphate(3-)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "fb6fd08200f6469cca623b134c5ac56f"
    },
    {
      "bel": "a(CHEBI:\"transfer RNA\")",
      "concept": {
        "name": "transfer RNA",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "b6e7d2098a8b4da7f3d66fa0a7f61910"
    },
    {
      "bel": "a(CHEBI:\"zinc(2+)\")",
      "concept": {
        "name": "zinc(2+)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "367064d7652079b87c47f3f5b95bdab2"
    },
    {
      "bel": "a(CHEBI:juglone)",
      "concept": {
        "name": "juglone",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "dd7eb464c5d07bccba339d36f8f7a8de"
    },
    {
      "bel": "a(CHEBI:tanespimycin)",
      "concept": {
        "name": "tanespimycin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "b6850241cac2c4aa77190fa5db86fc60"
    },
    {
      "bel": "a(CONSO:\"amyloid-beta derived diffusible ligands\")",
      "concept": {
        "name": "amyloid-beta derived diffusible ligands",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "b198bfd04e50cfcecc9ea9c71403ef51"
    },
    {
      "bel": "a(MESH:Microtubules)",
      "concept": {
        "name": "Microtubules",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "86177bbdcc4ebe2f7b5ae56407358336"
    },
    {
      "bel": "a(MESH:Neurons)",
      "concept": {
        "name": "Neurons",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "c429b8780142c504cf23cacfc2fa2b09"
    },
    {
      "bel": "bp(GO:\"Wnt signaling pathway\")",
      "concept": {
        "name": "Wnt signaling pathway",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5ead8084d77cd9bc2148133b735c31ba"
    },
    {
      "bel": "bp(GO:\"inflammatory response\")",
      "concept": {
        "name": "inflammatory response",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "abd32f6c5cca606061975532840db260"
    },
    {
      "bel": "bp(GO:\"microtubule polymerization\")",
      "concept": {
        "name": "microtubule polymerization",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "689df6bb44a41b81144f3915d73a445a"
    },
    {
      "bel": "bp(GO:\"neurofibrillary tangle assembly\")",
      "concept": {
        "name": "neurofibrillary tangle assembly",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "1f82590453fa284e3e950f8c5eb3e2da"
    },
    {
      "bel": "bp(GO:\"neuron apoptotic process\")",
      "concept": {
        "name": "neuron apoptotic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "d73c31b799210c2ae76d3426d593149c"
    },
    {
      "bel": "bp(GO:\"neuron development\")",
      "concept": {
        "name": "neuron development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "8f49298adb94366910ab16542f624780"
    },
    {
      "bel": "bp(GO:\"neuron projection development\")",
      "concept": {
        "name": "neuron projection development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "b7f19b107f0a29154ed6a83a68686b99"
    },
    {
      "bel": "bp(GO:\"vesicle-mediated transport\")",
      "concept": {
        "name": "vesicle-mediated transport",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "20095b3e7311ad3d28e52bcc46749279"
    },
    {
      "bel": "bp(GO:myelination)",
      "concept": {
        "name": "myelination",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "484ae6456551d888476839afe30f4dcf"
    },
    {
      "bel": "bp(MESH:\"Hot Temperature\")",
      "concept": {
        "name": "Hot Temperature",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "3ee77c1b5c1112d0e338eba1d0dff9e9"
    },
    {
      "bel": "bp(MESH:\"Oxidative Stress\")",
      "concept": {
        "name": "Oxidative Stress",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "9174b724412892a12c4da7cab55f893c"
    },
    {
      "bel": "complex(GO:\"Lewy body\")",
      "concept": {
        "name": "Lewy body",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "35d24639fdc356c8e3ab5df9335c90a2"
    },
    {
      "bel": "complex(GO:\"actin filament bundle\")",
      "concept": {
        "name": "actin filament bundle",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "187341428dac666f9224b2d8f81df48f"
    },
    {
      "bel": "complex(GO:\"filamentous actin\")",
      "concept": {
        "name": "filamentous actin",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "1dc808944278a8ce08d7297ee40bc4d8"
    },
    {
      "bel": "complex(GO:\"kinesin complex\")",
      "concept": {
        "name": "kinesin complex",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "2ad1ce929e6a7a6cada37e8f18832c3c"
    },
    {
      "bel": "complex(GO:\"neurofibrillary tangle\")",
      "concept": {
        "name": "neurofibrillary tangle",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "76999d0ff7e550eb8f9ab7a9f5522c97"
    },
    {
      "bel": "complex(GO:\"neuron projection\")",
      "concept": {
        "name": "neuron projection",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "41af677e182727b273c7b4a50b93e0f1"
    },
    {
      "bel": "complex(GO:\"proteasome complex\")",
      "concept": {
        "name": "proteasome complex",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "60eac9a2a13b2c4ebafe4ec275b444a2"
    },
    {
      "bel": "complex(GO:\"protein phosphatase type 2A complex\")",
      "concept": {
        "name": "protein phosphatase type 2A complex",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "b008e3ef1c2a14a854ac631e56910234"
    },
    {
      "bel": "complex(GO:axon)",
      "concept": {
        "name": "axon",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "a9b997ec5ace3bd90f0c74bf04f76937"
    },
    {
      "bel": "complex(GO:microtubule)",
      "concept": {
        "name": "microtubule",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "aae562c251c5c50bdc1083edb852c877"
    },
    {
      "bel": "complex(GO:neurofilament)",
      "concept": {
        "name": "neurofilament",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "fd6dd4bc319a6e34de9b7148747d5e75"
    },
    {
      "bel": "complex(a(CHEBI:\"calcium(2+)\"), p(FPLX:CALM))",
      "function": "Complex",
      "id": "e0be03aafcc4d8efaa503968a2579640",
      "members": [
        {
          "bel": "a(CHEBI:\"calcium(2+)\")",
          "concept": {
            "name": "calcium(2+)",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "94df77a2db8d9014b42535235da90e5d"
        },
        {
          "bel": "p(FPLX:CALM)",
          "concept": {
            "name": "CALM",
            "namespace": "FPLX"
          },
          "function": "Protein",
          "id": "722a364939ea93ba0730199474b6714c"
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:\"calcium(2+)\"), p(FPLX:CALM), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "2d0d38265a512a15e769705bc72f6813",
      "members": [
        {
          "bel": "a(CHEBI:\"calcium(2+)\")",
          "concept": {
            "name": "calcium(2+)",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "94df77a2db8d9014b42535235da90e5d"
        },
        {
          "bel": "p(FPLX:CALM)",
          "concept": {
            "name": "CALM",
            "namespace": "FPLX"
          },
          "function": "Protein",
          "id": "722a364939ea93ba0730199474b6714c"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:\"double-stranded DNA\"), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "cba01360172c293ea6aa2e38aba96118",
      "members": [
        {
          "bel": "a(CHEBI:\"double-stranded DNA\")",
          "concept": {
            "name": "double-stranded DNA",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "f0e185eea212dc432ed0447543ad55fa"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:Microtubules), p(HGNC:KIF5B))",
      "function": "Complex",
      "id": "c4754a9c7d2afcb6ab5c7a4d62faa9bb",
      "members": [
        {
          "bel": "a(MESH:Microtubules)",
          "concept": {
            "name": "Microtubules",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "86177bbdcc4ebe2f7b5ae56407358336"
        },
        {
          "bel": "p(HGNC:KIF5B)",
          "concept": {
            "name": "KIF5B",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "c20adf7ec828368e43bbc51fc21b8cdb"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:Microtubules), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "78f0e9133ea9c8a592988e0cbb6b0f88",
      "members": [
        {
          "bel": "a(MESH:Microtubules)",
          "concept": {
            "name": "Microtubules",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "86177bbdcc4ebe2f7b5ae56407358336"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:Microtubules), p(INTERPRO:\"Dynein associated protein\"))",
      "function": "Complex",
      "id": "d8cc7e1dea70212235170ba6c9efe512",
      "members": [
        {
          "bel": "a(MESH:Microtubules)",
          "concept": {
            "name": "Microtubules",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "86177bbdcc4ebe2f7b5ae56407358336"
        },
        {
          "bel": "p(INTERPRO:\"Dynein associated protein\")",
          "concept": {
            "name": "Dynein associated protein",
            "namespace": "INTERPRO"
          },
          "function": "Protein",
          "id": "93db18fd30f5fd18ee7e1c9b53001f6d"
        }
      ]
    },
    {
      "bel": "complex(complex(GO:\"filamentous actin\"), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "1a905314e7b14270f1700df11e9ba5c1",
      "members": [
        {
          "bel": "complex(GO:\"filamentous actin\")",
          "concept": {
            "name": "filamentous actin",
            "namespace": "GO"
          },
          "function": "Complex",
          "id": "1dc808944278a8ce08d7297ee40bc4d8"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(complex(GO:\"protein phosphatase type 2A complex\"), p(CONSO:\"microtubule-binding region\"))",
      "function": "Complex",
      "id": "7bbd8dc55082a6c65f5d756a9e176119",
      "members": [
        {
          "bel": "complex(GO:\"protein phosphatase type 2A complex\")",
          "concept": {
            "name": "protein phosphatase type 2A complex",
            "namespace": "GO"
          },
          "function": "Complex",
          "id": "b008e3ef1c2a14a854ac631e56910234"
        },
        {
          "bel": "p(CONSO:\"microtubule-binding region\")",
          "concept": {
            "name": "microtubule-binding region",
            "namespace": "CONSO"
          },
          "function": "Protein",
          "id": "a37bfc324c697c5840d8d099152b779c"
        }
      ]
    },
    {
      "bel": "complex(complex(GO:microtubule), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "96a9407f5eefa4328e0f9b11ac636d0c",
      "members": [
        {
          "bel": "complex(GO:microtubule)",
          "concept": {
            "name": "microtubule",
            "namespace": "GO"
          },
          "function": "Complex",
          "id": "aae562c251c5c50bdc1083edb852c877"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(complex(GO:microtubule), p(HGNC:PPP2CA))",
      "function": "Complex",
      "id": "9719f9586891d049d21493dec53c1e49",
      "members": [
        {
          "bel": "complex(GO:microtubule)",
          "concept": {
            "name": "microtubule",
            "namespace": "GO"
          },
          "function": "Complex",
          "id": "aae562c251c5c50bdc1083edb852c877"
        },
        {
          "bel": "p(HGNC:PPP2CA)",
          "concept": {
            "name": "PPP2CA",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "2d92165ca8a0570584f2d8e79172e84a"
        }
      ]
    },
    {
      "bel": "complex(complex(GO:neurofilament), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "7fa6cb9b85b0529ef64a0aeebe938fe1",
      "members": [
        {
          "bel": "complex(GO:neurofilament)",
          "concept": {
            "name": "neurofilament",
            "namespace": "GO"
          },
          "function": "Complex",
          "id": "fd6dd4bc319a6e34de9b7148747d5e75"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(CONSO:\"paired helical filaments\"), p(HGNC:HSPB1))",
      "function": "Complex",
      "id": "d5223da8a359a37cdcb5fd1748c34487",
      "members": [
        {
          "bel": "p(CONSO:\"paired helical filaments\")",
          "concept": {
            "name": "paired helical filaments",
            "namespace": "CONSO"
          },
          "function": "Protein",
          "id": "0bb08a6e59ca5c7490738810a0985e9f"
        },
        {
          "bel": "p(HGNC:HSPB1)",
          "concept": {
            "name": "HSPB1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "d5b5de04c466b9b3d8edde293c1f2a4f"
        }
      ]
    },
    {
      "bel": "complex(p(FPLX:\"Cytoplasmic_dynein\"), p(RGD:Snca))",
      "function": "Complex",
      "id": "a2afeb34d1dfd7ed668106c8de771600",
      "members": [
        {
          "bel": "p(FPLX:\"Cytoplasmic_dynein\")",
          "concept": {
            "name": "Cytoplasmic_dynein",
            "namespace": "FPLX"
          },
          "function": "Protein",
          "id": "4212218ab7f74307689accb45382e8e9"
        },
        {
          "bel": "p(RGD:Snca)",
          "concept": {
            "name": "Snca",
            "namespace": "RGD"
          },
          "function": "Protein",
          "id": "30c5192f67126a5451389596bbf9b1c2"
        }
      ]
    },
    {
      "bel": "complex(p(FPLX:CALM), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "3095b7a87b0c43e9b86c0cb65995d238",
      "members": [
        {
          "bel": "p(FPLX:CALM)",
          "concept": {
            "name": "CALM",
            "namespace": "FPLX"
          },
          "function": "Protein",
          "id": "722a364939ea93ba0730199474b6714c"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(FPLX:HSP90), p(HGNC:CDC37))",
      "function": "Complex",
      "id": "b91d27d2a93bdd718b788cbec0878333",
      "members": [
        {
          "bel": "p(FPLX:HSP90)",
          "concept": {
            "name": "HSP90",
            "namespace": "FPLX"
          },
          "function": "Protein",
          "id": "1d25d355c41148f8c1322364b79179e4"
        },
        {
          "bel": "p(HGNC:CDC37)",
          "concept": {
            "name": "CDC37",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "8ac61583b7b88b6635a828008797ef03"
        }
      ]
    },
    {
      "bel": "complex(p(FPLX:HSP90), p(HGNC:FKBP4))",
      "function": "Complex",
      "id": "96bff3c677e480b382afc155fb2415bb",
      "members": [
        {
          "bel": "p(FPLX:HSP90)",
          "concept": {
            "name": "HSP90",
            "namespace": "FPLX"
          },
          "function": "Protein",
          "id": "1d25d355c41148f8c1322364b79179e4"
        },
        {
          "bel": "p(HGNC:FKBP4)",
          "concept": {
            "name": "FKBP4",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "a405d4c8f4ec34d763d011b0c73bd788"
        }
      ]
    },
    {
      "bel": "complex(p(FPLX:HSP90), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "469b6c48d6b53ed924318d600dce44b2",
      "members": [
        {
          "bel": "p(FPLX:HSP90)",
          "concept": {
            "name": "HSP90",
            "namespace": "FPLX"
          },
          "function": "Protein",
          "id": "1d25d355c41148f8c1322364b79179e4"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:AHSA1), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "8a44999ceeceee02e608a6df941e7e40",
      "members": [
        {
          "bel": "p(HGNC:AHSA1)",
          "concept": {
            "name": "AHSA1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "801b5a3d09f90703dda1464396c4924f"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:ANXA2), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "238c7e9d232f7886fd5b700fddab0bf3",
      "members": [
        {
          "bel": "p(HGNC:ANXA2)",
          "concept": {
            "name": "ANXA2",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7a08a109c6b60fcf5a1048cb5ea526ef"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:BAG1), p(HGNC:HSPA8), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "63e410b481a8e948a9a2fb8eebf0d246",
      "members": [
        {
          "bel": "p(HGNC:BAG1)",
          "concept": {
            "name": "BAG1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "e99a022dd6d96a105b9a599748e7cf66"
        },
        {
          "bel": "p(HGNC:HSPA8)",
          "concept": {
            "name": "HSPA8",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "1e0e1cda4e0ab830cc8bb12a7035a8b2"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:DCTN1), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "f77d7447007502dedfd81ecc92030d00",
      "members": [
        {
          "bel": "p(HGNC:DCTN1)",
          "concept": {
            "name": "DCTN1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "dcf639e9ecb74332f35aad21be63c543"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:FKBP5), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "a629997837e7ab370b6235844b61806c",
      "members": [
        {
          "bel": "p(HGNC:FKBP5)",
          "concept": {
            "name": "FKBP5",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "6cdfe5e08dbab001c43d1af3146cfb92"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:FYN), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "bbc7f849ba5bd91d4344080f957e00f2",
      "members": [
        {
          "bel": "p(HGNC:FYN)",
          "concept": {
            "name": "FYN",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "9aaa70667f9bfd5fd59c45422ea4c02c"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:GRB2), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "6e36bc9bbcc0744bd1169333383ddb8f",
      "members": [
        {
          "bel": "p(HGNC:GRB2)",
          "concept": {
            "name": "GRB2",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "dac7b04df04d8a0bac1269d3918d2179"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:GSK3B), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "578ec40b5a39f09d3f8f5d9c9bf5fc3e",
      "members": [
        {
          "bel": "p(HGNC:GSK3B)",
          "concept": {
            "name": "GSK3B",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "8eaf29c9e491ff4e49619e77de92467c"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:GSK3B), p(HGNC:MAPT), p(HGNC:YWHAZ))",
      "function": "Complex",
      "id": "8f8802f1586ed285e9a8a9f7a429adc9",
      "members": [
        {
          "bel": "p(HGNC:GSK3B)",
          "concept": {
            "name": "GSK3B",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "8eaf29c9e491ff4e49619e77de92467c"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        },
        {
          "bel": "p(HGNC:YWHAZ)",
          "concept": {
            "name": "YWHAZ",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "88c1928bf6a95391d84d1e6b3886fa67"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:GSK3B), p(HGNC:MAPT, frag(\"1_244\")))",
      "function": "Complex",
      "id": "79a336c2d6654ab021c35fb6fee48dce",
      "members": [
        {
          "bel": "p(HGNC:GSK3B)",
          "concept": {
            "name": "GSK3B",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "8eaf29c9e491ff4e49619e77de92467c"
        },
        {
          "bel": "p(HGNC:MAPT, frag(\"1_244\"))",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "6ec527cd08261f59191498185fae3eb8",
          "variants": [
            {
              "kind": "frag",
              "start": 1,
              "stop": 244
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:GSK3B), p(HGNC:MAPT, frag(\"245_369\")))",
      "function": "Complex",
      "id": "df2a3cea78236c8d9a3580f65b64c2b4",
      "members": [
        {
          "bel": "p(HGNC:GSK3B)",
          "concept": {
            "name": "GSK3B",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "8eaf29c9e491ff4e49619e77de92467c"
        },
        {
          "bel": "p(HGNC:MAPT, frag(\"245_369\"))",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "0dfb2c8f62fece3393a7b6716d37c14c",
          "variants": [
            {
              "kind": "frag",
              "start": 245,
              "stop": 369
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:GSK3B), p(HGNC:MAPT, frag(\"245_441\")))",
      "function": "Complex",
      "id": "e399479e8223552dc0f7d82f5a977f5c",
      "members": [
        {
          "bel": "p(HGNC:GSK3B)",
          "concept": {
            "name": "GSK3B",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "8eaf29c9e491ff4e49619e77de92467c"
        },
        {
          "bel": "p(HGNC:MAPT, frag(\"245_441\"))",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "cf655ea9d24e9d93345c2dceae22c4fe",
          "variants": [
            {
              "kind": "frag",
              "start": 245,
              "stop": 441
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:HSPA8), p(HGNC:MAPT, pmod(Ph)), p(HGNC:STUB1), p(HGNC:UBE2D2))",
      "function": "Complex",
      "id": "0dfffcea19edd86e93ffdb262beaf597",
      "members": [
        {
          "bel": "p(HGNC:HSPA8)",
          "concept": {
            "name": "HSPA8",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "1e0e1cda4e0ab830cc8bb12a7035a8b2"
        },
        {
          "bel": "p(HGNC:MAPT, pmod(Ph))",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "a8fb3a87d5a0672c07462bb17c8b0947",
          "variants": [
            {
              "concept": {
                "name": "Ph",
                "namespace": "bel"
              },
              "kind": "pmod"
            }
          ]
        },
        {
          "bel": "p(HGNC:STUB1)",
          "concept": {
            "name": "STUB1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "d87d73cafef28fc2c05ea70f059c61a4"
        },
        {
          "bel": "p(HGNC:UBE2D2)",
          "concept": {
            "name": "UBE2D2",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "46dd50f2bc5df8acf431131a4a884bf5"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:HSPB1), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "6af837d90d0e354d296de284f6f9a1b6",
      "members": [
        {
          "bel": "p(HGNC:HSPB1)",
          "concept": {
            "name": "HSPB1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "d5b5de04c466b9b3d8edde293c1f2a4f"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:HSPB1), p(HGNC:MAPT, pmod(CONSO:hyperphosphorylation)))",
      "function": "Complex",
      "id": "b7611f29f2df365f8fb1c0bf429382af",
      "members": [
        {
          "bel": "p(HGNC:HSPB1)",
          "concept": {
            "name": "HSPB1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "d5b5de04c466b9b3d8edde293c1f2a4f"
        },
        {
          "bel": "p(HGNC:MAPT, pmod(CONSO:hyperphosphorylation))",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "0d2d8072f03dcdf148e658067d37b9cb",
          "variants": [
            {
              "concept": {
                "name": "hyperphosphorylation",
                "namespace": "CONSO"
              },
              "kind": "pmod"
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:HSPB1), p(HGNC:MAPT, pmod(Ph)))",
      "function": "Complex",
      "id": "f3869b701442af9285dfbcb85863afea",
      "members": [
        {
          "bel": "p(HGNC:HSPB1)",
          "concept": {
            "name": "HSPB1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "d5b5de04c466b9b3d8edde293c1f2a4f"
        },
        {
          "bel": "p(HGNC:MAPT, pmod(Ph))",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "a8fb3a87d5a0672c07462bb17c8b0947",
          "variants": [
            {
              "concept": {
                "name": "Ph",
                "namespace": "bel"
              },
              "kind": "pmod"
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:MAPT), p(HGNC:PIK3R1))",
      "function": "Complex",
      "id": "3ad35c8895f30f854fd7c0ad34ba6b3a",
      "members": [
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        },
        {
          "bel": "p(HGNC:PIK3R1)",
          "concept": {
            "name": "PIK3R1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "3aee3b2c3f137d96d17459c56e459e14"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:MAPT), p(HGNC:PLCG1))",
      "function": "Complex",
      "id": "e320ebed43d7fb120d0308557a51e8af",
      "members": [
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        },
        {
          "bel": "p(HGNC:PLCG1)",
          "concept": {
            "name": "PLCG1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "41296d7c819e63f9765f532f34f02d17"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:MAPT), p(HGNC:PTGES3))",
      "function": "Complex",
      "id": "ba73cac57786d05d8dc8190a55de9143",
      "members": [
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        },
        {
          "bel": "p(HGNC:PTGES3)",
          "concept": {
            "name": "PTGES3",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "f3cf891b5455730db56f755ea78283ad"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:MAPT), p(HGNC:S100B))",
      "function": "Complex",
      "id": "8775dd493bd907a527c66253d57744a3",
      "members": [
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        },
        {
          "bel": "p(HGNC:S100B)",
          "concept": {
            "name": "S100B",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "0050ea3402c2d3fac775a7145be655f2"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:MAPT), p(HGNC:SRC))",
      "function": "Complex",
      "id": "e175cc795e5364e1984d0c0774a6b612",
      "members": [
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        },
        {
          "bel": "p(HGNC:SRC)",
          "concept": {
            "name": "SRC",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "5bbd95ea1b6e2166887017af0837608d"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:MAPT), p(INTERPRO:\"Heat shock protein 70 family\"))",
      "function": "Complex",
      "id": "688d291e259416afed21e2f669b53a6c",
      "members": [
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        },
        {
          "bel": "p(INTERPRO:\"Heat shock protein 70 family\")",
          "concept": {
            "name": "Heat shock protein 70 family",
            "namespace": "INTERPRO"
          },
          "function": "Protein",
          "id": "43387e6260ac862bb69d16380eb79e5f"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:MAPT, pmod(Ph)), p(HGNC:STUB1), p(HGNC:UBE2D2))",
      "function": "Complex",
      "id": "a61c41bab9e4f1e4b393df4897e20b89",
      "members": [
        {
          "bel": "p(HGNC:MAPT, pmod(Ph))",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "a8fb3a87d5a0672c07462bb17c8b0947",
          "variants": [
            {
              "concept": {
                "name": "Ph",
                "namespace": "bel"
              },
              "kind": "pmod"
            }
          ]
        },
        {
          "bel": "p(HGNC:STUB1)",
          "concept": {
            "name": "STUB1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "d87d73cafef28fc2c05ea70f059c61a4"
        },
        {
          "bel": "p(HGNC:UBE2D2)",
          "concept": {
            "name": "UBE2D2",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "46dd50f2bc5df8acf431131a4a884bf5"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:MAPT, pmod(Ph, Thr, 231)), p(HGNC:PIN1, frag(\"5_39\")))",
      "function": "Complex",
      "id": "3edd5f12f0fe01dc1f5f53264aad68ea",
      "members": [
        {
          "bel": "p(HGNC:MAPT, pmod(Ph, Thr, 231))",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "1b27e2cacb75475db2ede3bb5867066c",
          "variants": [
            {
              "code": "Thr",
              "concept": {
                "name": "Ph",
                "namespace": "bel"
              },
              "kind": "pmod",
              "pos": 231
            }
          ]
        },
        {
          "bel": "p(HGNC:PIN1, frag(\"5_39\"))",
          "concept": {
            "name": "PIN1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "704fd9d4bd7fe3a2c70c77f552342cb0",
          "variants": [
            {
              "kind": "frag",
              "start": 5,
              "stop": 39
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(p(MGI:Klc1), p(MGI:Mapk8ip1))",
      "function": "Complex",
      "id": "f8708d0ae5d024f162b4f4c7a09884db",
      "members": [
        {
          "bel": "p(MGI:Klc1)",
          "concept": {
            "name": "Klc1",
            "namespace": "MGI"
          },
          "function": "Protein",
          "id": "822129ba94c4effa1958f5854fd7bcdd"
        },
        {
          "bel": "p(MGI:Mapk8ip1)",
          "concept": {
            "name": "Mapk8ip1",
            "namespace": "MGI"
          },
          "function": "Protein",
          "id": "77e115d97420c06da91a96396dc8449d"
        }
      ]
    },
    {
      "bel": "complex(p(RGD:Fkbp4), p(RGD:Mapt, pmod(Ph)))",
      "function": "Complex",
      "id": "1e6cc586f19a4df2daa0fd8595ceeab1",
      "members": [
        {
          "bel": "p(RGD:Fkbp4)",
          "concept": {
            "name": "Fkbp4",
            "namespace": "RGD"
          },
          "function": "Protein",
          "id": "4ffe3896ae3c931feadfb03d39098ce0"
        },
        {
          "bel": "p(RGD:Mapt, pmod(Ph))",
          "concept": {
            "name": "Mapt",
            "namespace": "RGD"
          },
          "function": "Protein",
          "id": "425f888fe9213332cada133bddf1a147",
          "variants": [
            {
              "concept": {
                "name": "Ph",
                "namespace": "bel"
              },
              "kind": "pmod"
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(p(RGD:Klc1), p(RGD:Mapt))",
      "function": "Complex",
      "id": "c8bd44e552dabf6d844e200d9b5328c2",
      "members": [
        {
          "bel": "p(RGD:Klc1)",
          "concept": {
            "name": "Klc1",
            "namespace": "RGD"
          },
          "function": "Protein",
          "id": "61029db3ab65fe644c170e4d21a33ab3"
        },
        {
          "bel": "p(RGD:Mapt)",
          "concept": {
            "name": "Mapt",
            "namespace": "RGD"
          },
          "function": "Protein",
          "id": "4491a7c731b98f8c5496132c49032c21"
        }
      ]
    },
    {
      "bel": "complex(p(RGD:Klc2), p(RGD:Mapt))",
      "function": "Complex",
      "id": "3ca27536632cb90bc7138b66103ad9a3",
      "members": [
        {
          "bel": "p(RGD:Klc2)",
          "concept": {
            "name": "Klc2",
            "namespace": "RGD"
          },
          "function": "Protein",
          "id": "c250c95a6e68e85c803a902cdecf00d2"
        },
        {
          "bel": "p(RGD:Mapt)",
          "concept": {
            "name": "Mapt",
            "namespace": "RGD"
          },
          "function": "Protein",
          "id": "4491a7c731b98f8c5496132c49032c21"
        }
      ]
    },
    {
      "bel": "complex(p(RGD:Klc2), p(RGD:Snca))",
      "function": "Complex",
      "id": "23e040e2f2254b01da0e38ba02912c81",
      "members": [
        {
          "bel": "p(RGD:Klc2)",
          "concept": {
            "name": "Klc2",
            "namespace": "RGD"
          },
          "function": "Protein",
          "id": "c250c95a6e68e85c803a902cdecf00d2"
        },
        {
          "bel": "p(RGD:Snca)",
          "concept": {
            "name": "Snca",
            "namespace": "RGD"
          },
          "function": "Protein",
          "id": "30c5192f67126a5451389596bbf9b1c2"
        }
      ]
    },
    {
      "bel": "composite(p(HGNC:MAPT), p(HGNC:SNCA))",
      "function": "Composite",
      "id": "ac4ba8f65519b83cec31812dad4abf2b",
      "members": [
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        },
        {
          "bel": "p(HGNC:SNCA)",
          "concept": {
            "name": "SNCA",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "8cd39bc202ad944395c27f63d95f6908"
        }
      ]
    },
    {
      "bel": "g(DBSNP:rs104893877)",
      "concept": {
        "name": "rs104893877",
        "namespace": "DBSNP"
      },
      "function": "Gene",
      "id": "434879c93b78fb438815b4a5d81db9a4"
    },
    {
      "bel": "g(DBSNP:rs63750424)",
      "concept": {
        "name": "rs63750424",
        "namespace": "DBSNP"
      },
      "function": "Gene",
      "id": "64f219a632fb3ca26f053d5c8fc96b82"
    },
    {
      "bel": "p(CONSO:\"Tau fibrils\")",
      "concept": {
        "name": "Tau fibrils",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "0fa53bcd9e91fea7f61fb06070df8ff9"
    },
    {
      "bel": "p(CONSO:\"Tau isoform F (441 aa)\")",
      "concept": {
        "name": "Tau isoform F (441 aa)",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "83682de7856cc379117e146862b26202"
    },
    {
      "bel": "p(CONSO:\"Tau isoform F (441 aa)\", var(\"p.Arg406Tyr\"))",
      "concept": {
        "name": "Tau isoform F (441 aa)",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "861f24478dd8c22b3ee91e1a8ed9d2d8",
      "variants": [
        {
          "hgvs": "p.Arg406Tyr",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"Tau isoform F (441 aa)\", var(\"p.Val337Met\"))",
      "concept": {
        "name": "Tau isoform F (441 aa)",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "938ff749e98366a92cf8db0774e43f1a",
      "variants": [
        {
          "hgvs": "p.Val337Met",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"VQIVYK motif\")",
      "concept": {
        "name": "VQIVYK motif",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "9b38965d99870547034625d1cd83bcfb"
    },
    {
      "bel": "p(CONSO:\"alpha-synuclein fibrils\")",
      "concept": {
        "name": "alpha-synuclein fibrils",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "ac4d837bea56b4618a658554b8c62c01"
    },
    {
      "bel": "p(CONSO:\"microtubule-binding region\")",
      "concept": {
        "name": "microtubule-binding region",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "a37bfc324c697c5840d8d099152b779c"
    },
    {
      "bel": "p(CONSO:\"paired helical filaments\")",
      "concept": {
        "name": "paired helical filaments",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "0bb08a6e59ca5c7490738810a0985e9f"
    },
    {
      "bel": "p(CONSO:\"tubulin-binding repeat 2\")",
      "concept": {
        "name": "tubulin-binding repeat 2",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "3fefe19d502fb8290e352dda70335e0d"
    },
    {
      "bel": "p(CONSO:\"tubulin-binding repeat 4\")",
      "concept": {
        "name": "tubulin-binding repeat 4",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "dfc444411cb4239be72b4a08ac247d5a"
    },
    {
      "bel": "p(FPLX:\"CAMK2_family\")",
      "concept": {
        "name": "CAMK2_family",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "9cae2955b3bd01b1f8202ed046b79b34"
    },
    {
      "bel": "p(FPLX:\"Cytoplasmic_dynein\")",
      "concept": {
        "name": "Cytoplasmic_dynein",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "4212218ab7f74307689accb45382e8e9"
    },
    {
      "bel": "p(FPLX:CALM)",
      "concept": {
        "name": "CALM",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "722a364939ea93ba0730199474b6714c"
    },
    {
      "bel": "p(FPLX:HSP90)",
      "concept": {
        "name": "HSP90",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "1d25d355c41148f8c1322364b79179e4"
    },
    {
      "bel": "p(FPLX:JNK)",
      "concept": {
        "name": "JNK",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "652ceb8427d17b6e5e19d76428838c42"
    },
    {
      "bel": "p(FPLX:JNK, pmod(Ph))",
      "concept": {
        "name": "JNK",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "5e3485722c3530db9992e8351c158687",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(FPLX:Ubiquitin)",
      "concept": {
        "name": "Ubiquitin",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "f69f5ee9195e488e5a05d06e4b697423"
    },
    {
      "bel": "p(GO:\"neurofibrillary tangle\")",
      "concept": {
        "name": "neurofibrillary tangle",
        "namespace": "GO"
      },
      "function": "Protein",
      "id": "e14be0be65938f1a7188ef056472736d"
    },
    {
      "bel": "p(HGNC:AGER)",
      "concept": {
        "name": "AGER",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6438987a3f1a4ac86a4360bddbf0bc6a"
    },
    {
      "bel": "p(HGNC:AHSA1)",
      "concept": {
        "name": "AHSA1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "801b5a3d09f90703dda1464396c4924f"
    },
    {
      "bel": "p(HGNC:AKT1)",
      "concept": {
        "name": "AKT1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "2fe8184c6afa461574b1e1fba8b00dab"
    },
    {
      "bel": "p(HGNC:ANXA2)",
      "concept": {
        "name": "ANXA2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7a08a109c6b60fcf5a1048cb5ea526ef"
    },
    {
      "bel": "p(HGNC:BAG1)",
      "concept": {
        "name": "BAG1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e99a022dd6d96a105b9a599748e7cf66"
    },
    {
      "bel": "p(HGNC:CDC37)",
      "concept": {
        "name": "CDC37",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8ac61583b7b88b6635a828008797ef03"
    },
    {
      "bel": "p(HGNC:CDK1)",
      "concept": {
        "name": "CDK1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "dd8065837c4f267f62011d07d870f0a3"
    },
    {
      "bel": "p(HGNC:CDK5)",
      "concept": {
        "name": "CDK5",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cb1e1b28f1d3fe30db837d601f26fe1b"
    },
    {
      "bel": "p(HGNC:DCTN1)",
      "concept": {
        "name": "DCTN1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "dcf639e9ecb74332f35aad21be63c543"
    },
    {
      "bel": "p(HGNC:DKK1)",
      "concept": {
        "name": "DKK1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e636ff26ba1222aa06fe20e813b28fe0"
    },
    {
      "bel": "p(HGNC:FKBP4)",
      "concept": {
        "name": "FKBP4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a405d4c8f4ec34d763d011b0c73bd788"
    },
    {
      "bel": "p(HGNC:FKBP4, frag(\"270_386\"))",
      "concept": {
        "name": "FKBP4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "de03b6c7ab945a2fae88a50a847d74a7",
      "variants": [
        {
          "kind": "frag",
          "start": 270,
          "stop": 386
        }
      ]
    },
    {
      "bel": "p(HGNC:FKBP4, var(\"p.Phe130Ala\"))",
      "concept": {
        "name": "FKBP4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "2a9657280fc25f1bcdcca7168bb8b672",
      "variants": [
        {
          "hgvs": "p.Phe130Ala",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:FKBP5)",
      "concept": {
        "name": "FKBP5",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6cdfe5e08dbab001c43d1af3146cfb92"
    },
    {
      "bel": "p(HGNC:FKBP5, var(\"p.Phe130Ala\"))",
      "concept": {
        "name": "FKBP5",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3c4ed57d2e3b3a0c60285c71d5c3ae4d",
      "variants": [
        {
          "hgvs": "p.Phe130Ala",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:FYN)",
      "concept": {
        "name": "FYN",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "9aaa70667f9bfd5fd59c45422ea4c02c"
    },
    {
      "bel": "p(HGNC:GRB2)",
      "concept": {
        "name": "GRB2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "dac7b04df04d8a0bac1269d3918d2179"
    },
    {
      "bel": "p(HGNC:GRB2, frag(\"1_57\"))",
      "concept": {
        "name": "GRB2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cd2505445166212f7f61570f4b2a3b69",
      "variants": [
        {
          "kind": "frag",
          "start": 1,
          "stop": 57
        }
      ]
    },
    {
      "bel": "p(HGNC:GSK3B)",
      "concept": {
        "name": "GSK3B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8eaf29c9e491ff4e49619e77de92467c"
    },
    {
      "bel": "p(HGNC:GSK3B, pmod(Ph))",
      "concept": {
        "name": "GSK3B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "dde2bce5abacd48b29eb5a38a1c7ccbc",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:HSPA8)",
      "concept": {
        "name": "HSPA8",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "1e0e1cda4e0ab830cc8bb12a7035a8b2"
    },
    {
      "bel": "p(HGNC:HSPB1)",
      "concept": {
        "name": "HSPB1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d5b5de04c466b9b3d8edde293c1f2a4f"
    },
    {
      "bel": "p(HGNC:KIF5B)",
      "concept": {
        "name": "KIF5B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c20adf7ec828368e43bbc51fc21b8cdb"
    },
    {
      "bel": "p(HGNC:KLC1)",
      "concept": {
        "name": "KLC1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e9214aed9abf09228825bd71f923b54a"
    },
    {
      "bel": "p(HGNC:MAPK8IP1)",
      "concept": {
        "name": "MAPK8IP1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6e9d64b58fb2b2ab7092f3623b12f98b"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7d1009217050e75d549c8c5aa83309a8"
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"1_244\"))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6ec527cd08261f59191498185fae3eb8",
      "variants": [
        {
          "kind": "frag",
          "start": 1,
          "stop": 244
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"237_367\"))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a7673cc51f75a94756c23e4c83367f7a",
      "variants": [
        {
          "kind": "frag",
          "start": 237,
          "stop": 367
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"245_369\"))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0dfb2c8f62fece3393a7b6716d37c14c",
      "variants": [
        {
          "kind": "frag",
          "start": 245,
          "stop": 369
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"245_441\"))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cf655ea9d24e9d93345c2dceae22c4fe",
      "variants": [
        {
          "kind": "frag",
          "start": 245,
          "stop": 441
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(CONSO:hyperphosphorylation))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0d2d8072f03dcdf148e658067d37b9cb",
      "variants": [
        {
          "concept": {
            "name": "hyperphosphorylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a8fb3a87d5a0672c07462bb17c8b0947",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 199))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "50d3e0e9923f34d9daf851227f55dd1d",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 199
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 202))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cdcc3b3f116c5db02d04ca383584aef0",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 202
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 262))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "06b0d7203a7f93cbb663eab8b9b593ab",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 262
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 356))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5eb6d95220e92f14e6fd76a31f51dcd4",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 356
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 396))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d20659abb6d812839958a31e9d5d259b",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 396
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 404))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c0bfbdd9489341f82d82ce560ba52523",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 404
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Thr, 205))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "18a670a34dac41b169d64c4316bdf50c",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 205
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Thr, 212))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e0c94e8066a56a138256460ca89ac300",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 212
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Thr, 231))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "1b27e2cacb75475db2ede3bb5867066c",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 231
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ub))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "38f6219c585227877fcde64c8558359b",
      "variants": [
        {
          "concept": {
            "name": "Ub",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MARK2)",
      "concept": {
        "name": "MARK2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6e8b2d15698adf8fc72bb10d3a7e06b3"
    },
    {
      "bel": "p(HGNC:PIK3R1)",
      "concept": {
        "name": "PIK3R1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3aee3b2c3f137d96d17459c56e459e14"
    },
    {
      "bel": "p(HGNC:PIK3R1, frag(\"3_79\"))",
      "concept": {
        "name": "PIK3R1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f626d00803204004252ed149bf2a71a4",
      "variants": [
        {
          "kind": "frag",
          "start": 3,
          "stop": 79
        }
      ]
    },
    {
      "bel": "p(HGNC:PIN1)",
      "concept": {
        "name": "PIN1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "24383f5cd8a14dfb9bb692e0fb5f9d7b"
    },
    {
      "bel": "p(HGNC:PIN1, frag(\"5_39\"))",
      "concept": {
        "name": "PIN1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "704fd9d4bd7fe3a2c70c77f552342cb0",
      "variants": [
        {
          "kind": "frag",
          "start": 5,
          "stop": 39
        }
      ]
    },
    {
      "bel": "p(HGNC:PIN1, var(\"p.Tyr23Ala\"))",
      "concept": {
        "name": "PIN1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c66eb090341b53ad87dfa7de050a5b81",
      "variants": [
        {
          "hgvs": "p.Tyr23Ala",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:PLCG1)",
      "concept": {
        "name": "PLCG1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "41296d7c819e63f9765f532f34f02d17"
    },
    {
      "bel": "p(HGNC:PLCG1, frag(\"790_851\"))",
      "concept": {
        "name": "PLCG1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4d57e40f1d2e07295ccc027abad523be",
      "variants": [
        {
          "kind": "frag",
          "start": 790,
          "stop": 851
        }
      ]
    },
    {
      "bel": "p(HGNC:PPP2CA)",
      "concept": {
        "name": "PPP2CA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "2d92165ca8a0570584f2d8e79172e84a"
    },
    {
      "bel": "p(HGNC:PTGES3)",
      "concept": {
        "name": "PTGES3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f3cf891b5455730db56f755ea78283ad"
    },
    {
      "bel": "p(HGNC:S100B)",
      "concept": {
        "name": "S100B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0050ea3402c2d3fac775a7145be655f2"
    },
    {
      "bel": "p(HGNC:SNCA)",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8cd39bc202ad944395c27f63d95f6908"
    },
    {
      "bel": "p(HGNC:SRC)",
      "concept": {
        "name": "SRC",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5bbd95ea1b6e2166887017af0837608d"
    },
    {
      "bel": "p(HGNC:SRC, frag(\"84_145\"))",
      "concept": {
        "name": "SRC",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "391b71e8ec6eb330cfdd28e044c2e074",
      "variants": [
        {
          "kind": "frag",
          "start": 84,
          "stop": 145
        }
      ]
    },
    {
      "bel": "p(HGNC:STUB1)",
      "concept": {
        "name": "STUB1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d87d73cafef28fc2c05ea70f059c61a4"
    },
    {
      "bel": "p(HGNC:UBE2D2)",
      "concept": {
        "name": "UBE2D2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "46dd50f2bc5df8acf431131a4a884bf5"
    },
    {
      "bel": "p(HGNC:YWHAZ)",
      "concept": {
        "name": "YWHAZ",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "88c1928bf6a95391d84d1e6b3886fa67"
    },
    {
      "bel": "p(INTERPRO:\"Dynein associated protein\")",
      "concept": {
        "name": "Dynein associated protein",
        "namespace": "INTERPRO"
      },
      "function": "Protein",
      "id": "93db18fd30f5fd18ee7e1c9b53001f6d"
    },
    {
      "bel": "p(INTERPRO:\"GRB2, N-terminal SH3 domain\")",
      "concept": {
        "name": "GRB2, N-terminal SH3 domain",
        "namespace": "INTERPRO"
      },
      "function": "Protein",
      "id": "2680920af827e6975be3496099f92d0d"
    },
    {
      "bel": "p(INTERPRO:\"Heat shock protein 70 family\")",
      "concept": {
        "name": "Heat shock protein 70 family",
        "namespace": "INTERPRO"
      },
      "function": "Protein",
      "id": "43387e6260ac862bb69d16380eb79e5f"
    },
    {
      "bel": "p(INTERPRO:\"Heat shock protein 70kD, C-terminal domain superfamily\")",
      "concept": {
        "name": "Heat shock protein 70kD, C-terminal domain superfamily",
        "namespace": "INTERPRO"
      },
      "function": "Protein",
      "id": "c29a9eb5eb1353720eb59b3967f99ab0"
    },
    {
      "bel": "p(INTERPRO:\"Kinesin motor domain\")",
      "concept": {
        "name": "Kinesin motor domain",
        "namespace": "INTERPRO"
      },
      "function": "Protein",
      "id": "39cc9ada7d490cb0aef86ee5af0baf42"
    },
    {
      "bel": "p(INTERPRO:\"MAP2/Tau projection\")",
      "concept": {
        "name": "MAP2/Tau projection",
        "namespace": "INTERPRO"
      },
      "function": "Protein",
      "id": "26def4a3bbeceb7dcc3c1c81519ae047"
    },
    {
      "bel": "p(INTERPRO:\"Phosphatidylinositol 3-kinase regulatory subunit alpha, SH3 domain\")",
      "concept": {
        "name": "Phosphatidylinositol 3-kinase regulatory subunit alpha, SH3 domain",
        "namespace": "INTERPRO"
      },
      "function": "Protein",
      "id": "2fea6e8fbfba41f334bde05e23898a4b"
    },
    {
      "bel": "p(INTERPRO:\"SH3 domain\")",
      "concept": {
        "name": "SH3 domain",
        "namespace": "INTERPRO"
      },
      "function": "Protein",
      "id": "e37f4a1100ace70d5d6036db228f66c3"
    },
    {
      "bel": "p(MESH:\"beta Catenin\")",
      "concept": {
        "name": "beta Catenin",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "417aacef98bc3740021ad5a2aaa60281"
    },
    {
      "bel": "p(MGI:Fyn)",
      "concept": {
        "name": "Fyn",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "c324717c23d8e619ecc634f9a22a8bca"
    },
    {
      "bel": "p(MGI:Fyn, pmod(Palm))",
      "concept": {
        "name": "Fyn",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "50668985875367be700e8e51dc4473e1",
      "variants": [
        {
          "concept": {
            "name": "Palm",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Klc1)",
      "concept": {
        "name": "Klc1",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "822129ba94c4effa1958f5854fd7bcdd"
    },
    {
      "bel": "p(MGI:Mapk8ip1)",
      "concept": {
        "name": "Mapk8ip1",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "77e115d97420c06da91a96396dc8449d"
    },
    {
      "bel": "p(MGI:Mapt)",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "a179f3829d42c3522d517c5ab2fc5b67"
    },
    {
      "bel": "p(MGI:Mapt, pmod(CONSO:hyperphosphorylation))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "f949656a30c3fadb71b0c12f1af31027",
      "variants": [
        {
          "concept": {
            "name": "hyperphosphorylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(RGD:Fkbp4)",
      "concept": {
        "name": "Fkbp4",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "4ffe3896ae3c931feadfb03d39098ce0"
    },
    {
      "bel": "p(RGD:Klc1)",
      "concept": {
        "name": "Klc1",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "61029db3ab65fe644c170e4d21a33ab3"
    },
    {
      "bel": "p(RGD:Klc2)",
      "concept": {
        "name": "Klc2",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "c250c95a6e68e85c803a902cdecf00d2"
    },
    {
      "bel": "p(RGD:Mapt)",
      "concept": {
        "name": "Mapt",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "4491a7c731b98f8c5496132c49032c21"
    },
    {
      "bel": "p(RGD:Mapt, frag(\"223_226\"))",
      "concept": {
        "name": "Mapt",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "f625eff1b578b5e07fd8ea200b63ab9d",
      "variants": [
        {
          "kind": "frag",
          "start": 223,
          "stop": 226
        }
      ]
    },
    {
      "bel": "p(RGD:Mapt, pmod(Ph))",
      "concept": {
        "name": "Mapt",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "425f888fe9213332cada133bddf1a147",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(RGD:Snca)",
      "concept": {
        "name": "Snca",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "30c5192f67126a5451389596bbf9b1c2"
    },
    {
      "bel": "path(CONSO:Neurodegeneration)",
      "concept": {
        "name": "Neurodegeneration",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "e18248b0d7323caa29b448e45437a1e5"
    },
    {
      "bel": "path(MESH:\"Frontotemporal Dementia\")",
      "concept": {
        "name": "Frontotemporal Dementia",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "876d8dfbadfb211122e2ba889d763c19"
    },
    {
      "bel": "rxn(reactants(p(HGNC:MAPT, pmod(CONSO:hyperphosphorylation))), products(a(CHEBI:\"phosphate(3-)\"), p(HGNC:MAPT)))",
      "function": "Reaction",
      "id": "69b200385241ca48baeea89fc55dc097",
      "products": [
        {
          "bel": "a(CHEBI:\"phosphate(3-)\")",
          "concept": {
            "name": "phosphate(3-)",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "fb6fd08200f6469cca623b134c5ac56f"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ],
      "reactants": [
        {
          "bel": "p(HGNC:MAPT, pmod(CONSO:hyperphosphorylation))",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "0d2d8072f03dcdf148e658067d37b9cb",
          "variants": [
            {
              "concept": {
                "name": "hyperphosphorylation",
                "namespace": "CONSO"
              },
              "kind": "pmod"
            }
          ]
        }
      ]
    },
    {
      "bel": "rxn(reactants(p(HGNC:MAPT, pmod(Ph))), products(a(CHEBI:\"phosphate(3-)\"), p(HGNC:MAPT)))",
      "function": "Reaction",
      "id": "b84dcdab96f3460ce15abde37881b758",
      "products": [
        {
          "bel": "a(CHEBI:\"phosphate(3-)\")",
          "concept": {
            "name": "phosphate(3-)",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "fb6fd08200f6469cca623b134c5ac56f"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ],
      "reactants": [
        {
          "bel": "p(HGNC:MAPT, pmod(Ph))",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "a8fb3a87d5a0672c07462bb17c8b0947",
          "variants": [
            {
              "concept": {
                "name": "Ph",
                "namespace": "bel"
              },
              "kind": "pmod"
            }
          ]
        }
      ]
    }
  ]
}